13t* EDITION
EMERY'S
E FRcpcH FRcp, MB, chB, Peter D. Turnpenny, BSc, Consuttaht Ctinicat Geneticist RoyalDevonandExeterHospitat & Peninsula Medicat School SeniorCtinicat Lecturer. Exeter, UK
PhD, MRCPath Sian E[lard, BSc. Molecular Geneticist Consuttant Ctinicat RoyalDevonandExeterHospitat
& SchooI Medical Genetics, Peninsuta Professor of HumanMotecutar Exeter: UK
13t* EDITION
EMERY'S
AtanE.H.Emery Emeritus Professor of HumanGenetics & Honorary Fettow University of Edinburgh
Dedication - sources Toourfathers of encouragement andsupport whowoutdhavebeenproudofthiswork.
TheElements wasfirstpubtished in the UnitedStatesin 1968underthe titleHeredity,Diseose, ondManby the University of California Press. WhenProfessor Emeryreturned to theUKhepersuaded Churchitt Livingstone in Edinburgh to pubtish it underthetitleE/ernenfs of Medicol Genetics. Underhisauthorship it subsequentty evotved intomanyeditions, taterwithco-authorship of BobMuetter andthenlanYoung. lt seemsappropriate to commemorate this13theditionto hisindustry andto hiseffortsovermanyyearsto estabtish Ctinicat Genetics asa speciatity in its ownright.
Commissioning Edifor:KateDimock DevelopmentEditor:HeatherMcCorm ick Editori oI Assistont:KirstenLowson ProjectMonoger:GemmaLawson Designer:ErikBigtand IllustrotionMonoger:BruceHogarth /{lustrotor:Antbits Marketing Monogers(USA/UK).AtysonSherby/lanJordan
CHURCHILL LIVINGSTONE
British Library Cataloguing in Publication Data A cataloguerecord for this book is availablefrom the British Library
EISEVIER
An imprint of ElsevierLimited O Harcourt PublishersLtd , 200i @ ElsevierScienceLtd , 2002 O 2005,ElsevierLtd O 2007,ElsevierLimited All rights reserved First edition 1968 Secondedition 1971 Third edition 1974 Fourth edition 1975 Fifth edition 1979 Sixth edition 1983 Seventhedition 1988 Eighth edition 1992 Ninth edition 1995 Tenth edition 1998 Eleventhedition 2001 Twelfth edition 2005 This edition 2007 The rights of Peter Turnpenny and Sian Ellard to be identified as authors of this work has been assertedby them in accordancewith the Copyright, Desiqnsand PatentsAct 1988 No part of this publication may be reproduced, stored in a retrieval system,or transmitted in any form or by any means,electronic,mechanical, photocopying,recording or otherwise, without the prior permission of the PublishersPermissionsmay be soughtdirectly from Elsevier'sHealth SciencesRights Department, l600John E KennedyBoulevard,Suite 1800, Philadelphia,PA 19103-2899, USA: phone:(+1) 215 239 3804; fax: (+1) 215 239 3805;or, ermail:
[email protected]. You may also complete your request on-line via the Elsevier homepage (http://wwwelsevier com), by selecting'support and contact'and then 'Copyright and Permission'.
Library of Congress Cataloging in Publication Data A catalogrecord for this book is availablefrom the Library of Congress Notice Medical knowledgeis constantly changing. Standard safety precautions must be followed, but as new researchand clinical experiencebroaden our knowledge, changesin treatment and drug therapy may become necessary or appropriate Readersare advised to check the most current product information providedby the manufacturerof eachdrug to be administered to verify the recommendeddose,the methodand durationofadministration, and contraindicationsIt is the responsibilityof the practitioner,relying on experienceand knowledgeof the patient, to determine dosagesand the best treatmentfor eachindividual patient Neither the Publishernor the authors assumeany liability for any injury and/or damageto personsor property arisingfrom this publication The Publisher
www.elsevierheolth.com
'Working
togetherto grow librariesin developingcountries www.elsevier.com I www.bookaid.org I www.sabre.org
ISBN 978-0-7020-29 t7-Z
tv
Printedin China Last digit is the print number: 9 8 7 6 5 4 3 2 1
The publisheis policyis to use papermanulactured f rcmsustainable torests I I
TE
.. -,,. .t::i::::,r:
3, ,,,,,'"'
.ll,il'.,::;ll:',,""'":
Cettdivision40 43 Gametogenesis 45 Chromosomeabnormatities
Dedication ii Preface ix Acknowtedgementsx
SECTION
PRINCIPLES OF HUMANGENETICS T h e h i s t o r ya n d i m p a c to f g e n e t i c si n m e d i c i n e GregoM r e n d eal n dt h e l a w so f i n h e r i t a n c e3 DNAas the basisof inheritance 5 The fruit fty 6 T h e o r i g i n so f m e d i c agl e n e t i c s 7 T h ei m p a co t f g e n e t i cd i s e a s e 9 Majornew developments 9 T h e c e [ [ u t a ra n d m o l e c u l a rb a s i so f i n h e r i t a n c e 12 The cetl 12 y aterial 12 D N A : t h eh e r e d i t a rm C h r o m o s o m e s t r u c t u r1 e4 T y p e s o f D N A s e q u e n c1e4 Transcriotion 18 Translation 18 T h eg e n e t i c o d e 2 0 R e g u l a t i oonf g e n ee x p r e s s i o n 2 0 DNAsynthesis 22 RNA-directed Mutations 22 M u t a t i o nas n d m u t a g e n e s i s2 6
andce[[division 30 Chromosomes 30 Humanchromosomes analysis 5 Z Methods ofchromosome 34 Motecularcytogenetics 38 Chromosomenomenclature
andapptications55 DNAtechnotogy 55 DNActoning of DNAanatysis59 Techniques of DNAtechnotogy70 hazards Biotogicat genesfor monogenic andidentifying Mapping disorders 73 of humandisease identification Position-independent genes 73 74 Positionatctoning Project 75 TheHumanGenome 82 Developmentalgenetics andgastrutation82 Fertitization genefamities 83 DevelopmentaI model 93 Thetimbasa developmental genesandcancer 94 DevetopmentaI genes 95 anddevetopmentaI effects Positionat motes 96 Hydatidiform anddetermination96 differentiation SexuaI anddevetopment98 Epigenetics Twinning101 Patternsof inheritance 103 studies 103 Famity 103 inheritance Mendetian traits 113 andcomptex attetes Muttipte Anticipation114 Mosaicism114 disomy 115 UniparentaI imprinting115 Genomic 120 Mitochondriatinheritance genetics 122 andpoputation Mathematicat in populations122 Attelefrequencies 128 Geneticpotymorphism 129 Segregationanatysis [inkage 130 Genetic
CONTENTS
M e d i c aat n ds o c i e t ai In t e r v e n t i o n1 3 3 Conctusion 134 9
P o t y g e n i ca n d m u t t i f a c t o r i aiIn h e r i t a n c e 1 3 6 P o l y g e n iicn h e r i t a n caen dt h e n o r m a Id i s t r i b u u o n t J o - the tiabitity/threshotd MuttifactoriaI inheritance mode[ 138 Heritabitity 139 ldentifyinggenesthat causemultifactoriaI disorders 140 Conctusion 143
SECTION
GENETICS IN MEDICINE 1 0 H e m o g t o b i na n d t h e h e m o g l o b i n o p a t h i e s1 4 7 Structureof hemoglobin 147 DevelopmentaI expression of hemogl.obin 147 Gtobinchainstructure 148 Synthesisand controlof hemogtobin expression 149 D i s o r d e ros f h e m o g t o b i n 1 5 0 C t i n i c a t v a r i a t ioofnt h e h e m o g t o b i n o p a t h i e1s5 6 B i o c h e m i c a l g e n e t i c s1 5 8 I n b o r ne r r o r so f m e t a b o l i s m 1 5 8 D i s o r d e r os f a m i n o - a c i d metabotism158 D i s o r d e ros f b r a n c h e d - c h aai nm i n o - a c i d metabotism 163 Ureacycledisorders 153 Disordersof carbohydrate metabotism 164 Disordersof steroidmetabotism 165 Disordersof tipidmetabotism 167 LysosomaI storagedisorders 168 Disordersofpurine/pyrimidine metabolism 171 Disordersof porphyrinmetabolism 171 0 r g a n i c - a c iddi s o r d e r s 1 7 2 Disordersof coppermetabotism 172 P e r o x i s o m a I d i s o r d e r1s7 3 D i s o r d e r s a f f e c t im n gi t o c h o n d r i a t f u n c t i o1n7 4 Prenataldiagnosisof inbornerrorsof metabolism 1i6
12 P h a r m a c o g e n e t i c s1 7 7 Definition 177 Drug metabotism 177 Geneticvariationsreveatedsotetyby the effectof drugs 178 VI
F h a r m a c o g e n e t i c 1s 8 . licogenetics 182
13 fmmunogenetics184 lrnmunity 184 I r r n a t iem m u n i t y 1 8 4 c cquired Sp e c i f i a immunity 185 l r r h e r i t eidm m u n o d e f i c i e ndcivs o r d e r s 1 9 0 Eloodgroups 192
1 1 Cancergenetics 196 Differentiation betweenqeneticand environmentaI f.rctorsin cancer 196 0ncogenes 198 Trmor suppressorgenes 201 E p i g e n e t i casn dc a n c e r 2 0 5 G e n e t i cosf c o m m o nc a n c e r s 2 0 7 G e n e t i c o u n s e t i nign f a m i t i act a n c e r 2 1 2
1 5 Geneticfactors in common diseases 219 Geneticsusceptibitity to commondisease 219 Diabetesmeltitus 221 C- o h nd i s e a s e 2 2 4 Hypertension 225 Crrronary arterydisease 225 E p i l e o s i e s2 2 7 Artism 228 S,:hizophrenia228 A z h e i m e rd i s e a s e 2 2 9 H:mochromatosis 23O Vrrnousthrombosis 231 A t o p i cd i s e a s e 2 3 2 A r ; e - r e t a t em d a c u t a r d e g e n e r a t i o 2n 3 2
sECTION
CLINICAL GENETICS 16 C on g e n i t a Ia b n o r m a l i t i e sa n d d y s m o r p h i c syndromes 237 l n < : i d e n c e2 3 7 Definitionand classification of birthdefects 238 Geneticcausesof matformations 243 EnvironmentaI agents(teratogens) 2/+8 M:rtformations of unknowncause 251 Counsetino 252
17 Geneticcounseling 253 Definition 253 Estabtishing the diagnosis 253 Catcutating and presentingthe risk 254 the options 255 Discussing Communication and support 255 - directiveor non-directive? 256 Geneticcounseting 0 u t c o m e si n g e n e t i c o u n s e t i n g2 5 6 S p e c i apl r o b l e m si n g e n e t i c o u n s e l i n g 2 5 7
1 8 Chromosomedisorders 261 l n c i d e n coef c h r o m o s o maeb n o r m a t i t i e s2 6 1 Disordersof the sex chromosomes 271 C h r o m o s o mdei s o r d e r as n db e h a v i o r a I phenotypes 275 Disordersof sexuaIdifferentiation2]5 C h r o m o s o m a t b r e a k asgyen d r o m e s 2 7 7 l n d i c a t i o nf so r c h r o m o s o m aaIn a l v s i s 2 7 9
1 9 Singte-genedisorders 282 Huntingtondisease 282 Myotonicdystrophy 284 Hereditarymotorand sensoryneuropathy 286 Neurofibromatosis287 Marfansyndrome 289 Cysticfibrosrs 291 I n h e r i t e cd a r d i a a c r r h y t h m i aasn d c a r d i o m y o p a t h i e 2s 9 4 S p i n am I u s c u t aar t r o p h y 2 9 6 Duchennemuscutardystrophy 297 Hemoohitia 299 2 0 S c r e e n i n gf o r g e n e t i cd i s e a s e 3 0 3 S c r e e n i ntgh o s ea t h i g hr i s k 3 0 3 andX-tinked Carriertestingfor autosomaIrecessive disorders 303 P r e s y m p t o m a tdi ci a g n o s iosf a u t o s o m adto m i n a n t disorders 305 in carrierdetectionand predictive Ethicatconsiderations testing 308 P o p u t a t i o n s c r e e n i n3g0 8 Criteriafor a screeningprogram 309 N e o n a t asIc r e e n i n g 3 1 0 Populationcarrierscreening 311 Geneticregisters 313
genetics 315 21 PrenataItestingandreproductive diagnosis315 usedin prenataI Techniques screening318 PrenataI 321 lndicationsforprenatatdiagnosis prenatal 323 diagnosis probtems in Speciat pregnancy 325 of Termination genetic diagnosis325 Preimptantation forgenetic imptications and conception Assisted 326 disease circulation328 offetatcetlsin thematernaI Detection 328 treatment PrenataI
22 Riskcalculation 330 theory 330 Probabitity 331 Autosomatdominantinheritance 333 AutosomaIrecessiveinheritance inheritance334 recessive Sex-tinked Theuseof tinkedmarkers 336 screening337 andprenatal Bayes'theorem risks 337 Emoiric
23 Treatmentof geneticdisease 340 of genetic to treatment approaches ConventionaI disease340 DNA of recombinant appLications Therapeutic technotogy342 Genetherapy 342 24 Ethicatandtegatissuesin medicalgenetics 354 principtes354 GeneraI 356 Ethicatditemmas in a widercontext 359 dilemmas Ethicat 362 Conclusion Appendix- Websitesandctinicatdatabases 354 Gtossary 366 questions 378 Muttipte-choice 390 Case-basedquestions answers 395 Muttipte-choice answers 407 Case-based lndex 413
vll
EFA
A man ought to read.just as inclination lead.shirn; for what he read.s as a task will d,ohim little good.' Dr SamuelJohnson Advances and breakthroughs in genetic science are continually in the news, attracting great interest because of the potential, not only for diagnosing and eventually treating disease,but also for what we learn about humankind through these advances.In addition, almost every new breakthrough raises a fresh ethical, social and moral debate about the uses to which genetic science will be put, particularly in reproductive medicine and issues relating to identity and privacy. Increasingly today's medical graduates must be equipped to integrate genetic knowledge and
doctors and scientists seeking to equip themselves with enough medical genetics to know the basics well, there have to be some limits - in order that the wood is not obscured by the trees. At the same time, however, we have tried to provide sufficient detail for those wanting a little more, for example in the area of epigenetics and imprinting. As before, we have sought to provide a comprehensive basic text for those who seeka work ofreference through which they can swim in calm waters, rather than one in whose rapids they will quickly drown. We continue to be grateful to our predecessors in this work, namely Bob Mueller, Ian Young and Alan Emery to whom we are indebted. In this edition we acknowledge and celebrate Alan's colossal contribution to this well established book, and medical genetics in general, by
scienceappropriately into all areasofmedicine in order to deliver a dimension of practice and patient care that has hitherto largely been the domain of a small breed of specialists. In this 13th edition of Emery's Elementsof Med,ical Genetics we have provided some much needed updates from the l2th
including a portrait in the frontispiece. We hope this text proves to be a friendly companion both for those who require familiarity with medical genetics and for those who wish to make it their career, as similar texts once did for us.
edition and are conscious that there is so much more that could be included. However, for those undergraduate and postgraduate
PeterD. Turnpennyand SianEllard October2006
Exeter,UK
ACKN
For this edition more of our patients were approached for consent to publish their pictures for the first time and we are grateful for their universal willingness, especially those whose pictures have not made it into print this time. Several new fetal ultrasonographic images have been included and we are grateful
to Dr Helen Liversedge for these.Peter Turnpenny is again gratefulto DebbieBristowfor secretarialhelp,and we rhankour colleagues and familiesfor putting up with papersscatteredover deskand floorspaceboth at work and at homewhile the updating wasunder way.
CHAPTER
Thehistoryandimpact in medicine ofgenetics
'It's just a little trick, but there is a long story connectedwith it which it would take too long to tell.' Gregor Mendel, in conversation with C W Eichling 'It has not escapedour notice that the specificpairing we havepostulatedimmediately suggestsa possiblecopying mechanism for the geneticmaterial.' Watson & Crick (April 1953) Presentinghistorical truth is at leastaschallengingasthe pursuit of scientilictruth and our view of human endeavorsdown the ages is heavily biasedin favor of winners - those who haveconquered on military, political or, indeed, scientific battlefields. The history of geneticsin relation to medicine is one of breathtaking discovery from which patients and families already benefit hugely, but in today's world successwill be measured by continuing progressin the treatment and prevention of disease.
and has become an important and integral component of the undergraduatemedical curriculum. In order to put the exciting developmentand growth of genetic scienceinto context we start with a brief overview of some of the most notable milestones in the history of medical genetics. The importance of understanding its role in medicine is then illustrated by reviewing the overall impact of genetic factors in causingdisease.Finally, new developmentsof mafor importance are discussed. It is not known precisely when Homo sapiensfirst appearedon this planet, but according to current scientilic consensusit may havebeen anything from 50 000 to 200 000 yearsago.It is reasonable to supposethat our first thinking ancestorswere as curious as we are about matters of inheritance and, iust as today, they would have experiencedthe birth of babieswith all manner of physical defects.Engravings in Chaldea in Babylonia (now lraq) dating back at least 6000yearsshow pedigreesdocumenting the transmission of certain characteristicsof the horse's mane. However, any early attempts to unravel the mysteries of geneticswould have
G R E G OM R E N D EA L N DT H EL A W S O FI N H E R I T A N C E EARLY BEGINNINGS Developments in genetics during the twentieth century have beentruly spectacularIn 1900Mendel's principles were awaiting rediscovery,chromosomeswere barely visible, and the science of molecular geneticsdid not exist. By contrast, at the time of writing in the year 2006, chromosomescan be analyzedto a very high level of sophisticationand the sequenceof the entire human genome has been published. Nearly 11000 human genes with known sequenceare listed and nearly 6000 genetic diseasesor phenotypeshave been described,of which the molecular genetic basisis known in some 2200. This revolution in scientific knowledgeand expertisehas led to the realizationthat geneticsis an areaof major importance in almost every medical discipline. Recent discoveriesimpinge not iust on rare genetic diseasesand syndromes,but also on many 'acquired' of the common disorders of adult life that may be predisposedby genetic variation, such as cardiovasculardisease, psychiatric illness and cancer. Consequently genetics is now widely accepted as being at the forefront of medical science
been severelyhampered by a total lack ofknowledge and understandingofbasic processessuch as conceptionand reproduction. Early Greek philosophers and physicians such asAristotle and Hippocrates concluded, with typical masculine modesty, that important human characteristics were determined by semen' utilizing menstrual blood as a culture medium and the uterus as an incubator. Semen was thought to be produced by the whole body; hence bald-headedfathers would beget bald-headedsons. These ideasprevaileduntil the seventeenthcentury,when Dutch scientists such as Leeuwenhoek and de Graaf recognized the existenceofsperm and ova,thus explaininghow the femalecould also transmit characteristicsto her offspring. The blossomingof the scientific revolution in the eighteenth and nineteenth centuries saw a revival of interest in heredity by both scientistsand physicians,among whom two particular names stand out Pierre de Maupertuis, a French naturalist' studied hereditary traits such as extra digits (polydactyly) and lack of pigmentation (albinism), and showed from pedigree studies that these two conditions were inherited in different ways. JosephAdams (175G1818), a British doctor, alsorecognizedthat different mechanisms of inheritance existed and published I Treutiseon the Su\plsetl Heretlitary Prlperties of Diseases,whrch was intended as a basisfor geneticcounseling.
1
T H EH I S T O R Y A N I MDP A COTFG E N E T I CI N SM E D I C I N E
Our present understanding of human genetics owes much to the u'ork of the Austrian monk Gregor Mendel (1822-1884; Fig. Ll) who, in 1865, presentedthe results of his breeding experiments on garden peas to the Natural History Society of Briinn in Bohemia (now Brno in the Czech Republic) Shortly afterwards Mendel's observations were published by this associationin the Transactions of the Society, where they remained largely unnoticed until 1900, some l6years after his death, when their importance was first recognized. In essence Mendel's work can be consideredas the discovery of genesand how they are inherited. The term'gene'was first coined in 1909 by a Danish botanist, Johannsen,and was derived from the term 'pangen' introduced by De Vries This term was itself a derivative of the word 'pangenesis',coined by Darwin in 1868. In acknowledgementof Mendel's enormous contribution, the term mendeliaz is now applied both to the different patterns of inheritanceshown by single-genecharacteristicsand to disorders found to be the result of defectsin a single gene. In his breeding experiments Mendel studied contrasting charactersin the garden pea, using for eachexperiment varieties that differed in only one characteristic.For example, he noted that when strains that were bred for a feature such as tallness were crossed with plants bred to be short all of the offspring in the firsty'/ial or F7 generation were tall. If plants in this F1 generationwere interbred, this led to both tall and short plants in a ratio of three to one (Fig. 1.2). Characteristics that were manifest in the Fl hybrids were referred to as tlominant,whereas those that reappearedin the F2 generation were described as betng recessiae. On reanalysisit has been suggestedthat Mendel's results were'too good to be true', in that the segregationratios
Firstfilial cross Purebred Tall
F1
Tt
Purebred Short
x Tt
Tt
Tt
Tall
Secondfilial cross
Hybrid Tall
Hvbrid
iarl
X
Tt
f2' TT
Tt
1.ll
tT
JJ,
Fis.1.2 An rLlustration ofoneof Mendelsbreeding experiments andhow he cnrrectlv internreted theresults
he derived were suspiciouslycloser to the value of 3:1 than the laws of statisticswould predict. One possibleexplanationis that he may have published only those results that best agreed with his preconceivedsingle-genehypothesis.Whatever the truth of the matter, eventshaveshown that Mendel's interpretation of his results was entirely correct. Mendel's proposal was that the plant characteristics being studied were each controlled by a pair of factors, one of which was inherited from each parent The pure-bred plants, with two identical genes,used in the initial cross would now be referred to as hrmlzlgous. The hybrid F1 plants, each of which has one gene for tallness and one for shortness,would be referred to as heterozygous. The genesresponsiblefor these contrasting characteristics are referred to as allelomorphs,or alleles for short. An alternativemethod for determining genrqlpesin offspring involvesthe construction of what is known as a Punnett's square (Fig. 1 3). This is utilized further in Chapter 7 when considering how genessegregatein large populations. On the basis of Mendel's plant experiments, three main principles were established.These are known as the laws of uniformity, segregationand independent assortment
T H EL A WO FU N I F O R M I T Y The lan oJ'uniformityreferstothe fact that when two homozygotes with different allelesare crossed,all of the offspring in the Fl generation are identical and heterozygous.In other words, the
Fi9.1.1 (Reproduced Gregor Mendel withpermission fromBMJBooks )
characteristicsdo not blend, as had beenbelievedpreviously,and can reappearin later generations.
IN MEDICINE IN4PACT OFGENETICS THEHISTORYAND
Hybrid Tall
E o
Fig.1.3 A Punnett's square showing thedifferent waysinwhichgenes c a ns e g r e g aat en dc o m b i nient h es e c o nfdr l r a l c r ofsr so mF i g1 2 Consiruction ofa Punneit's squareprovides a simplemethodfor [ ea m e t ceo m b i n a t i ornnd s h o w r ntgh ep o s s i b g s r f f e r em n ta t r n g s
TH EL A WO FSE GR E GA T ION The law of segregationrefersto the observationthat eachindividual possessestwo genes for a particular characteristic,only one of which can be transmitted at any one time Rare exceptions to this rule can occur when two allelic genesfail to separatebecause of chromosome non-disjunction at the lirst meiotic division
(p.as).
in 1902 that Walter Sutton, an American medical student, and Theodour Boveri, a German biologist, independently proposed that chromosomes could be the bearers of heredity ( F i g . 1 . 4 ) . S u b s e q u e n t l y ,T h o m a s M o r g a n t r a n s f o r m e d Sutton's chromosome theory into the theory of the gene, and Alfons Janssensobserved the formation of chiasmata between homologouschromosomesat meiosis.During the late 1920sand 1930sCyril Darlington began to emerge as the world's leading cytologist of his time, helping to clarify chromosomemechanics by the use of tulips collected on expeditions to Persia. It was 'genome' entered the scientific during the 1920sthat the term 'genom'(German for gene) and vocabulary, being the fusion of 'ome'from chromosome the connection between mendelian inheritance and When chromosomes was first made, it was thought that the normal chromosome number in humans might be 48, although various papers had come up with a range of figures. The figure of 48 was settled upon largely as a result of a paper in 1921 from Theophilus Painter, an American cytologist who had been a student of Boveri. In fact, Painter himself had some preparations clearly showing 46 chromosomes,even though he finally settled on 48. These discrepancieswere probably due to the poor quality of the material at that early stage of the science, and even into the early 1950s cytologists were counting 48 chromosomes.It was not until 1956that the correct number of 46 was established by Tjio and Levan, 3years after the correct structure of DNA had been proposed.Within a few years it was shown that some disorders in humans could be causedby loss or gain of a whole chromosome as well as by an abnormality in a single gene' Chromosome disorders are discussedat length in Chapter 18. Some chromosomeabnormalities,such astranslocations'can run in families (p.47), and are sometimessaid to be segregatingin a
mendelian fashion. T H EL A WO FI N D E P E N D E N T A S S O R T M E NT The larp of independentassortmentrefers to the fact that members of different genepairs segregateto offspring independentlyof one another.In reality, this is not alwaystrue, as genesthat are close together on the samechromosometend to be inherited together, 'linked' (p. becausethey are 130). There are a number of other rvaysby which the laws of mendelian inheritance are breached but, overall, they remain foundational to our understanding of the science.
T H EC H R O M O S O MBAAL S I S O FI N H E R I T A N C E As interest in mendelian inheritance Breq there was much speculation as to how it actually occurred. At that time it was also known that each cell contains a nucleus within which
D N A A ST H EB A S I SO FI N H E R I T A N C E Whilst JamesWatson and Francis Crick are justifiably credited with discovering the structure of DNA in 1953, they were attracted to working on it only becauseofits key role asthe genetic material, as establishedin the 1940s.Formerly many believed that hereditary characteristics were transmitted by proteins, until it was appreciatedthat their molecular structure was far too cumbersome.Nucleic acids were in fact discoveredin 1849. In 1928 Fred Griffith, working on two strains of steptoclccus, reahzedthat characteristicsof one strain could be conferred on the other by something that he called the transformingprinciple'
In 1944, at the Rockefeller Institute in New York, Oswald Avery, there are several thread-like structures known as chromosomes, Maclyn McCarty and Colin Macleod identified DNA as the Even then, genetic material whilst working on the Pneumocoraas. so called becauseof their affinity for certain statns(chroma= coIor, many in the scientific community were skeptical;DNA was only slma=body). These chromosomeshad been observed since a simple molecule with lots of repetition of four nucleic acids the second half of the nineteenth century as a result of - very boring! The genius of Watson and Crick, at Cambridge, the development of cl,tologic staining techniques. Human was to hit on a structure for DNA that would explain the very mitotic hgures were observed from the late 1880s,and it was
1
1
THE HISTORYANDIMPACTOFGENETICSIN MEDICINE
B
Fis.1.4 C h r o m o s o mdeisv i d i ni g n t ot w o daughter cettsatdifferent stagesof ceLL d i v i s i oAn,m e t a p h a sBe,:a n a p h a s e : C t e l n n h a s eT h c h e h a v i o r o f
c h r o m o s o m iensc e l d [ i v i s i o(nm i t o s i s ) i sd e s c r i b eadtt e n g t ihn C h a p t e3r (Photographs courtesy of Dr K Ocraft, CityHospitat. Nottingham )
essenceof biological reproduction, and their elegant double helix has stood the test of time. Crucial to their discovery was the X-ray crystallographywork of Maurice Wilkins and Rosalind Franklin at King's College,London. The relationship between the sequenceof basesin DNA and the sequence of amino acids in protein - the geneticcnde- w^s unravelledin someelegantbiochemicalexperimentsin the 1960s. Thus it becamepossibleto predict the basechangein DNA that led to the amino-acid change in the protein. However, direct confirmation of that prediction had to wait until DNA sequencing methods becameavailableafter the advent of recombinant DNA techniques. Interestingly; however, the first genetic trait to be characterizedat the molecular level had already been identified in 1957by laborioussequencingof the purified proteins.This was sickle-cell anemia,in which the mutation affectsthe amino-acid sequenceof the blood protein hemoglobin.
THEFRUIT FLY Before returning to historical developmentsin human genetics, it is worth a brief diversion to consider the merits of this unlikely creature, which has proved to be ofgreat value in genetic research. The fruit fly, Drosophila, possessesseveral distinct advantagesfor the study of genetics: l. It can be bred easilyin a laboratory. 2. It reproducesrapidly and prolifically at a rate of 20 to 25 generatlonsper annum. 3. It has a number ofeasily recognizedcharacteristics,such as curly wings and,ayellom body,thtt follow mendelian inheritance. 4. Drosophilamelanogaster, the speciesstudied most frequently, has only four pairs of chromosomes,eachof which has a distinct appearanceso that they can be identified easily.
IN MEDICINE IMPACT OFGENETICS THEHISTORYAND
5. The chromosomes in the salivar-vglands of Drosophila larvaeare among the largest known in nature, being at least 100 times bigger than those in other body'cells.
Increasingly,it is becoming clear that the interplay of different genes(polygenic inheritance) is important in disease,and that a somatic genetic disease- should also further category- acquired, be included.
In view ofthese unique properties,fruit flieswereusedextensivelv in earlv breeding experiments.Today their study is still proving of great value in fields such as developmental biology where knowledgeof genehomolog-vthroughout the animal kingdom has enabledscientiststo identify families of genesthat are important in human embryogenesis(Ch. 6). When considering major scientific achievementsin the history of genetics it is notable that sequencingof the 180 million basepairs of the Drosophila genomewas completed towards the end of 1999. melunogaster
T H EO R I G I NO S FM E D I C AG L ENETICS In addition to the afore-mentioned Pierre de Maupertuis and JosephAdams, whose curiosity was aroused by polydact-vlyand albinism, there rvere other pioneers John Dalton, of atomic theorv fame, observed that some conditions, notably color blindness and hemophilia, show what is now referred to as sexor X-linked inheritance, and to this day color blindness is still occasionallvreferred to as daltonism. Inevitably,these founders of human and medical geneticscould only speculateon the nature of hereditary mechanisms In 1900 Mendel's work resurfaced.His papers were quoted
S I N G L E . G E NDEI S O R D E R S In addition to alkaptonuria,Garrod suggestedthat albinism and cvstinuria could also show recessiveinheritance. Soon other examples followed, leading to an explosion in knowledge and diseasedelineation. By 1966 almost 1500 single-genedisorders or traits had been identified, prompting the publication by an American physician, Victor McKusick (Fig. 1.5), of a catalog of all known single-gene conditions. By 1998, when the l2th edition of this catalog was published, it contained more than 'McKusick's Catalog' has 8500 entries (Fig. 1.6).The growth of now accessiblevia the internet as Online beenexponentialand it is MentlelianInheritancein Man (OMIM) (seeAppendix). By mid2006 OMIM containeda total of 16808 entries.
EM ABNORMALITIES CHROMOSO Improved techniques for studying chromosomes led to the demonstrationin 1959that the presenceof an additional number 2l chromosome (trisomy21) results in Down syndrome. Other similar discoveries followed rapidly - Klinefelter and Turner syndromes - also in 1959. The identification of chromosome abnormalitieswas further aided by the developmentof banding
almost simultaneouslyby three European botanists De Vries (Holland), Correns (Germany) and Von Tschermak (Austria) and this marked the real beginning of medical genetics,providing an enormous impetus for the study of inherited disease Credit for the first recognition of a single-genetrait is sharedby William Bateson and Archibald Garrod, rvho together proposed that alkaptonuriawasa rare recessivedisorder.In this relativelybenign condition urine turns dark on standing or on exposureto alkali becauseof the patient'sinability to metabolizehomogentisicacid (p. 162). Young children show skin discoloration in the napkin (diaper) area and affected adults may develop arthritis in large joints Realizing that this was an inherited disorder involving a chemical process, Garrod coined the term inborn error of metabolismin 1908 However, his work was largely ignored until the mid-trventieth centurl', when the advent of electrophoresis and chromatography revolutionized biochemistry. Several hundred such disorders have now been identified, giving rise to the field of study known as biochemical Benetics(Ch. l1). The historl' of alkaptonuria neatly straddles almost the entire trventieth centurli, starting with Garrod's original observations of recessiveinheritancein 1902and culminating in cloning of the relevantgeneon chromosome3 in 1996. During the course of the twentieth centur]' it gradually became clear that hereditary factors ryere implicated in many conditions and that different geneticmechanismswere involved. Traditionallli hereditary conditions havebeen consideredunder the headings of singlegene, chromosomaland multifactorial.
Fis.1.5 havebeenso andcatalogs whosestudies VictorMcKusicktn1994. r - p o ' r a ntto m e d i c agle n e t i c s
1
THE HISTORYANDIMPACTOFGENETICSIN MEDICINE
11000 10000 o 9000 c 8000 7000 6000 c 5000 4000 E 3000 = z. 2000 1000 0'a '68 1966
include congenitalmalformationssuch ascleft lip and palate,and Iate-onsetconditions such ashypertension,diabetesmellitus and Alzheimer disease.The prevailing view is that genesat several loci interact to generate a susceptibility to the effects of adverse environmental trigger factors. Recent researchhas confirmed that many genesare involved in most of these adult-onset disorders, although progress in identifying specific susceptibility loci has
'71
',7s ',78
'83 '86'88'90'92'94 '97 2003 Year
been disappointingly slow. It has also emerged that in some conditions, such as type I diabetes mellitus, different genes can exert major or minor effects in determining susceptibility (p. 219). Overall, multifactorial or polygenic conditions are now known to make a major contribution to chronic illness in adult life (Ch. 15).
Fis.1.5 Histogramshowingthe rapidincreaseIn recognition of conditions (traits)showing sing [e-gene inheritance and characteristics ( A d a p t e fdr o m M c K u s i c k 1 9 9a8n d 0 M l [ / - s e e A p p e n d i x )
A C Q U I R ESDO M A T IG C E N E T ID CI S E A S E Not all geneticerrors are presentfrom conception.Many billions of cell divisions (mitoses)occur in the course of an average
techniquesin 1970(p. 32).These enabledreliableidentificationof individual chromosomesand helped confirm that loss or gain of
human lifetime. During each mitosis there is an opportunity for both single-genemutations to occur, becauseof DNA copy errors, and for numerical chromosome abnormalities to arise
even a very small segmentof a chromosomecan havedevastating effectson human development(Ch. l8). Most recently it has been shown that severalrare conditions featuring learning difliculties and abnormal physical features
as a result of errors in chromosome separation.Accumulating somatic mutations and chromosome abnormalities are now known to play a major role in causing cancer (Ch. l4), and they probably alsoexplain the rising incidencewith ageof many other
are due to loss of such a tiny amount of chromosome material that no abnormality can be detected using even the most highpowered light microscope. These conditions are referred to
seriousillnesses,as well as the aging processitself. It is therefore necessaryto appreciatethat not all diseasewith a geneticbasisis hereditary.
as microdeletion syndromes (p. 264) and are diagnosed using a technique known as FISH (fluoresc€ntin,situ hybridization), which combines conventional chromosome analysis(cytogenetics) with much newer DNA diagnostic technology (moleculargenetics) (p. 3a). Increasingly, in the future, it is likely that rhe new technique of microarray CGH (comparatittegenomichybridization) will play a large part in diagnosingtheseconditions (p 37).
Before considering the impact of hereditary diseaseit is necessaryto introduce a few definitions.
Incidence Incid.encerefers to the rate at which new casesoccur. Thus, if the birth incidenceof a particular condition equalsI in 1000, then on average I in every 1000 newborn infants is affected
M U L TFI AC T OR IADLIS OR D E R S Francis Galton, a cousin of CharlesDarwin, had a long-standing interest in human characteristicssuch as stature, physique and intelligence. Much of his research was based on the study of identical twins, in whom it was realized that differencesin these parametersmust be largely the result of environmental influences. Galton introduced to genetics the concept of the regression cofficient as a means of estimating the degree of resemblance between various relatives.This concept was later extended to incorporate Mendel's discovery of genes,to try to explain how parameterssuch as height and skin color could be determined by the interaction of many genes,each exerting a small additive effect. This is in contrast to single-genecharacteristicsin which the action ofone geneis exertedindependently,in a non-additive fashion. This model of quantitatiaeinheritanceis now widely accepted and has been adapted to explain the pattern of inheritance observedfor many relatively common conditions (Ch. 9). These
Prevalence This refers to the proportion of a population affected at any one time. The prevalenceof a genetic diseaseis usually less than its birth incidence, either because life expectancy is reduced or becausethe condition sholvsa delayedageof onset.
Frequency Frequencyis a general term that lacks scientific specificity although the word is often taken as being synonymous with incidence when calculatinggene 'frequencies'(Ch. 8).
Congenital Congenitalmeansthat a condition is present at birth Thus, cleft palate representsan example of a congenital malformation. Not all genetic disordersare congenital in terms of age of onset (e.g.
INMEDICINE IMPACT OFGENETICS THEHISTORYAND
Huntington disease),nor are all congenitalabnormalitiesgenetic in origin (e.9.fetal disruptions, as discussedin Ch. l6).
T H EI M PA C T OFGE N E T IC D IS E A S E During the twentieth century improvements in all areas of medicine, most notably public health and therapeutics,resulted in changing patterns of disease,with increasing recognition of the role of genetic factors in causing illness at all ages.For some parameters,such as perinatal mortality, the actual numbers of caseswith exclusively genetic causeshave probably remained constant but their relatiae contribution to overall figures has increasedas other causes,such as infection, have declined. For other conditions, such as the chronic diseasesof adult life, the overall contribution of genetics has almost certainly increased as greater life expectancy has provided more opportunity for adversegeneticand environmental interaction to manifest itself, for examplein coronary heart diseaseand diabetesmellitus. Consider the impact of genetic factors in diseaseat different agesfrom the follouing observations.
Spontaneous miscarriages A chromosome abnormality is present in 40-50o/o of all recognizedfirst-trimester pregnancyloss.Approximately I in 6 of all pregnanciesresults in spontaneousmiscarriage,thus around 5-7oloof all recognizedconceptionsare chromosomallyabnormal (p. 261). This value would be much higher if unrecognized pregnanciescould alsobe included, and it is likely that a significant proportion of miscarriageswith normal chromosomesdo in fact havecltastrophicsubmicroscopic geneticerrors.
Newborninfants Of all neonates, 2-3olo have at least one major congenital abnormalitl', of which at least 50o/oare caused exclusively or partially by genetic factors (Ch. l6). The incidences of chromosomeabnormalitiesand single-genedisordersin neonates are approximately I in 200 and I in 100, respectively.
Chitdhood Genetic disorders account for 50o/oof all childhood blindness, 50o/oof all childhood deafnessand 50o/oof all casesof severe learning difficulty. In developed countries genetic disorders and congenital malformations together also account for 30o/oof all childhood hospital admissionsand 40-50o/oof all childhood deaths.
Adutt tife Approximately 1oloof all malignancy is caused by single-gene inheritance, and between 5oloand l0o/o of common cancers such
as those of the breast, colon and ovary have a strong hereditary component. By the age of 25years, 5oloof the population will have a disorder in which genetic factors play an important role. Thking into account the genetic contribution to cancer and cardiovasculardiseases,such as coronary artery occlusion and hypertension, it has been estimated that more than 50o/oof the older adult population in developed countries will have a geneticallydetermined medical problem.
NEWDEVELOPMENTS MAJOR The study of geneticsand its role in causing human diseaseis now widely acknowledgedas being among the most exciting and influential areasof medical research.Since 1962 when Francis Crick, JamesWatson and Maurice Wilkins gained acclaim for their elucidation of the structure of DNA, the Nobel Prize for Medicine and/or Physiology has been won on 19 occasionsby scientists working in human and molecular genetics or related frelds (Thble Ll). These pioneering studies have spawned a thriving molecular technology industry with applications as diverse as crops' the dcvelopment of geneticallymodilied disease-resistant produce therapeutic to animals the use of geneticallyengineered drugs, and the possible introduction of DNA-based vaccines for conditions such as malaria. Pharmaceutical companies are investing heavily in the DNA-based pharmacogenomics - drug therapy tailored to personalgeneticmake-up.
ER O J E C T T H EH U M A NG E N O M P With DNA technology rapidly progressing,a group of visionary scientists in the USA persuaded Congress in 1988 to fund a coordinated international program to sequencethe entire human genome.The program would run from 1990to 2005 and 3 billion US dollars were initially allocatedto the project. Some 5oloof the budget was allocatedto study the ethical and socialimplications of the new knowledge, in recognition of the enormous potential to influence public health policies, screening programs and personal choice. The proiect was likened to the Apollo moon mission in terms of its complexity, although in practical terms the long-term benefits are likely to be much more tangible. The draft DNA sequenceof 3 billion basepairs was completed successfully in 2000 and the complete sequence was published ahead of schedule in October 2004. Before the closing stages of the project it was believed that there might be approximately 100000 coding genesthat provide the blueprint for human life. It has come as a surprise to many that the number is much lower, with current estimatesat between 25000 and 30000. However, many genes have the capacity to perform multiple functions, which in some casesis challenging traditional concepts of disease classilication. The immediate benefits of the sequence data are being realized in researchthat is leading to better diagnosisand counseling for families with a genetic disease.A number of large, long-term, population-based studies are under way in the wake of
1
1
THE HISTORYANDIMPACTOFGENETICSIN MEDICINE
Table1.1 Genetic discoveries thathaveledto the awardof the NobelPrizefor Medicine and/orPhysiotogy 1962-2006 Year
Prize-winners
Discovery
1962
FrancisCrick JamesWatson Maurice Wrtkins
Themotecuiar srrucrure of DNA
1965
FrangoisJacob Jacques Monod And16Lwoff
Genetic regulatron
1966
PeytonRous
Oncogenic viruses
1968
RobertHotley Gobind Khorana Marshatt Nireberg
Deciphering ofthegenetic code
DavidBattimore Renato Dutbecco HowardTemrn
Interaction between tumor vtruses anonuctear DNA
1978
WernerArber Daniet Nathans Hamrlton Smith
Restrictron endonucteases
l9EU
BarulBenacerraf JeanDausset George Sne[[
Genetic controtof immunologrc responses
1983
Barbara McClrntock
genes Mobite (transposons)
1985
MichaelBrown JosephGoldstein
Cel[receptors in famrtiat hypercholesterotemia
1987
SusumuTonegawa
Genetic aspects oI antibodies
1989
Michaet Bishop Harotd Varmus
Studyofoncogenes
T H EI N T E R N E T
1993
Rrchard Roberts Phittip Sharp
Sp[itgenes'
The availability of information in genetics has been enhanced greatly by the developmentof severalexcellentonline databases,
1995
EdwardLewis Homeotrc andother ChristianeNusstein-Volhard devetopmentatgenes EricWreschaus
1915
In the longer term an improved understanding of how genes are expressed will hopefully lead to the development of new strategiesfor the prevention and treatment of both single-gene and polygenic disorders. Rapid DNA sequencing technologies currently under development will in due course greatly extend the range and ease of genetic testing, although many such applicationshaveimportant ethical and socialimplications.
1997
Stantey Prusrner
Prions
1999
GiinterBtobel
Proteintransportsignating
2000
ArvidCarlsson Pau[Greengard EricKandel
Signattransductron Inthe nervoussystem
2001
LelandHartwett Timothy Hunt PauINurse
Regulators ofthece[[cycte
2002
SydneyBrenner RobertHorritz JohnSutston
Genetrc regulation rn development and programmed cettdeath (apoptosrs)
AndrewFrre CraigMetto
RNAinterference
2006
10
the successfulHuman Genome Project, including, for example, UK Biobank, which aims to recruit 500000 individuals aged 40-69 to study the progressionof common disease,lifestyle and geneticsusceptibility.
THERAPY GENE Most genetic diseaseis resistant to conventional treatment so that the prospect ofsuccessfully modifying the genetic code in a patient's cells is extremely attractive. Despite major investment and extensiveresearch,successin humans has so far been limited to a few very rare immunologic disorders. For more common conditions, such as cystic fibrosis, maior problems have been encountered, such as targeting the correct cell populations, overcoming the body's natural defensebarriers and identifying suitably non-immunogenic vectors. However, the availability of mouse models for genetic disorders, such as cystic fibrosis (p. 291), Huntington disease(p. 282) and Duchenne muscular dystrophy (p.297), has greatly enhancedresearchopportuniries, particularly in unraveling the cell biology ofthese conditions. In recent yearsthere has been increasing optimism for novel drug therapiesand stem cell treatment (p.347), besidesthe prospects for gene therapy itself(Ch. 342).
a selectionof which is listed in the Appendix. These are updated r e g u l a r l y a n d p r o v i d e i n s t a n t a c c e s st o a v a s t a m o u n t o f contemporary information. For the basicscientist,facilities such asthe Genome Databaseand GenBank enablerapid determination ofwhether a particular genehas beencloned,togetherwith details ofits sequence,location and pattern ofexpression. For the clinician, OMIM offers a full account of the important genetic aspectsof all mendelian disorders,together with pertinent clinical details and extensivereferences.Although it is unlikely that more traditional sourcesof information, such as this textbook, will becometotally obsolete,it is clearthat only electronic technology can hope to match the explosivepaceof developmentsin all areasof genetic research.
FURTHER READING Baird P A, AndersonT W, NewcombeH B, Lowry R B 1988Geneticdisorders in childrenandyoungaduls:a populationstudy.AmJ HumGenet4Z:677493 A comprehennxe studyofthe incidenceofgeneticdiseasein a large Western urbanpopulation
1 Dunham I, Shimizu N, Roe B A et al 1999The DNA sequenceof human chromosome22. Nature,[02: 489495 Thefr* reportofthe completesequencing of a humanchromosome. Emery A E H 1989Portraits in medical genetics-Joseph Adams 175G1818.J Med Genet 26: I 16-l l8 An accountof the life of a Londond,octorwho rnaderemarkableobsentations about hereditary diseasein hispatients. Garrod A E 1902The incidence of alkaptonuria: a study in chemical individuality. Lancet ii: 1916-1920 A landmarhpaper in phich Garrod,proposed. that alhaptonuriacouldshow mendelianinheritance and aho noted that 'the mating offirst cousinsgiaes exactly the conditionsnost likelJ to enablea rare, and usually recessiue, characterto showitself'. McKusickV A 1998Mendelian inheritance in man, I I th edn. Johns Hopkins University Press,Baltimore An exhaustioethree-tsolutne catalogof all knoon contlitionsail traits shooing mend.elian in herit ance. Online Mendelian Inheritance in Man, OMIMru. Johns Hopkins University, Baltimore. Online. Available:http://www3.ncbi.nlm.nih. gov/omim/ Regularfu updated,online ztersionofmendelian inheitance in man. OrelV 1995Gregor Mendel: the first geneticist.Oxford University Press, Oxford A detailed biography of the ffi and oorh of the Moratsian monk Dho Das describedby his abbot as heing 'zteryd.iligentin the study ofthe sciencesbut muchlessfittedforwork as a parishpriest'. Ouellette F 1999Internet resourcesfor the clinical geneticist.Clin Genet 56:179-185 A guide to how to accesssomeof the mostuseful online d,atabases. Shapiro R 1991The human blueprint: the race to unlock the secretsofour genetic script. St Martin's Press,New York WatsonJ 1968The double helix. Atheneum, New York The storlr of the discoaeryrof the stucture of DNA, through the eyesof Watson himself.
manifest in a hybrid (heterozygote) @ A "hrr..teristic is dominant. A recessive characteristic is expressed only in an individual with two copies of the gene (i.e. a homozygote). @ Mendel proposed that each individual has two genes for each characteristic: one is inherited from each parent and one is transmitted to each child. Genes at different loci act and segregateindependently. @ Chto-orome separation at cell division facilitates gene segregation. @ Genetic disorders are present in at least 2o/o of all neonates, account for 50o/oof childhood blindness, deafness,learning difficulties and deaths, and affect 5oloof the population by the age of 25 years. @ Molecular genetics is at the forefront of medical research. The Human Genome Project and the prospect of gene therapy represent maior new initiatives that will revolutionize the management and treatment of genetic diseases.
11
CHAPTER
Thece[[ular andmolecutar basis of inheritance
'There
is nothing, Sir, too little for so little a creatureas man It is by studying little things that we attain the great arr of having as little misery and as much happinessas possible.'
in the degradation and disposal of cellular waste material and toxic molecules.
SarnuelJohnson The hereditary material is present in the nucleus of the cell, whereas protein synthesis takes place in the cvtoplasm. What is the chain of events that leads from the gene to the linal product? This chapter covers basic cellular biology outlining the structure of DNA, the processof DNA replication, the tvpes of DNA sequences,gene structure, the genetic code, the processes of transcription and translation, the various types of mutations, mutagenicagentsand DNA repair
T H EC E L L Within each cell of the body, visible with the light microscope, is the c.ytoplasmand a darkly staining body, the nur;leus,the latter containing the hereditary material in the form of chromosomes (Fig. 2.1). The phospholipid bilayer of the plasma membrane protects the interior of the cell but remains selectivelypermeable and has integral proteins involved in recognition and signaling between cells. The nucleus has a darkly staining area, the nucleolusThe nucleus is surrounded by a membrane, the nuclear enaelope,which separatesit from the cvtoplasm but still allows communication through nuclearpores The cytoplasm contains the cytosol, which is semifluid in consistency;containing both soluble elements and cytoskeletal structural elements.In addition, in the cytoplasm there is a complex arrangement of very fine, highly convoluted, interconnecting channels,the endoplasmic reticulum.The endoplasmicreticulum, in associationwith the ribosomes, is involved in the biosynthesisof proteins and lipids. Also situated within the cytoplasm are other
12
even more minute cellular organellesthat can be visualizedonly with an electron microscope.These include the Golgi appararus, which is responsiblefor the secretion of cellular products, the mitochondria,which are involved in energy production through the oxidative phosphorylation metabolic pathways(p.226), and the peroxisomes(p. 173) and lysosomes, both of which are involved
DNA:THEHEREDITARY MATERIAL c0MP0stil0N Nucleic acid is composed of a long polymer of individual molecules cilled nucleotides.Each nucleotide is composed of a nitrogenous base, a sugar molecule and a phosphate molecule. The nitrogenous basesfall into two types, 1,1rinesandp.yrimid,ines. The purines include adenine and guanine; the pyrimidines include cytosine,thymine and uracil. There are two different types of nucleic acid, ribonucleic arll (RNA), which contains the five carbon sugar ribose, and deoxyribonuclercacid (DNA), in which the hydroxyl group at the 2' position ofthe ribose sugar is replaced by a hydrogen (i.e. an oxygen molecule is lost, hence 'deoxy'). DNA and RNA both contain the purine basesadenineand guanineand the pyrimidine cytosine, but thymine occurs only in DNA and uracil is found only in RNA. RNA is present in the cytoplasm and in particularly high concentrations in the nucleolus of the nucleus. DNA. on the other hand, is found mainly in the chromosomes.
STRUCTURE For genesto be composedof DNA it is necessarythat the latter should have a structure sufficiently versatile to account for the great variety of different genesand yet, at the sametime, be able to reproduce itself in such a manner that an identical replica is formed at each cell division. In 1953, Watson and Crick, based on X-ray diffraction studies bv themselves and others, proposed a structure for the DNA molecule that fulfilled all the essentialrequirements.They suggestedthat the DNA molecule is composed of two chains of nucleotidesarranged in a double helix. The backboneof each chain is formed by phosphodiester bonds between the 3' and 5' carbons of adjacent sugars,the two chains being held together by hydrogen bonds between the nitrogenousbases,rvhich point in towardsthe center of the helix.
2 Golgicomplex Smooth endoplasmic reticulum Chromatin Rough endoplasmic reticulum Ribosomes Nucleolus Lysosome
EachDNA chainhasa polarity determinedby the orientationof The chainendterminatedby the backbone. the sugar-phosphate 5' carbonatomof the sugarmoleculeis referredto asthe 5' end, andthe endterminatedby the 3' carbonatomis calledthe 3'end. In the DNA duplex the 5' end of one strand is oppositethe 3' end ofthe other,that is, they haveoppositeorientationsand are saidto be antiparallel. The arrangementof the basesin the DNA moleculeis not random.A purine in one chainalwayspairswith a pyrimidine in the other chain,with specificpairing ofthe basepairs: guanine in one chain alwayspairs with cytosinein the other chain, and adeninealwayspairs with thymine, so that this basepairing forms complementarystrands(Fig.2.2). For their work Watson and Crick, alongwith MauriceWilkins, wereawardedthe Nobel Prize for Medicineor Physiologyin 1962(p. 9).
Nucleus Centriole
Fig.2.1 Diagrammatic representation ofan animalcett.
REPLICATION The process of DNA replica'tiln provides an answer to the question of how genetic information is transmitted from one generation to the next. During nuclear division the two strands
3 -hydoxyl
Flg.2.2
thymine: adenine:T, hetix(P phosphate:A. pairing oftheDNAdoubLe DNAdoubtehelixA,Sugar-phosphate backbone andnucteotide hetix G,guanine; C,cytosine). B,Representation oftheDNAdoubLe
13
2
THECELLULARAND MOLECULAR BASISOFINHERITANCE
of the DNA double helix separatethrough the action of enzyme DNA helicase,each DNA strand direcing rhe synrhesis of a complementary DNA strand through specific base pairing, resulting in two daughter DNA duplexes that are identical to the original parent molecule. In this way, when cells divide, the genetic information is conservedand transmitted unchanged to each daughter cell. The process of DNA replication is termed semiconseraatiue, as only one strand of each resultant daughter molecule is newly synthesized. DNA replication, through the action of the enzyme DNA polymerase, takes place at multiple points known as origins of replitation, forming bifurcated Y-shaped structures known as replicationforks.The synthesisof both complementary antiparallel DNA strandsoccurs in the 5'to 3' direction. One strand, known as the leatling strand, is synthesized as a continuous process.The other strand, known as the laggingstranl, is synthesized in pieces called Okazaki fragments, which are then joined together as a continuous strand by the enzyme DNA ligase(Fig'.2.3A). DNA replication progressesin both directions from these points of origin, forming bubble-shaped structures, or replicationbubbles(Fig. 2.38). Neighboring replicarion origins are approximately 50-300kilobases (kb) apart and occur in clustersor replicationunitsof 20 to 80 origins of replication.DNA replication in individual replication units takesplace at different times in the S phaseofthe cell cycle (p. 4l), adfacentreplication units fusing until all the DNA is copied, forming rwo complete identical daushter molecules.
C H R O M O S OSMTER U C T U R E The idea that eachchromosomeis composedof a singleDNA double helix is an oversimplification.A chromosomeis very much wider than the diameterof a DNA doublehelix. In addition, the amount of DNA in the nucleus of each cell in humans means that the total length of DNA contained in the chromosomes,if fully extended, would be several meters long! In fact, the total length of the human chromosomecomplement is lessthan half a millimeter. The packaging of DNA into chromosomes involves several orders of DNA coiling and folding. In addition to the primary coiling of the DNA double helix, there is secondarycoiling around spherical histone 'bead,s', forming what are called nucleosomes. There is a tertiary coiling of the nucleosomesto form the chromatinfbers that form long loops on a scaffoldof non-histone acidic proteins, which are further wound in a tight coil to make up the chromosome as visualized under the light microscope (Fig. 2.4), the whole structure making up the so-calledsolenoid model of chromosomestructure.
TYPES OFDNASEOUENCE DNA, if denatured, will reassociateas a duplex at a rate that is dependent on the proportion of unique and repeat sequences
;l:i-iivr'!rii.L.:i:l::i*,{;,,L-__./r.,t*,,-.*+\;ft..J,-."rt,
New strands
Old strands
Fis.2.3 14
DNArepticatron A,Detarted diagram of DNArepLication atthesiteof origininthereplication forkshowing asymmetrrc strandsynthesis withthecontinuous synthesis oftheleading strandandthedisconiinuous synthesis oftheLagging strandwithtigation oftheOkazaki fragmentsB,Muttrpte pointsoforiginandsemiconservative modeof DNArepticatron
BASISOFINHERITANCE THE CELLULARANDMOLECULAR
D N Ad o u b l e helix
Nucleosomes
Chromatin fi ber
Extended section of chromosome
Loopsof c h r o m a t i nf i b e r
2
M e t ap h a s e cnromosome
Fis.2.4 Simptifie dd iagram o fp r o p o s esdo L e n om i do d eoLfD N Ac o i t i ntgh a tl e a d st ot h ev i s r b tset r u c t u roeft h ec h r o m o s o m e
present,the latter occurring more rapidly.Analysis of the results of the kinetics of the reassociationof human DNA have shown that approximately 60-700lo of the human genomeconsists of single or low copy number DNA sequences.The remainder of the genome, some 30-40o/o,consistsof either moderately or highly repetitiaeDNA sequencesthat are not transcribed. This latter portion consistsof mainly satelliteDNA and interspersedDNA (Box 2.1). sequences
N U C L E AG RE N E S It is estimatedthat there are between 25000 and 30000 genesin the nuclear genome.The distribution of these genesvaries greatly between chromosomal regions. For example, heterochromatic and centromeric (p 35) regions are mostly non-coding' with the highest gene density observedin sub-telomeric regions (p. 36). Chromosomes 19 and 22 are gene rich, whereas 4 and 18 are relatively genepoor. The size of genesalso shows great variability: from small geneswith single exons to geneswith up to 79 exons (e.g.dystrophin, which occupies2 5 Mb of the genome).
Box2.1 Typesof DNAsequence
Uniquesingle-copygenes
Nuctear(-3x lOebp) (-30000) Genes
Most human genes are unique single-copy genes coding for polypeptidesthat are involved in or carry out a variety of cellular functions. These include enzymes, hormones, receptors, and structural and regulatory proteins.
Ll n r n r a < r n n l o r n n r r
famities Muitigene l^la<
Genesuperfamities Extragenic DNA(unique/lowcopynumberor moderate/ highly repetitive) Tandem repeat Satettite M n satetlite Tetomeric Hyperva riabte Mrcrosatetlite Inrersperse0 Sho.r.ntcrsnersed n.rrlearetements I nrn rn'er
(15.6kb,37 genes) Mitochondria[ TworRNAgenes 22tRNAgenes
Muttigenefamilies Man-v genes have similar functions, having arisen through gene duplication eventswith subsequentevolutionary divergencemaking up what are knownasmubigenefamilies.Some are found physically close together in clusters,for example the cx- and B-globin gene clusterson chromosomesl6 and l1 (Fig. 2.5), whereasothers are widely dispersedthroughout the genomeoccurring on different chromosomes,such as the HOXhomeobox genefamily (p. 86). Multigene families can be split into two types, classicgene fumilies that show a high degree of sequence homology and genesupeffimiliesthat have limited sequencehomology but are functionally related,having similar structural domains
15
THE CELLULAR AND MOLECULAR B A S I SO F I N H E R I T A N C E
--3
C h r o m o s o m1e6
j
C h r o m o s o m1e1
Fi1.2.5 Representation oftheq,-andB-globn regions on chTomosomes 1 6a n d ' l ' l
of introns in various genes in humans are extremely variable, although there is a general trend that the larger the gene, the greater the number and size ofthe exons.Individual introns can be far larger than the coding sequencesand some have been found to contain coding sequencesfor other genes(i.e. genesoccurring within genes).Genes in humans do not usually overlap, being separatedfrom each other by an averageof 30 kb, although some of the genesin the HLA complex (p. 189) have been shown to be overlapping.
Pseudogenes ClassicAenefamilies Examples of classic gene families include the numerous copies of genes coding for the various ribosomal RNAs, which are clustered as tandem arravs at the nucleolar organizing regions on the short arms of the five acrocentric chromosomes(p. 3l), and the different transfer RNA (p. l8) gene families, which are dispersedin numerous clusters throughout the human genome
Particularly fascinating is the occurrence of genes that closely resembleknown structural genesbut which, in general, are not functionally expressed:so-calledpseudogenes (p. 149). These are thought to have arisen in two main ways: either by genes undergoing duplication events that are rendered silent through the acquisition of mutations in coding or regulatory elements,or as the result of the insertion of complementaryDNA sequences, produced bv the action of the enzyme ret)ersetransrriptaseon a naturally occurring messengerRNA transcript, that lack the promoter sequencesnecessaryfor expression
Genesuperfamilies Examples of gene superfamilies include the HLA (human leukocyte antigen) genes on chromosome 6 (p. 189) and the T:cell receptor genes,which have structural homology with
EXTRAGENIC DNA
the immunoglobulin (Ig) genes(p. 185). It is believed that these are almost certainly derived from duplication of a precursor gene, with subsequentevolutionarv divergence forming the Ig
The estimated 25000 to 30000 unique single-copy genes in humans representlessthan 2o/oof the genomeencodingproteins. The remainder of the human genome is made up of repetitive
superfamily.
DNA sequencesthat are predominantly transcriptionally inactive. It has been described asjunk DNA, but some regions show evolutionary conservationand may play a role in the regulation of geneexpression.
Genestructure The original concept of a geneas a continuous sequenceof DNA coding for a protein rvasturned on its head in the early 1980sby detailed analysisof the structure of the human B-globin gene It was revealedthat the gene was much longer than necessaryto code for the B-globin protein, containing non-coding intervening sequences, or introns, that separatethe coding sequencesor exons (Fig. 2.6). It appearsto be the exceprionfor genesin humans ro consistof uninterrupted coding sequences. The number and size
TandemlyrepeatedDNAsequences Thndemlyrepeated, DNA sequences consist of blocks of tandem repeatsof non-coding DNA that can be either highly dispersed or restricted in their location in the genome.Thndemly repeated DNA sequencescan be divided into three subgroups: satellite, minisatelliteand microsarelliteDNA.
Transcription
Transcription termination
CAATTATAiniti'tion
o?" b?* C
a
lt
Promoter r e gr on
3
I
Intron1
I
T r an s l a t i o n i ni t i a t i o n codon
IATG)
Fis.2.6 16
Representation ofa typicat humanstructuratgene
Intron2
A
II
A
II Translation Polyadenylation termination signal co00n
ITAA)
BASISOFINHERITANCE N/OLECULAR THECELLULARAND
SotelliteDNA Satellite DNI accounts for approximately 10-l5o/o of the repetitive DNA sequencesof the human genome and consists of very large seriesof simple or moderately complex, short, tandeml.v repeated DNA sequencesthat are transcriptionally inactive and are clustered around the centromeres of certain chromosomes.This class of DNA sequencescan be separated on density-gradientcentrifugation as a shoulder,or'satellite', to the main peak of genomic DNA, and has thereforebeen referred to as satelliteDNA.
Minisotellite DNA
repetitiveDNA Hightyrepeatedinterspersed sequences Approximatel-vone-third of the human genome is made up of two main classesof short and long repetitive DNA sequences that are interspersedthroughout the genome.
Short i nterspe rsed nucleor eIem e nts About 5oloof the human genome consists of some 750000 copies of short interspersednuclear elementsor S/ly'Es. The most common are DNA sequencesof approximately 300bp that har.e sequence similarity to a signal recognition particle involved in protein synthesis.They are called Alu
consists of two families of tandemlr. repeated short DNA sequences:telomeric and hypervariable m i n i s a t e l l i t e D N A s e q u e n c e st h a t a r e t r a n s c r i p t i o n a l l . v lnactlve
rel)eutsbecause they contain tn AluI restriction enzyme recognitton site.
Telorneric DNA The terminal portion of the telomeres of the chromosomes (p 31) contains 10-15kb of tandem repeatsof a 6-base pair (bp) DNA sequencc known as telomericDNA. The tclomeric
About 5o/crof the DNA of the human genome is made up of long interspersednuclear elementsor LINEs. The most commonly occurring LINE, known as LINE-I or an L1 element, consists of morc than 100000copiesof a DNA sequenceof up to 6000bp
repeat scquencesare necessarvfor chromosomalintegrity in replication and are added to the chromosome by a specialized enzyme known as telomerase(p. 31)
that cncodesa re\ ersetranscriptase. The function of these interspersed repeat sequencesis not clear at present Members of the Alu repeat family are f l a n k e d b y s h o r t d i r e c t r e p e a t s e q u e n c e sa n d t h e r e f o r e resemble unstable DNA sequencescalled transposable Transposons, originally identified in elements or transp0s0ns.
tl/linisutellite DNI
Hypervariable rninisatellite DNA H l p e r L ^ a r i a b l em i n i s a t e l l l r e D N A i s m a d e u p o f h i g h l y ' polymorphic DNA sequencesconsistingof short tandem repeats of a common core sequence,the highly variable number of repeat units in different hypervariable minisatellites forming the basisof DNA hngerprinting used in forensic and paternity testing (p. 69). Although often located near the telomeres, hl,pervariableminisatellite DNA alsooccurs at other locationsin the chromosomes.
MicrosotelliteDNA Microsatellite DNA consists of tandem single, di-, tria n d t e t r a - n u c l e o t i d e r e p e a t b a s e - p a i r s e q u e n c e sl o c a t e d throughout the genome. Microsatellite repeats rarell'' occur within coding sequencesbut trinucleotide repeats in or near genes are associatedwith certain inherited disorders (p.62). DNA microsatellites are highly polymorphic (p. 69), i.e. the number of CA repeats varies between persons, and can be used in linkage studies in gene mapping (p 74) This variation in repeat number is thought to arise by incorrect pairing of the tandem repeats of the two complementary DNA strands during DNA replication, or what is known as slippetl strand mispairing. Duplications or deletions of longer sequencesof tandemly repeated DNA are thought to arise through unequal cross-over of non-allelic DNA sequenceson chromatids of homologous chromosomes or sister chromatids (p.31).
2
Long i nterspersed nucleor elem e nts
maize by Barbara McClintock (p. 10), move spontaneously throughout the genome from one chromosome location to another and appear to be ubiquitous in the plant and animal kingdoms. It is postulated that Alu repeats could promote unequal recombination,which could lead to pathogenic mutations (p. 22) or provide selective advantagein evolution b-v gene duplication Both Alu and LINE-1 repeat elements have been implicated as a cause of mutation in inherited human disease.
M I T O C H O N D R IDANLA In addition to nuclear DNA, the severalthousand mitochondria o f e a c h c e l l p o s s e s st h e i r o w n 1 6 . 6 k b c i r c u l a r d o u b l e stranded DNA, mitochontJrialDNA or mtDNA (Fig. 2.7). The mitochondrial DNA genomeis verS-compact,containing little repetitive DNA, and codes for 37 genes, which include two types of ribosomal RNA, 22 transfer RNAs (p' l8) and l3 protein subunits for enzymes, such as cytochrome E and cytochrome oxidase, which are involved in the energy producing oxidative phosphorylation pathways. The genetic code of the mtDNA differs slightly from that of nuclear DNA. The mitochondria of the fertilized zygote arc inherited almost cxclusively from the oocyte, leading to the maternal pattern of inheritance that characterizesmany mitochondrial disorders
(p.174).
17
2
THE CELLULAR AND N/OLECULAR BASISOFINHERITANCE
spliced together to form a shorter mature mRNA before its transportation to the ribosomesin the cytoplasm for translation. The processis known as nRNA splicing(Fig. 2.8). The boundary between the introns and exons consists of a 5' donor GT dinucleotide and a 3' acceptor AG dinucleotide. These, along with surrounding short splicing consensussequences,another intronic sequenceknown asthe splicing branch site,small nuclear RNA molecules and associatedproteins, are necessaryfor the splicing process.
165 rRNA
5'capping
e pIi c a t i o n
LVII
ND4L
ATPS
Fis.2.7 T h e h u m a nm i t o c h o n d r i a l g e n o mHei s t h e h e a v ys t r a n da n d L the tightstrand
TRANSCRIPTION
Shortly after transcription, the nascent mRNA is modified by the addition of a methylated guanine nucleotide to the 5'end of the molecule by an unusual 5' to 5' phosphodiesterbond, the so-called5' cap.'[he 5' cap is thought to facilitate transport of the mRNA to the cytoplasm and attachment to the ribosomes, as well as to protect the RNA transcript from degradation by endogenouscellular exonucleases.
Polyadenylation The cleavageof the 3' end of the mRNA moleculefrom the DNA involves the addition of approximately 200 adenylateresidues, the so-calledp oly (A) tail, after cleavageof the RNA transcript at a site downstream from a specific six-nucleotide sequence.The addition of the poly(A) tail is thought to facilitatetransport of the mRNA to the cytoplasm and translation.
The process whereby genetic information is transmitted from DNA to RNA is called transcription.The information stored in the genetic code is transmitted from the DNA of a gene to messenger RNA or mRNA Everv base in the mRNA molecule is complementaryto a correspondingbasein the DNA of the gene, but with uracil replacing thymine in mRNA. mRNA is single stranded, being synthesized by the enzyme RNA polymerase, which addsthe appropriatecomplementaryribonucleotideto the 3' end of the RNA chain In any particular gene only one DNA strand of the double helix actsasthe so-calledtemplutestrand The transcribedmRNA moleculeis a copy of the complementarystrand, or what is called the sensestrand of the DNA double helix. The template strand is sometimescalled the antisense strantl.The particular strand of the DNA double helix used for RNA synthesisappearsto differ
18
TRANSLATION Tianslationis the transmission of the genetic information from mRNA to protein. Newly processedmRNA is transported from the nucleus to the cytoplasm, where it becomesassociatedwith the ribosomes, which are the site of protein synthesis.Ribosomes are made up of two different sized subunits, which consist of four different types of ribosomalRNI (rRNA) moleculesand a largenumber of ribosomalspecificproteins.Groups of ribosomes associatedwith the same molecule of mRNA are referred to as polyribosomes or polysomes.In the ribosomes,the mRNA forms
throughout different regions of the genome.
the template for producing the specificsequenceof amino acids of a particular pofupeptide.
R N AP R O C E S S I N G
TRANSFER RNA
Before the primary mRNA molecule leaves the nucleus it undergoesa number of modihcations,or what is known as Rly'l processing. This involvessplicing, capping and polyadenylation.
In the cytoplasm there is anorher form of RNA calledtransferRNA or tRNA. The incorporation of amino acids i nto apolypeptidechain requires the amino acids to be covalentlybound by reacting with ATP to the specificIRNA moleculeby the activity of the enzyme
mRNAsplicing
aminoacyl IRNA synthetase.The ribosome, with its associated rRNAs, moves along the mRNA, the amino acids linking up by the formation of peptide bonds through the action of the enzyme peptidyl transferaseto form a polypeptide chain (Fig. 2.9).
After transcription, the non-coding introns in the primarv mRNA are excised, and the non-contiguous coding exons are
2 ption Transcri initiation
ption Transcri termination
+
+
JJ
Translation Poly(A)signal stop
Translation start
I I I
Transcription Polyadenylation Capping
PrimaryRNA Poly(A)tail
5'cap---J
Fi s . 2 . 8 post-transcriptionaI Transcription, processing, processing translation andpost-translationaI
DNA
UUUUUUUUUUUUUUU
AAACTCCACTTCTTC
UUUGAGGUGAAGAAG mRNA
Nuclear membrane
Ribosome
mRNA (template)
UUU
AAGAAG
cA
C
I
Peptide
Fis.2.9 Representation ofthewayinwhichgenetic information istranslated intoprotein
19
2
T H EC E L L U L A R A M ND OLECULA BR ASIS O FI N H E R I T A N C E
POST.TRANSLATI ONAL MODI FICATION
genetic code is non-overlapping The order ofthe triplet codons in a gene is known as the translational readingfrd,me. Howeye\
Many proteins, before they attain their normal structure or functional activitl-, undergo posl-t ranslational motlifc ation, which
some amino acids are coded for by more than one triplet, so (Thble 2.1). Each IRNA species the code is said to be degenerate for a particular amino acid has a specilic trinucleotide sequence called the unticodon,which is complementary to the codon of
can include chemical modilication of amino-acid side-chains (e.9. hydroxylation, methylation), the addition of carbohydrate or lipid moieties (e.g. glycos-vlation),or proteolytic cleavageof polypeptides(e.g.the conr.ersionofproinsulin to insulin).
the mRNA. Although there are 64 codons, there are only 30 cy'toplasmictRNAs, the anticodons of a number of the tRNAs recognizing codons that differ at the position of the third base, with guanine being able to pair with uracil as well as cytosine. Termination of translation of the mRNA is signaled by the presenceof one of the three stopor terminationcod,ons. The genetic code of mtDNA differs from that of the nuclear
This post-translationalmodification, along with certain short amino-acidsequencesknown aslocalizationsequentes in the newly synthesizedproteins, results in transport to specihc cellular locations(e.9.the nucleus),or secretionfrom the cell.
genome.Eight of the 22 tRNAs are able to recognizecodons that differ only at the third baseofthe codon, l4 can recognizepairs of codons that are identical at the first two bases,with either a purine or pyrimidine for the third base,the other four codons acting as stop codons (seeTable 2. I ).
T H EG E N E T C I CO D E Thent-v different amino acids are fbund in proteins; as DNA is composed of four different nitrogenous bases,obviousl-va single basecannot specify one amino acid. If two baseswere to specify one amino acid, there would onll be 42 or 16 possible combinations.If, however,three basesspecifiedone amino acid then the possiblenumber of combinationsof the four baseswould be ,13or 64. This is more than enough to account for all the 20 known amino acids and is known as the senetic codc.
R E G U L A T I OONFG E N EE X P R E S S I O N Nlanv cellular processes,and therefore the genesthat are expressed, are common to all cells, for example ribosomal, chromosomal and cvtoskeleton proteins, constituting what are called the genes.Somecellsexpresslargequantitiesofa specific housekeelting protein in certaintissuesor at specifictimes in development,such ashemoglobinin red blood cells(p. 147) This differential control of geneexpressioncan occur at a variety of stages.
TRIPLEC T ODONS The triplet of nucleotide basesin the mRNA that codes for a particular amino acid is called a cotlon.Each triplet codon in sequencecodes for a specific amino acid in sequenceand so the
qenomes Tabte2.1 Genetic codeof the nuctearandmitochondrial First base
C
A
G
20
Secondbase A
U
c
Phenyla[anine Phenytalanine Leucine
Serine Serine Serine
Tyrosine Tyrosine
Leucine
Serine
Slop
Stop lTryptophon) Tryptophan
L e u cnr e L e u cni e Leucine Leucrne
Protine Pro[ine Pro[ine Proiine
Histidine Hrstrdine Gtutamine Gtutamine
Arginine Arginine Arginrne Arginine
A G
Isoteuct ne Isoteuci ne lsoteucine (Methionine) Methionine
Threonine Threonine Threonine
Asparagine Asparagine Lysine
Serine Serine Arginine
A
Threonrne
Lysrne
Arginine
G
Atanine Atanine Atanine Atanine
A^^^-r:^^:! H>Pdt LtL dLru
Gtycine Gtycine Gtycine Gtycine
A G
Valine Va[ine Valine Vatine
(tnn
G
Third base
U C A
G
a a
( Sinnl
Differencesin the mitochondriatgeneticcode are in itolics
A-^--ri-^,f, H>Pdr LrL dL'U
G t u t a m i ca c i d G t u t a m i ca c i d
a
ANDMOLECULAR BASISOFINHERITANCE THECELLULAR
C O N T R OOLFT R A N S C R I ION PT The control of transcription can be affected permanently or reversibly by a variety of factors, both environmental ( e . 9 . h o r m o n e s ) a n d g e n e t i c ( c e l l s i g n a l i n g ) .T h i s o c c u r s through a number of different mechanisms which include s i g n a l i n g m o l e c u l e s t h a t b i n d t o r e g u l a t o r y s e q u e n c e si n the DNA known as resplnseelements,intracellular receptors knorvn as hormonenuclear receptlrs,and receptors for specific ligands on the cell surface involved in the process of signal transduction All of these mechanismsaffect transcription through the binding of transcription factors to short specific DNA promoter elements located within 200bp 5' or upstreamof most eukaryotic genes in the so-called promoter region that l e a d s t o a c t i v a t i o n o f R N A p o l v m e r a s e( F i g . 2 . 1 0 ) . T h i s
usuallv mediated through a helical protein motifs, and are known as transcriptionfactors. These gene regulatory proteins have a transcriptional activation domain and one of four main types of DNA-binding domains.The most common type of gene regulatory protein are the helix-turn-helit proteins, so named becausethey are made up of two a helices connected 'turn'. Perhaps b.va short chain of amino acids that make up the not surprisingly, structural analysis of the homeodomain sequenceof the homeotic genes (p. 86) has revealed that they contain a helix-turn-helix motif. Analysis of other generegulatory proteins has shown them to contain one of three other types of DNA-binding motif: the zinc Jinger, leucine zipper or helixloop helix motifs, so named as a result of specific structural features
includes the TATA (or Hogness), the GC (or GGGCGGG clnsensus sequeme)and the CAAT boxes.The TATA box, which is about 25 bp upstream ofthe transcription start site, is involved
CONTRO L POST- TRANSCRIPTIONAL O FG E N EE X P R E S S I O N
in the initiation of transcription at a basal constitutive level and mutations in it can lead to alteration of the transcription start site. The GC box, which is about 80bp upstream, and the CAAT box increasethe basal level of transcriptional activity of the TATA box. The regulatory elements in the promoter region are said to be cis-acting,that is, they only affect the expression of the adjacentgeneon the sameDNA duplex, whereasthe transcription
Regulation of expression of most genes occurs at the level of transcription but can also occur at the levels of RNA processing,RNA transport, mRNA degradationand translation. For example,the G to A variant at position 20210 in the 3' untranslated region of the prothrombin gene increasesthe stability of the mRNA transcript, resulting in higher plasma
factors are said to be trans-acting,acting on both copies of a geneon eachchromosomebeing synthesizedfrom genesthat are locatedat a distance.DNA sequencesthat increasetranscriptional
R N A . M E D I A T ECDO N T R OOLFG E N E EXPRESSION
activity,such as the GC and CAAT boxes,are known asenhuncers. There are also negative regulatory elements or silencersthat
RNA-mediated silencing was first described in the early 1990s but it is only in the last few yearsthat its key role in controlling post-transcriptional gene expressionhas been both recognized and exploited (Ch 23). Small interfering RNAs (siRNAs) were discovered in 1998 and are the effector molecules of the RNA interference pathway (RNAi). These short doublestranded RNAs (21 to 23 nucleotides)bind to mRNAs in a
inhibit transcription. In addition, there are short sequences of DNA, usually 500bp to 3kb in size and known as boundar.y elemenls, that block or inhibit the influenceof regulatoryelements of adjacentgenes.
TR A N S C R I P T ION F A C T OR S An increasingnumber of genesare being identified that encode proteins involved in the regulation of gene expression Thev have DNA-binding activity to short nucleotide sequences,
prothrombin levels.
sequence-specificmanner and result in their degradation via a r i b o n u c l e a s e - c o n t a i n i n gR N A - i n d u c e d s i l e n c i n g c o m p l e x (RISC). MicroRNAs (miRNAs) also bind to mRNAs in a manner, but they block translation rather than sequence-specific destroying the mRNA.
-
Trans-acti ng elements
2
CAAT box
80bp+: TATA
, TranscriPtion
--*ry* ption Transcri factors enhancers cis-acting
Fig.2.10 Diagrammatic representation geneexpression ofihefactors thatregulate
21
2
THECELLULARAND MOLECULAR BASISOFINHERITANCE
A L T E R N A T IVSEP L IC IN G
MUTATIONS
The majority of human genes(at leastT4o/o)undergo alternatite splicingand thereforeencodemore than one protein. Some genes have more than one promoter, and these alternatiuepromoters may result in tissue-specific isoforms. Alternative splicing of exons is also seen with individual exons present in only some isoforms. The extent of alternative splicing in humans may be inferred from the finding that the human genome includes only 25000 to 30000 genes,far fewer than the original prediction of more than 100000.
RNA.DIRECTED DNASYNTHESIS The process of the transfer of the genetic information from DNA to RNA to protein has been called the central tlogma.It was initially believed that genetic information was transferred only from DNA to RNA and thence translated into protein. However, there is evidence from the study of certain types of virus - retroviruses- that genetic information can occasionally
A mutation is defined as a heritable alteration or change in the genetic material. Mutations drive evolution but can also be pathogenic.Mutations can arise through exposureto mutagenic agents(p. 26), but the vastmajority occur spontaneouslythrough errors in DNA replication and repair. Sequencevariantswith no obvious effect upon phenotype may be termed polymorphisms. Somatic mutations may cause adult-onset diseasesuch as cancer but cannot be transmitted to offspring. A mutation in gonadal tissueor a gametecan be transmitted to future generations unlessit affectsfertility or survival into adulthood. It is estimated that eachindividual carriesup to six lethal or semilethalrecessive mutant alleles that in the homozygous state would have very serious effects.These are conservativeestimatesand the actual figure could be many times greater.Harmful allelesof all kinds constitute the so-calledgeneticload ofthe population There are also rare examples of 'back mutation' in patients with recessivedisorders. For example, reversion of inherited deleteriousmutations has been demonstratedin phenotypically normal cells present in a small number of patients with Fanconi
flow in the reversedirection, from RNA to DNA (p. 197).This is referred to as RNA-directedDNA rynthesh.It has been suggested
anemla.
that regions of DNA in normal cells serve as templates for the synthesis of RNA, rvhich in turn then acts as a template for the synthesisof DNA that later becomesintegrated into the nuclear DNA of other cells Homology between human and retroviral
TYPESOFMUTATION
oncogene sequencescould reflect this process (p. 198), which could be an important therapeutic approachfor the treatment of inherited diseasein humans.
Mutations can range from single base substitutions, through insertions and deletions of single or multiple bases to loss or gain of entire chromosomes(Table 2.2). Base substitutions are most prevalent (Thble 2.3) and missensemutations account for nearlv half of all mutations.A standardnomenclatureto describe
Tabte2.2 Mainclasses, groups product andtypesofmutation andeffects onprotein Class
Group
5ubstrtution Synonymous Non-synonymous
Detetion
Largedetetion
Muttipte of3 (codon) Notmultipteof 3 Largeinsertio n Expansion oftrinucteotide repeat
22
Effecton protein product
Sitento Missenseo Nonsenseo Snlirc
S a m ea m i n oa c i d Atteredaminoacid- mayaffectproteinfunction or stability Stopcodon- lossoffunction or expression dueto degradation o fm R N A - exonskrpping Aberrant sp[icing or intronretention
Promoter
Alicred
Framesh rft Partialgenedeletion
- mayaffect protein In-frame deieiion of oneoTmoreaminoacid(s) function or stabitrty Likelyto resu[t in premature termrnatron withlossoffunctionor expressl0 n Mayresuttin premature termination withlossoffunction or expression
\.il,/figlg nono
I ncc nf g1p;ggEl6Tl
Multipte of3 (codon) Noimultipleof 3
Insertion
Type
"Somehavebeenshownto causeaberrant soticino
doloirnn
ncnc evnrc<
- mayaffect In-frame insertion ofoneor moreaminoacid(s) proteinfunction or stability Frameshift Liketytoresultin premature termination wrthlossoffunctron or expresSron Partialgeneduptication Mayresultin premature termination withlossoffunction or expression Whotegeneduptication Mayhaveaneffect genedosage dueto rncreased Dynamic mutation geneexpression protein Attered or altered stabilrty or function
BASISOFINHERITANCE N4OLECULAR THECELLULARAND
Tabte2.3 Frequency ofdifferent typesofmutation
2
are known as CpG dinucleotides (p representsthe phosphate) frequentl-vbeing methylatedin genomic DNA with spontaneous deaminationof methylcytosineconverting them to thymine. CpG 'hotspots' for mutation' dinucleotideshavebeen termed
Typeof mutation
Percentageof totat
Mrssense or nonsense
51
Spticing
10
Detetions
Regutatory
1
Smatldeletions insertions or indets"
24
Grossdetetions or insertions
1
A deletioninvolves the loss of one or more nucleotides.If this occurs in coding sequencesand involves one, two or more nucleotides that are not a multiple of three, the reading frame rvill be disrupted (p. 25). Larger deletions may result in partial
0 t h e r ( c o - n o t e rxe a r r a n g e r n e n tosr r e p e a t variations)
<1
or whole gene deletions and may arise through unequal crossover betweenrepeat sequences(e g hereditary neuropathy with liabilitl' to pressurepalsies;p.287).
Datafromhttp://www.hgmd org olndets aremutations thatinvolve anda detetron ol bothaninsertion nucteoti des
lnsertions
mutations (Thble 2.1) has been agreed(see http:/,/www.hgvs orglmutnomen/), although it is not used universally.Examples of chromosomeabnormalitiesare discussedin Chaoter 3.
Substitutions A substitutionis the replacement of a single nucleotide by another These are the most common type of mutation. If the substitution involvesreplacementby the sametype of nucleotide a pyrimidine for a pyrimidine (C for T or vice versa) or a purine for a purine (A for G or vice versa); this is termed a transition.Substitution of a pyrimidine by a purine or vrce versa is termed a transrer.sion. tansitions occur more frequently than transversions.This may be due to the relatively high frequenc.v of C to T transitions, which is likely to be the result of the nucleotides cytosine and guanine occurring together, or what
An insertioninvolvesthe addition of one or more nucleotidesinto a gene Again, if an insertion occurs in a coding sequenceand involves one, two or more nucleotidesthat are not a multiple of three, it will disrupt the reading frame (p. 25). Large insertions can also result from unequal crossover(e.g' hereditary sensory a n d m o t o r n e u r o p a t h yt y p e 1 a ; p . 2 8 6 ) o r t h e i n s e r t i o n o f transposableelements(p. 17). In 1991, expansion of trinucleotide repeat sequenceswas identified as a mutational mechanism. A number of singlegene disorders have subsequentlybeen shown to be associated with triplet repeat expansions(Thble 2 5). These are described as dynamic mutations becausethe repeat sequencebecomes more unstable as it expands in size. The mechanism by which amplilication or expansionof the triplet repeat sequenceoccurs is not clear at present.Triplet repeatsbelow a certain length for eachdisorder are faithfully and stablytransmitted in mitosis and meiosis.Above a certain repeatnumber for eachdisorder they are more likell' to be transmitted unstably' usually with an increase or decreasein repeat number. A variety of possibleexplanations
Tabte2.4 Mutationnomenctature: exampLes of CFTRqenemutations Typeof mutation
Nucleotide designation
Protein description
Consequence
Missense
c482G>A
p Arg117His
to histidine Arginine
Nonsense
c1756G>f
p Gty542X
to Stop Gtycine
Spticing
c 621+ 1G>T
(1bp) Detetion
c10787
p Vat358TyrfsXll
mutation Frameshift
(3bp) Detetion
c1652l654detCTT
p Phe508det
l n - f r a m ed e l e t i o no f o h e n v l a [ a n t n e
tnsefIron
c3905 3906rnsT
p Leul25BPhefsXT
F r a m e s h i fm t utation
donorsitemutatton Sptice
u eAn) c e a n d a r e p r e f i x e d boy rgc r e s p e c t i v e t y . T h e f i r s t b a s e o f t h e s t a r t M u t a t i o n s c a n b e d e s i g n a t e d a c c o r d i n g t o t h e g e n o m i c o r c D N A (smeRq N c o d o n( A T G i)s c 1 H o w e v e 6f o r h i s t o r i c arIe a s o n st h i s i s n o t a t w a y st h e c a s e ,a n d t h e f i r s tb a s eo f t h e C F I R c D N Ai s a c t u a t l yn u c t e o t i d1e3 3
23
2
THE CELLULARANDMOLECULAR BASISOFINHERITANCE
Tabte2.5 ExampLes of diseases arisingfromtripletrepeatexpansions Disease
Repeat sequence
Normal range (repeats)
Pathogenic range (repeats)
Repeat location
(HD) Huntington disease
CAG
o2R
36-100
Coding
Myotonic dystrophy type1(DM1)
CTG
tr ?f
50-4000
3'UTR
FragiteXsiteA(FRAXA)
CGG
10-50
200-2000
5'uTR
(SBMA) Kennedy disease
CAG
13-30
40-62
Coding
Spinocerebeltar 1(5CAl) ata."ia
CAG
6-38
39-80
Coding
Spinocerebettar ataxia2 (SCA2)
CAG
16-30
36-52
Coding
M a c h a d o - J o s e pdhi s e a s e( M J D S C A 3 )
CAG
14-40
60->85
Coding
Spinocerebertar ataxra 6 (SCA6)
CAG
5-20
21-28
Coding
Spinocerebettar ataxia7 (SCA7)
CAG
/19
37,220
Codrng
Sprnocerebeltar ataxra B (SCA8)
CTG
16-31
100->500
3'UTR
Spinocerebe[ar ataxia 12(SCA12)
CAG
a_/,q
55-78
5'UTR
Spinocerebettar ataxia17(SC417)
CAG
25-42
47-55
Codrng
(DRPLA) Dentatorubrat-pattidoluysian atrophy
CAC
7-23
49->75
Coding
Friedrerch ataxia(FA)
GAA
100-900
rnlronrc
FragiteXsrteE(FRAXE)
CCG
L)E
>200
Promoter
OcutopharyngeaI muscutar dystrophy
GCG
b
B-13
Coding
UTR.untranslated region
has been offered as to how the increasein triplet repeat number occurs. These include unequal cross-over or unequal sister chromatid exchange(pp. 45, 278) in non-replicaring DNA,
DMPK allele somehow interferes with the cellular processing of RNA produced by a variety of other genes The expandedDAIPK transcripts accumulatein the nuclei of cells and this is believed
and slipped-strand mispairing and polymerase slippage in replicating DNA. tiplet repeat expansionsusually take place over a numbcr of generationswithin a family, providing an explanation for some unusual aspects of patterns of inheritance as well as possibly being the basis of the previously unexplained phenomenon of anticipation(p ll4).
to havea gain-of-function effect through its binding with a CUG RNA-binding protein (CUG-BP). Excess CUG-BP has been shown to interfere with a number of genes relevant to MD, and CUG repeatsare known to exist in various alternatively spliced muscle-specificenzymes(p. 285). The spectrum of repeat expansion mutations also includes
The exact mechanisms by which triplet repeat expansions causediseaseare not known [Jnstabletrinucleotide repeatsmav be within coding or non-coding regions of genesand hence vary in their pathogenicmechanisms.Expansionof the CAG repeatin the coding region of the I1D geneand someSCI genesresultsin a protein with an elongatedpolyglutamine tract that forms toxic
24
aggregateswithin certain cells. In fragile X the repeat expansion in the 5' untranslated region (UTR) results in methylation of promoter sequencesand lack of expressionof the FMRI protein. In myotonic dystrophy (MD) it is believed rhar rhe expandcd
a dodecamer repeat expansion upstream from the cystatin B gene that causesprogressivemyoclonus epilepsy (EPM1), a tetranucleotiderepeat expansion in intron 1 of the ZNFg gene which causesa secondtype of myotonic dystrophy (type 2 MD, formerly known as proximal myotonic myoparhy - PROMM) and a pentanucleotiderepeat expansionin intron 9 of the ATXNI0 gene shown in families with spinocerebellarataxia type 10. Spinocerebellar ataxia is an extremely heterogeneousdisorder and, in addition to the dynamic mutarions shown in Table 2.5, non-repeat expansion mutations have been reported in four additional eenes.
BASISOFINHERITANCE ANDMOLECULAR THECELLULAR
STRUCTURAL EFFECTS OFMUTATIONS O NT H EP R O T E I N Mutations can alsobe subdividedinto trvo main groups according to the effect on the polypeptide sequenceof the encodedprotein, being either s.ynonym0us or nln-s.ynlnymlus.
2
results in the loss of an important functional domain(s) of the protein. mRNA transcriptscontaining premature termination codons are frequentlv degradedby a processknown as nlnsensemediuteddecay.This is a form of RNA surveillance that is believed to haveevolved to protect the body from the possibleconsequences of truncated proteins interfering with normal function.
Synonymous or silentmutations If a mutation doesnot alter the pol,vpeptideproduct of the gene, it is termed a synonymousor silent mutatiln. A single base-pair substitution, particularly if it occurs in the third position of a codon becauseof the degeneracyof the genetic code, will often result in another triplet that codesfor the sameamino acid with no alteration in the properties of the resulting proteln
Non-synonymous mutations
Fromeshift If a mutation involvesthe insertion or deletion of nucleotidesthat arc not a multiple of three, it will disrupt the reading frame and constitute what is known as r frameshift mutation. The aminoacid sequenceof the protein subsequentto the mutation bears no resemblanceto the normal sequenceand may have an adverse effect on its function. Most frameshift mutations result in a premature stop codon downstream to the mutation. This may lead to expressionof a truncated protein, unless the mRNA is
If a mutation leads to an alteration in the encoded polypeptide, it is known as a nln-s.ynonymous mutution. Non-synonymous
degraded b1'nonsense-mediateddecay.
mutations are observedto occur lessfrequently than synonymous mutations. Synonvmous mutations are selectively neutral, whereas alteration of the amino-acid sequenceof the protein product of a geneis likely to result in abnormal function, which is
M U T A T I O NI N S N O N - C O D I NDGN A
usually associatedwith disease,or lethality, which has an obvious selectivedisadvantage. Non-synonymous mutations can occur in one of three main ways.
In general,mutations in non-coding DNA are lesslikely to have a phenotypic effect Exceptions include mutations in promoter sequencesor other regulatory regions that affect the level of gene expression.With our new knowledge of the role of RNA interference in gene expression, it has become apparent that mutations in miRNA or siRNA binding sites within UTRs are alsolikely to result in disease.
Missense A single base-pairsubstitution can result in coding for a different amino acid and the synthesis of an altered protein, a so-called mutation If the mutation codes for an amino acid that missense is chemically dissimilar, for example has a different charge,the structure of the protein will be altered. This is termed a nontonserxu,tiae substitutionand can leadto a grossreduction, or even a complete loss,of biological activity. Single base-pairmutations can lead to qualitative rather than quantitative changes in the function of a protein, such that it retains its normal biological activity (e.9.enzymeactivit-y)but differs in characteristicssuch as its mobility on electrophoresis,its pH optimum, or its stability so that it is more rapidly broken down in uiao. Many of the abnormal hemoglobins(p. l5l) are the result of missensemutations. Some single base-pairsubstitutions,although resulting in the replacementby a different amino acid if it is chemically similar, often have no functional effect. These are termed Lons(rl)attre
Spticingmutations Mutations of the highly conservedsplice donor (GT) and splice acceptor (AG) sites (p. l8) usually result in aberrant splicing This can result in the loss of coding sequence(exon skipping) or retention of intronic sequence,and may lead to frameshift mutations. Cryptic splice sites, which resemble the sequence of an authentic splice site, may be activated when the conserved splice sites are mutated. The spectrum of splicing mutations has recentll, been extended with the observation that base substitutionsresulting in apparentsilent, missenseand nonsense mutations can causeaberrant splicing through mutation of exon sltlidng enhancersequences.These purine-rich sequencesare required for the correct splicing of exons with weak splice-site consensussequences.
substitutions.
OFMUTATIO N S EFFECTS FUNCTIONAL O NT H EP R O T E I N
Nonsense
N,Iutations exert their phenotypic effect in one of two ways, through either loss or gain of function
A substitution that leads to the generation of one of the stop codons (see Table 2 l) rvill result in premature termination of translation of a peptide chain, or what is termed a nonsense mutation In most casesthe shortenedchain is unlikely to retain
mutations Loss-of-function
normal biological activity, particularly if the termination codon
mutations can result in either reduced activity or Loss-oJ-Junction complete loss of the geneproduct. The former can be the result
25
2
THECELLULAR ANDMOLECULAR BASISOFINHERITANCE
of reduced activity or of decreasedstability of the gene product and is known as a h.ypomorpl2, the latter being known as a null
or function, as a consequenceof the mutant gene product interfering with the function of the normal gene product of
alleleor umorph.Loss-of-function mutations in the heterozvgous statewould, at worst, be associatedwith half normal levelsof the protein product. Loss-of-function mutations involving enzymes are usually inherited in an autosomal or X-linked recessive manner, becausethe catalytic activity of the product of the
the corresponding allele. Dominant-negative mutations are particularly common in proteins that are dimers or multimers,
normal allele is more than adequateto carry out the reactionsof most metabolicpathwa-\ s.
GENOTYPE.PH ENOTYPECORRELATI ON
Hoplo-insufficiency
Many geneticdisordersare well recognizedas being very variable in severity,or in the particular featuresmanifested by a person with the disorder (p 105) Developments in molecular genetics
Loss-of-function mutations in the heterozygousstate in which half normal levels of the gene product result in phenoty.pic
increasingll, allow identification of the mutational basis of the specificfeaturesthat occur in a person with a particular inherited
effects are termed hapltt-insfficienc.ymutations.The phenotypic manifestationssensitiveto gene dosageare a result of mutations occurring in genesthat code for either receptors,or more rarely enzymes,the functions of which are rate limiting, for example familial hypercholesterolemia (p 167) and acure inrermittent porph-vria(p.172)
disease,or what is known as the phenotype.This has resulted in attempts to correlatethe presenceof a particular mutation, which is often called the genotype,with the specificfeaturesseenin a person with an inherited disorder, this being referred to as gent4ype phenotypecorrelation.This can be important in the management
In a number of autosomaldominant disordersthe mutational basis of the functional abnormalitv is the result of haploinsufficiencv in which, not surprisingly; homozvgousmutations result in more severephenotypic effects;examplesareangioneurotic edema(p. 190) and familial hypercholesterolemia(p 167).
Gain-of-function mutations Gain-o.f-functiozmutations, as the name suggests,result in either increased levels of gene expression or the development of a new function(s) of the gene product. Increasedexpression levelsdue to activatingpoint mutations or increasedgenedosage are responsiblefor one type of Charcot-Marie-Tooth disease, hereditary motor and sensory neuropathy type I (p. 286) The expanded triplet repeat mutations in the Huntington gene cause qualitative changesin the gene product that result in its aggregationin the central nervous system leading to the classic clinical featuresof the disorder (p.282). Mutations that alter the timing or tissue specificity of the expressionof a genecan alsobe consideredto be gain-of-function mutations. Examples include the chromosomal rearrangements that result in the combination of sequencesfrom two different genesseenwith specifictumors (p 199).The novel function of the resulting chimeric genecausesthe neoplasticprocess. Gain-of-function mutations are dominantly inherited and the rare instances of gain-of-function mutations occurring in the homozygous state are often associatedwith a much more severe phenotvpe,which is often a prenatallylethal disorder,for example homozygous achondroplasia(p. 91) or Waardenburg syndrome type I (p 89).
Dominant-negative mutations 26
for instancestructural proteins such as the collagens,mutations in which can lead to osteogenesis imperfecta (p. 103).
A dominant-negatiTemntation is one in which a mutant gene in the heterozygousstate results in the loss of protein activity
of a patient.One exampleincludesthe associationof mutations in the BRCAI genewith the risk of developing ovarian canceras well as breast cancer (p. 2l l). Particularly striking examplesare mutations in the receptor tyrosine kinasegeneREIwhich, depending on their location, can lead to four different syndromesthat differ in the functional mechanism and clinical phenotype. Loss-offunction nonsensemutations lead to lack of migration of neural crest-derived cells to form the ganglia of the myenteric plexus of the large bowel, leading to Hirschsprung disease,whereas gain-of-function missensemutations result in familial medullary thyroid carcinomaor one of the two types of multiple endocrine neoplasiatype 2 (p. 95) Mutations in the LMNA gene are associatedwith an even broader spectrum ofdisease (p. 105).
MUTATIONS ANDM UTAGENES IS Naturally occurring mutations are referred to as splnteneous mut&tionsand are thought to arise through chance errors in chromosomaldivision or DNA replication Environmental agents that causemutations are known as mutasens.
MUTAGENS These include natural or artificial ionizinq radiation and chemical or physicalmutagens.
lonizingradiation Ionizing ratlia,tionincludes electromagneticwavesof very short wavelength (X-rays and y rays) and high-energy parricles (o particles, B particles and neutrons). X-rays, y rays and neutrons have great penetrating power, but CX, particles can penetratesoft tissuesto a depth of only a fraction of a millimeter and B particles only up to a few millimeters.
BASISOFINHERITANCE AND MOLECULAR THE CELLULAR
2
Meosuresof rodiotion The amount of radiation received by irradiated tissuesis often referred to as the 'dose', which is measuredin terms of the rad,iationabsorbed doseor rad.The rad is a measureof the amount of any ionizing radiation that is actually absorbedby the tissues, I rad being equivalentto l00ergs ofenergy absorbedper gram of tissue The biological effectsofionizing radiation depend on the volume of tissue exposed.In humans, irradiation of the whole body with a dose of 300-500rads is usually fatal, but as much as l0000rads can be given to a small volume of tissue in the treatment of malignant tumors without seriouseffects Humans can be exposedto a mixture of radiation, and the rem (roentgenequit:alentforman)is a convenientunit asit is a measureof any radiationin terms ofX-rays. A rem ofradiation is that absorbed dosethat producesin a given tissuethe samebiological effect as I rad of X-rays. Expressingdosesof radiationin terms of rems permits a comparisonof the amountsof different typesof radiationto which humansareexposed.A millirem (mrem) is one-thousandthof arem; l00rem is equivalent to lsie"^ert(Sv), and 100rad is equivalent to I gray (Gy) in SI units. For all practical purposes,sievertsand grays are approximately equal. In this discussion sieverts and millisieverts (mSv) are used as the units of measure
averagedosesof ionizing Tabte2.5 Approximate to the gonadsof the general fromvarioussouTCes radiation OODULATION
Averagedoseper year (mSv)
Averagedoseper 3OYears(mSv)
Natural radiation Cosmrc
025
1.5
y radiationo External
150
450
Sourceof radiation
Internalyradiation 030
90
Artificiat radiology Medrcat
0 30
90
fallout Radioactive
0 01
03
and Occupationat miscellaneous
0 04
12
Totat
240
720
olnctuding radonin dwelting T R E 1989Risksfrom ionizing Datafrom CtarkeR H, Southwood Nature338:197-198 radiation.
Dosimetry Dosimetryis the measurementof radiation.The doseof radiation is expressedin relation to the amount received by the gonads becauseit is the effects of radiation on germ cells rather than somaticcellsthat are important asfar astransmissionof mutations to future progenv is concerned. The gonad doseof radiation is often expressedas the amount received in 30years This period of time has been chosen becauseit correspondsroughly to the generationtime in humans.
the dose:the larger the dose,the greaterthe number of mutations produced. It is believed that there is no threshold below which irradiation has no effect - even the smallest dose of radiation can result in a mutation. The geneticeffectsof ionizing radiation are also cumulative, so that each time a person is exposed to radiation the dose received has to be added to the amount of radiation alreadyreceived.The total number of radiation-induced mutations is directly proportional to the total gonadaldose.
Sourcesof rodiotion The various sourcesand averageannual doses of the different types of natural and artificial ionizing radiation are listed in Thble 2.6. Natural sourcesof radiation include cosmic ra1,-s, external radiation from radioactive materials in certain rocks, and internal radiation from radioactive materials in tissues Artificial sources include diagnostic and therapeutic radiology, occupationalexposureand fallout from nuclear explosions. The averagegonadaldoseofionizing radiationfrom radioactive fallout resulting from the testing of nuclear weaponsis lessthan that from an-vof the sourcesof background radiation. However, the possibilit-vof serious accidents involving nuclear reactors, as occurred at Three Mile Island in the USA in 1979, and at Chernobl-l in the Soviet Union in 1986,with widespreadeffects, alwaysmust be borne in mind.
Geneticeffects Experiments with animals and plants have shown that the number of mutations produced by irradiation is proportional to
dose Permissible The hazard from mutations induced in humans by radiation is not so much to ourselvesas to our descendants.Unfortunately, in humans there is no easyway to demonstrategenetic damage causedby mutagens.Nevertheless,the International Commission on RadiologicalProtection (ICRP), working in close liaison rvith various agenciesof the United Nations - World Health Organization (WHO), United Nations Educational, Scientific and Cultural Organization (UNESCO)' International Atomic Energl- Agency (IAEA) - has been mainly responsible for defining rvhat is referred to as the maximum permissibledoseof radiation. This is an arbitrary safety limit and is probably very much lower than that which would causeany significant effect on the frequency'of harmful mutations within the population. It has beenrecommendedthat occupationalexposureshould not exceed 50mSv per year.However, there is currently much controversy over exactll' rvhat the permissible dose should be and some countries,such asthe USA, set the upper limit significantlylower than many others. In the UK the Radiation Protection Division
27
2
THECELLULAR ANDMOLECULAR BASISOFINHERITANCE
of the Health Protection Agency advisesthat occupational exposureshould not in fact exceedl5 mSv in a 1ear.To put this into perspective,I mSv is roughly 50 times the dose receivedin
DNA strand by an endonuclease,removalof the damagedregion by an exonuclease,insertion of new basesby the enzyme DNA polymerase,and sealingof the break by DNA ligase.
a single chest X-ray and 100 times the doseincurred when flying from the UK to Spain in a jet aircraft!
Nucleotide excisionrapair (NER) removes thymine dimers and large chemical adducts. It is a complex processinvolving more than 30 proteins that remove fragments of approximately 30 nucleotides. Mutations in at least eight of the genes encoding these proteins can cause xeroderma pigmentosum (p.277),
There is no doubting the potential dangers,both somatic and genetic,of exposureto ionizing radiation. In the caseof medical radiology, the dose of radiation resulting from a particular procedurehas to be weighedagainstthe ultimate beneficialeffect to the patient. In the caseof occupationalexposureto radiation, the answerlies in defining the risks and introducing and enforcing adequate legislation. With regard to the dangers from fallout from nuclear accidentsand explosions,the solution would seem obvious.
Chemicalmutagens
characterized by extreme sensitivity to ultraviolet light and a high frequency of skin cancer.A different set of repair enzymes is utilized to excisesingle abnormal bases(baseercisionrepair or BER), with mutations in the geneencoding the DNA glycosylase MYH having recently been shown to causean autosomal recessive form of colorectalcancer(p.207). Naturally occurring reactive oxygen speciesand ionizing radiation induce breakageof DNA strands.Double-strand breaks
In humans, chemical mutagenesismay be more important than radiation in producing genericdamage.Experiments haveshown that certain chemicals, such as mustard gas, formaldehyde,
result in chromosome breaks that can be lethal if not repaired. Post-replicationrepair is required to correct double-strand breaks and usually involves homologous recombination with a sister DNA molecule. Human genesinvolved in this pathway include
benzene,some basic dyes and food additives, are mutagenic in animals.Exposure to environmental chemicalsmay result in the formation of DNA adducts, chromosomebreaks or aneuploidy-.
NBS, BLilI and BRCAI /2, mutated in Nijmegen breakage s-vndrome,Bloom syndrome (p. 277) and hereditary breast cancer (p. 2ll), respectivell'.Alternatively, the broken ends may
Consequently all new pharmaceuticalproducts are subject to a battery of mutagenicity tests that include both in dtro and in cit:o studiesin animals.
be rejoined by non-homologous end-joining, which is an errorprone pathway.
DNAREPAIR The occurrence of mutations in DNA, if left unrepaired, would have serious consequencesfor both the individual and subsequentgenerations.The stability of DNA is dependentupon continuous DNA repair by a number of different mechanisms (Table2.7) Some types of DNA damagecan be repaired directly. Examples include the dealkylation of O6-alkyl guanine or the removal of thymine dimers by photoreactivation in bacteria. The majority of DNA repair mechanismsinvolve cleavageof the
Mismatch repair (MMR) corrects mismatched basesintroduced during DNA replication. Cells defectivein MMR havevery high mutation rates(up to 1000times higher than normal). Mutations in at least six different MMR genes cause hereditary nonpoly'posiscolorectalcancer(HNPCC; p. 209). Although DNA repair pathways have evolved to correct DNA damage and hence prorect the cell from the deleterious consequencesof mutations, some mutations arise from the cell's attempts to tolerate damage. One example rs translesion DNA 1ynthesis, where the DNA replication machinery bypasses sites of DNA damage, allowing normal DNA replication and gene expression to proceed downstream Human diseasemay
Tabte2.7 DNArepairpathways, genesandassociated disorders
28
Typeof DNArepair
Mechanism
Genes
Disorders
B a s ee x c i s i o nr e p a i r( B E R )
R e m o v aol f a b n o T m aD r ases
MYH
CotorectaI cancer
Nucteotide excision repair(NER)
Removat ofthymrne dimersandlarge chemicat adducts
Xp genes
piqmentosum Xeroderma
Post-replication repair
RemovaI of doubte-strand breaks byhomotogous recombination or non-homotogous end-joining
,ryB5 BLM BRCA\/2
Nijmegen breakage syndrome Btoomsyndrome Breastcancer
Mismatch repair(MMR)
Corrects mismatched basescaused bymistakes in DNAreptication
MSHondMLH genes
(HNPCC) CotorectaI cancer
H N P C Ch , e r e d i t a r yn o n- p o t y p o s i sc o i o r e c t acIa n c e r
E OFINHERITANC BASIS ANDMOLECULAR THECELLULAR
also be causedby defective cellular responsesto DNA damage. Cells have complex signaling pathways that allow cell cycle arrest to provide increasedtime for DNA repair. If the DNA damage is irreparable, the cell may initiate programmed cell death (apoptosrs).The ATM protein is involved in sensing DNA 'guardian of the genome'. damageand has been describedas the Mutations in the ATM gene cause ataxia telangiectasia(AT; p.192), characterizedby hypersensitivityto radiation and a high risk of cancer.
FURTHER READING Alberts B, JohnsonA, Lewis J et al 2002 Molecular biology of the cell, 4th edn Garland,London pell pritten arul laaishfuillustratedcomprehensiae text oJ' hry atcessible, problemsbookand,CD ROI4 using molecularbiologywith accompanying ssmen I multimedia rexiem and,selJ:asse DawkinsR 1989The selfishgene,2nd edn Oxford University Press, Oxford An int eresting controrersial concep t EpsteinRJ 2003Human molecularbiology:an introductionto the molecularbasisof healthand diseaseCambridgeUniversity Press, Cambridge A moderntextboobaboutmolecules and their role in humandiseaseFire A, Xu S, Montgomery M K, KostasS A, Driver S E, Mello C C 1998 Potent and specific genetic interferenceby double-strandedRNA in Caenorhubdins elegansNature 391:80G8l l Landmarkpaperdescribingthe discoxeryof RNAi. Lewin B 2004GenesVIII,8th edn. Oxford University Press,Oxford The eighthedition oJ'thisetcellenttextbllk of moletularbiolog.ywith nlor diagramsandfgures Hard Io tmproaeupon Mettler F A, Upton A C 1995Medical effectsof ionisingradiation, 2nd edn WB Saunders,Philadelphia oJ ioniang radiation Cood otertiep of all uspectsoJ'themedicalconsequences Schull WJ, NeelJV 1958Radiationand the sexratio in man Ser ratio amongchildrcn of survivorsof atomicbombingssuggestsinducedsexlinked lethalmutations Science228:134 ,138 The original reportof posible et;itlenterl the eJJicnof atomicradiation StrachanT, ReadA P 200.1Human molecular genetics,3rd edn Garland Science,London An uf to-datecomlrehensiae textbolk 0fall asfettsoJmolecularand cellular in humans biolog-7' s5 h relatesto inheriteddisease Tirrner J E 1995Atoms, radiationand radiationprotection John Wiley, Chichester BusisoJ'thephysicsof radiation,applicationsand harmful effects \lhtson J D, Crick F H C 1953Molecularstructureof nucleicacids- a nucleicacid Nature 171:737-738 structurefor deoxJ'ribose in thislaper, lresentedinjust o.^er,ne fage, resultedin the authors The c7ncepts recei'^ingthe Nobel PrizeI
2
ELEMENTS Q Genetic information is stored in DNA (deoxyribonucleicacid) as a linear sequenceof two types of nucleotide, the purines (adenine [A] and guanine [G]) and the pyrimidines (cytosineIC] and thymine [T])' linked by a sugar-phosphate backbone. @ A molecule of DNA consists of two antiparallel strands held in a double helix by hydrogen bonds between the complementary G-C and A-'l base pairs. pNA replication has multiple sites of origin and is €) semiconservative,each strand acting as a template for synthesisof a complementarystrand. @ G.n.t coding for proteins in higher organisms (eukaryotes) consist of coding (exons) and non-coding (introns) sections. @ T.anscription is the synthesis of a single-stranded complementarycopy of one strand of a genethat is known as messengerRNA (mRNA). RNA (ribonucleic acid) differs from DNA in containing the sugar ribose and the baseuracil insteadof thymine. @ mRNA is processedduring transport from the nucleus to the cytoplasm, eliminating the non-coding sections.In the cytoplasm it becomesassociatedwith the ribosomes, where translation (i.e. protein synthesis)occurs. 'universal' and consistsof triplets @ fn. geneticcode is (codons)of nucleotides,eachof which codesfor an amino acid or termination of peptide chain synthesis.The code is degenerate,as all but two amino acids are specifiedby more than one codon. @ fn. major control of gene expressionis at the level of transcription by DNA regulatory sequencesin the 5' flanking promoter region of structural genesin eukaryotes. General and specifictranscription factorsare alsoinvolved in the regulation of Benes. @ Mutations occur both spontaneouslyand as a result of exposureto mutagenicagentssuch asionizing radiation. Mutations are continuously corrected by DNA repair enzvmes.
29
CHAPTER
Chromosomes andce[[division
'Let
us not take it for granted that life existsmore fully in what is commonly thought big than in what is commonly thought small.'
eachhuman cell contained48 chromosomesand that human sex was determined by the number of X chromosomespresent at conception. Following the developmentin 1956of more reliable techniques for studying human chromosomes it was realized
Vireinia Woolf At the molecularor submicroscopiclevel DNA can be regardedas the basictemplate that providesa blueprint for the formation and maintenance of an organism DNA is packaged into chromosomes and at a very simple level these can be considered as being made up of tightly coiled long chains of genes.Unlike DNA, chromosomescan be visualizedduring cell division using a light microscope,under which they appear as thread-like structures or 'colored bodies'. The word chromosome is derived from the Greek chroma(= color) and soma(= body). Chromosomesare the factorsthat distinguish one speciesfrom another and that enablethe transmissionof genetic information from one generationto the next. Their behavior at somatic cell division in mitosisprovidesa meansof ensuring that eachdaughter cell retainsits own completegeneticcomplement. Similarly, their behaviorduring gameteformation in meiosisenableseachmature ovum and sperm to contain a unique single set of parental genes. Chromosomes are quite literally the vehicles that facilitate reproduction and the maintenanceof a species. The study of chromosomesand cell division is referred to as cytogenetics. Prior to the 1950sit was believed, incorrectly, that
that the correct chromosomenumber in humans is 46 (p. 5) and that malenessis determined by the presenceof a Y chromosome regardlessof the number of X chromosomes present in each cell. It was also realized that abnormalities of chromosome number and structure could seriously disrupt normal srowth and development. Thble 3.1 highlights the methodological developmenrs rhar have taken place during the past five decadesthat underpin our current knowledeeof human cvtosenetics.
H U M A NC H R O M O S O M E S MORPHOLOGY At the submicroscopiclevel chromosomesconsistof an extremely elaboratecomplex, made up of supercoils of DNA, which has been likened to the tightly coiled network of wiring seen 1n a solenoid (p. 30). Under the electron microscope chromosomes can be seento have a rounded and rather irregular morphology
Tabte3.1 Devetopment of methodotogies for cytogenetics
30
Decade
Development
Examplesof application
1950s
Reliabte methods forchromosome preparations
Chromosome numberdetermined as46(1956)
1970s
Giemsa chromosome banding
Phitadetphia chromosome identified as t(9:22)(1973)
1980s
(FISH) Ftuorescent rn-sduhybridization
Interphase (1994) FISHforrapiddetection of Downsyndrome SpectraI karyotyping (i996) forwhole-genome chromosome anatysis
1990s
(CGH) Comparative genomic hybridization
genomic Mapping imbalances in sotidtumors(1992)
2000s
ArrayCGH
Analysis of consitutionaI rearrangements: e g identification of -5Mbdetetion in a patient withCHARGE syndrome thatledto identification oftheqene(2004)
CHARGE' cotobomaof the eye,heart defects,otresiaof the choanae,retardationof growth and/or deve[opment,genitaIand/or urinary abnormalities. a n d e a r a b n o r m a l i t i eas n d d e a f n e s s
ANDCELLDIVISION CHROMOSOMES
(Fig. 3.1). However, most of our knowledge of chromosome structure has been gained using light microscopy.Special stains selectively taken up by DNA have enabled each individual chromosome to be identified. These are best seen during cell division, when the chromosomesare maximally contracted and the constituent genescan no longer be transcribed. At this time each chromosome can be seen to consist of two identical strands known as chromatid,s,or sisterchromatids,which are the result of DNA replication having taken place during the S (synthesis)phaseof the cell cycle (p. 4l). These sisterchromatids can be seento be joined at a primary constriction known as the centrrmere.Centromeres consist of several hundred kilobases of repetitive DNA and are responsible for the movement of chromosomes at cell division. Each centromere divides the chromosome into short and long arms, designatedp (= petite) and q ('g' = grande), respectively. The tip of each chromosome arm is known as the telomere. Telomeresplay a crucial role in sealingthe ends of chromosomes and maintaining their structural integrity. Telomeres have been highly conserved throughout evolution and in humans they consist of many tandem repeatsof a TTAGGG sequence. During DNA replication an enzymeknown as telomerase replaces the 5' end of the long strand, which would otherwise become progressivelyshorter until a critical length was reachedwhen the
3
cell could no longer divide and thus becamesenescent.This is in fact part of the normal cellular aging process,with most cells being unable to undergo more than 50 to 60 divisions. However, in sometumors increasedtelomeraseactivity hasbeen implicated as a causeof abnormally prolonged cell survival. Morphologically chromosomes are classified according to the position of the centromere. If this is located centrally, the chromosome is metacentric,if terrninal it is acrocentric,and,if the centromere is in an intermediate position the chromosome is submet acenuic(Fig. 3.2) Acrocentric chromosomessometimes have stalk-like appendagescalledsatellitesthat form the nucleolus of the resting interphasecell and contain multiple repeat copies of the genesfor ribosomal RNA.
CLASSIFICATION Individual chromosomesdiffer not only in the position of the centromere but also in their overall length. Based on the three parameters of length, position of the centromere, and the presenceor absenceof satellites,early pioneers of cytogenetics were able to identify most individual chromosomes,or at least subdivide them into groups labelledA-G on the basisof overall morphology(A, l-3; B, 4-5; C,6-12 * X; D, l3-15; E, 1Gl8; F, 19-20; G,21-22 + Y). In humans the normal cell nucleus and contains 46 chromosomes,made up of 22 patrs of autosomes a single pair of sex chromosomes - XX in the female and XY in the male. One member of each of these pairs is derived from each parent. Somatic cells are said to have a d'iploid complement of 46 chromosomes,whereas gametes (ova and sperm) have a haploid complement of 23 chromosomes.Members of a pair of chromosomes are known as homologs. The development of chromosome banding @. 32) enabled very precise recognition of individual chromosomes and the detection of subtle chromosome abnormalities.This technique
Chromatids Iites Satel
Fis.3.1 E t e c t r omni c r o g r a pohf h u m a nc h r o m o s o m sehs o w i ntgh e (Courtesy andwetldefined chromatids of centromeres Dr Christine HarrisonReproduced fromHarrison etal1983 Cytogenet CettGenet35:21-27wtlhpermission ofthepubtisher; S K a r g eB r asel)
M e t ac en t r i c
Submetacentric
Acrocentric
Fi9.3.2 as metacentric, aredescribed chromosomes MorphoLogicatly ofthe ontheposition depending oracrocentric, submetacentric centr0mere
31
3
CHROMOSOM AE NSDC E L LD I V I S I O N
alsorevealedthat chromatin,thecombinationof DNA and histone proteins that comprise chromosomes,exists in trvo main forms Euchromatinstainslightly and consistsof genesthat are actively expressed.In contrast, heterochromatiz stainsdarkly and is made up largelv of inactive,unexpressed,repetitive DNA The total number of chromosomes in different organisms varies considerably but is constant for any particular species. Whereas the marmoset and certain monkeys resemblehumans in having 46 chromosomes,higher primates more closelvrelated
E G
to humans, such as the chimpanzee, gorilla and orangutan, have 48 chromosomes.Among these primates the chromosomes of the chimpanzee most closely resemble those of humans. This is consistent u'ith the fact that there is a difference of only lolo between human and chimpanzee DNA. There is general agreement that the human number 2 chromosome is the product of fusion of two chimpanzee chromosomes, with
N
E .L
Fis.3.3 P u n n e t ts' sq u a r seh o w i nsge xc h r o m o s o mceo m b i n a t r of o n rs --
^
-^!
f^--l^
^--^+^-
many other differencesbetween the chromosome complements in the two speciesbeing due to paracentric and pericentric inversions (p. 52) These observationshave been exploited bymolecular biologiststo help map and clone genesin humans.
T H ES E XC H R O M O S O M E S The X and Y chromosomesare knorvn as the sex chromosomes b e c a u s eo f t h e i r c r u c i a l r o l e i n s e x d e t e r m i n a t i o n . T h e X chromosome rvas originall-v labeled as such because of uncertaintl, as to its function when it was realized that in some insects this chromosome is present in some gametes but not in others. In these insects the male has only one sex chromosome(X), whereasthe female has two (XX) In humans, and in most mammals, both the male and the female have two sex chromosomes- XX in the female and XY in the male. The Y chromosome is much smaller than the X and carries only a few genes of functional importance, most notablv the testisdetermining factor, known as SRY (p. 89). Other genes on the Y chromosome are known to be important in maintaining spermatogenesls. In the femaleeachovum carriesan X chromosome,whereasin the male each sperm carries either an X or a Y chromosome.As there is a roughly equal chanceof either an X-bearing sperm or a Y-bearing sperm fertilizing an ovum, the numbers of male and female conceptions are approximately'equal (Fig. 3.3). In fact, slightly more male babiesare born than females,although during childhood and adult life the sex ratio evensout at I :1 The processof sex determination is consideredin detail later
(p.e6).
modifications, are nolv universally employed in cytogenetic laboratories to analyze the chromosome constitution of an individual, which is known as a karyotype.This term is alsoused to describea photomicrograph of an individual's chromosomes, arrangedin a standardmanner.
CHROM OSOM E PREPARATION Any tissue rvith living nucleatedcells that undergo division can be used for studying human chromosomes.Most commonly circulating lymphocytesfrom peripheralblood are used,although samples for chromosomal analysis can be prepared relatively easily using skin, bone marroq chorionic villi or cells from amniotic fluid (amniocytes). In the caseof peripheral (venous)blood, a sampleis added to a small volume of nutrient medium containingphytohemagglutinin, which stimulatesT lymphocytesto divide. The cells are cultured under sterile conditions at 37"C for about 3da1's,during which they divide, and colchicine is then added to each culture. This drug has the extremely useful property of preventing formation of the spindle, thereby arresting cell division during metaphase, the time when the chromosomesare maximally condensedand therefore most visible. Hypotonic saline is then added, which causesthe red blood cells to lyze and results in spreadingof the chromosomes, which are then fixed, mounted on a slide and stainedready for analysis(Fig. 3.a).
CHROMOSOM ENDING BA Several different staining methods can be utilized to identify individual chromosomes.
M E T H O DS OFC H R OMOS OME A N ALYSIS
32
It was generallybelievedthat eachcell contained48 chromosomes until 1956,whenTjio and Levan correctly concluded on the basis of their studies that the normal human somatic cell contains only 46 chromosomes(p. 5). The methods they used,with cerrain
G ( G i e m s ab) a n d i n g This is the method used most commonly.The chromosomesare treated rvith trypsin, which denaturestheir protein content, and then stained with a DNA-binding dye known as Giemsa, which
AE NSDC E L LD I V I S I O N CHROMOSOM
3
frHHM HH HH HX HfiHH HH XHfrfrXHHH fiH ffi$ frHHfr X$ ffiHfrH"Xfr ffiH Karyotype
A n al y z e
sprea0
withtrypsin Digest andstain withGiemsa
Addphytohemagglutinin a n dc u l t u r em e d i u m
S p r e a dc e l l so n t o s l i d eb y d r o p p i n g
A d dc o l c h i c i n e and h y p o t o n i cs a l i n e
C e l l sf i x e d
Fis.3.4 Preparation ofa karyotype
giveseachchromosomea characteristicand reproducible pattern oflight and dark bands(Fig. 3.5).
banding 0 (quinacrine) This gives a banding pattern similar to that obtained with Giemsa, and requires examination of the chromosomeswith an ultraviolet fl uorescencemlcroscoDe
R (reverse)banding The chromosomes are heat-denaturedbefore staining with Giemsa, yielding light and dark bands which are the reverseof those obtained using conventionalG banding (Fig. 3.6).
H i g h - r e s o l u t i obna n d i n g G banding generallyprovides high-quality chromosomeanalysis with approximately 400 to 500 bands per haploid set. Each of these bands corresponds on average to approximately 6000-8000kilobases(kb) (i.e. 6-8megabases) of DNA. Highresolution banding of the chromosomes at an earlier stage of mitosis, such as prophase or prometaphase, provides greater sensitivitywith up to 800 bandsper haploid set,but is much more demanding technically.This involvesfirst inhibiting cell division with an agent such as methotrexateor thymidine. Folic acid or deoxy-cytidineis added to the culture medium, releasingthe cells into mitosis. Colchicine is then added at a specifictime interval, when a higher proportion of cellswill be in prometaphaseand the chromosomeswill not be fully contracted,giving a more detailed banding pattern.
C (centromeric heterochromatin) banding If the chromosomesare pretreated with acid followed by alkali prior to G banding,the centromeresand other heterochromaticregions containing highly repetitive DNA sequencesare stained preferentially.
ANALYSIS KARYOTYPE The next stagein chromosome analysisinvolves first countinB the number of chromosomespresent in a specifiednumber of cells,
33
CHROMOSOM AE NSDC E L LD I V I S I O N
pattern of the individual chromosomes is carried out on both members of eachpair of homologsin approximatelythree to five metaphasespreads,which show high-quality banding. The banding pattern of each chromosome is specific and
12
can be shown in the form of a stylized ideal karyotype known as an id,iogram(Fig. 3.7). The cytogeneticistanalyzeseach pair
3
xtl An
9
11
12
of homologous chromosomes, either while looking down the microscope or, increasingly,on a photograph of the metaphase spread, which can now be produced electronically (Fig. 3.8). Until the advent of banding in 1971, chromosomes could be classified only on the basis of their overall morphology. Now a formally presented karyotype, or karyogram, will show each chromosomepair in descendingorder of size.
MOLECULAR CYTOGEN ETIC5
13
14
15
16
17
18
FLUO RESCENT'N.S'TU HYBRI DIZATI ON This diagnostic tool combines conventional cytogenetics with molecular genetic technology.It is based on the unique ability of a portion of single-strandedDNA (i.e. a probe; p. 35) to
a
f* 19
20
21
22
Fig.3.5 A normaI G-banded malekaryotype
1
10
6789
11
12
14
,r s3 19
20
15
16
45X
X
*e
i
13
3
17
18
6
10
11
12
,;x ** 2122Y
Fig.3.5 (Courtesy A normal R-banded malekaryotype ofH J Evans )
IJ
sometimes referred to Ls meta.phase spreads,followed by careful analysisof the banding pattern of eachindividual chromosomern selectedcells.Usually the total chromosomecount is determined in l0 to l5 cells, but if mosaicism is suspectedthen 30 or more cell counts will be undertaken. Detailed analysisof the banding
19
Fig.3.7 A n i d i o g r a ms h o w i n gt h e b a n d i n gp a t t e r n so f i n d i v r d u a L chromosomesas revealedby f[uorescent and Giemsastaining
AE NS DC E L LD I V I S I O N CHROMOSOM
3
e,tlpa
Oq
l*
Fis.3.8 s yf M r A W i l k r n s oCny, t o g e n e tU A G - b a n d em d e t a p h a ssep r e a d( C o u r t e o i cnsr tC, i t yH o s p i t aNl ,o t t i n g h a)m
anneal with its complementary target sequenceon a metaphase chromosome,interphasenucleusor extendedchromatin fiber. In fluorescentin-srtu h.ybridization(FISH), the DNA probe is labeled with a fluorochrome which, after hybridization with the patient's sample, allows the region where hybridization has occurred to
submicroscopic deletions and duplications (Fig. 3.10) The group of disorders referred to as the microdeletionsyndromes are described in Chapter 18. Another application is the use of
be visualized using a fluorescencemicroscope.FISH is widely used for clinical diagnosticpurposes and there are a number of different types of probes that may be employed.
Differenttypesof FISHprobe probes Centromeric These consistof repetitive DNA sequencesfound in and around the centromereof a specificchromosome.They were the original probes used for rapid diagnosis of the common aneuploid.v syndromes(trisomies 13, 18, 21; seep. 262) using non-dividing cells in interphaseobtained from a prenataldiagnosticsampleof chorionicvilli (Fig. 3.9).
Chromosome- specificunique- seque nceprobes These are specilic for a particular single locus. Locus-specific probes for chromosome 13q14 and the critical region for Down on chromosome2l(21q22.1321q22.2)canbe utilized s-vndrome together with centromeric probes for chromosomes 18, X and Y to provide rapid prenatal diagnosisfor some of the more common numerical chromosomalabnormalities(p. 45). Uniquesequence probes are particularly useful for identifying tiny
Fis.3.9 (FISH) nucleiwrth of interphase ln-situhybrrdizatron FLuorescent 18.X andY (AneuVysion probesforchromosomes centrorneric consistent probessupptied threeaquasignaLs showing byVysrs) (Courtesy BristoLGenetics Detmege. of Catherine withtrisomy'18 Bristot Hospital, Southmead ) Laboratory,
35
3
CHROMOSOM AE NSDC E L LD I V I S I O N
an interphase FISH probe to identify HER2 overexpressionin breast tumors in order to identify patients likely to benefit from herceptin treatment.
probes Telomeric A complete set of telomeric probes has been developed for all 24 chromosomes(i.e. autosomes| 22 plus X and Y). Using these,a method has been devised that enablesthe simultaneous analysis of the subtelomeric region of every chromosome by meansof only one microscopeslide per patient. This has proved to be a particularly useful technique for identifying tiny'cryptic' subtelomericabnormalities,such as deletionsand translocations, in a small but significantproportion of children with unexplained intellectual impairment (p. 269).
Whole- chromosomepoint probes These consist of a cocktail of probes obtained from different parts of a particular chromosome When this mixture of probes is used together in a single hybridization, the entire relevant chromosomefluoresces(i.e. is 'painted') Chromosome painting is extremely useful for characterizingcomplex rearrangements, such as subtle translocations(Fig. 3.11), and for identifying the origin of additional chromosome material, such as small
Fis.3.11 Chromosomepainting showrng a reciprocaItranslocation g involvin chromosomes3 (red)and 20 (qreen)
supernumerary markers or rings. The latest technology, described as multiplex FISH (M-FISH) or spectral karyotyping (SKY), utilizes pools of whole human chromosome paint probes to provide a multicolor human karyotype in which each pair of homologous chromosomescan be identified on the basis of its unique color when studied using computer-basedimage analysis (Fig. 3.12). These approacheshave proved to be extremely useful for detecting subtle chromosome rearrangements, such as deletions and translocations,and for identifying small supernumerarymarkers and ring chromosomes.
Probesderivedfrom flow-sortedchromosomes Because of their differing size and DNA composition, chromosomes bind different amounts of fluorescent dyes, some of which bind specificallyto GC ('gene rich') sequences and others to AT ('gene poor') sequences.This property of differential binding allows chromosomes to be separated by the process of flow c.ytometrl or fluorescent actiaaterLcell sorting (FACS). This involves staining metaphasechromosomes wirh
Fis.3.10
35
(ELN)regionprobe(Vysrs), Metaphase imageofWrllrams chromosome band7q11 23,showing thedeletion assocrated with WiLLiam s ysn d r o mTeh en o r m a t c h r o m o s ohmaess i g n a lfso r thecontroI probe(green) andtheELNgeneprobe(orange), but thedeLeted chromosome showsontythecontrolprobesignaI (Courtesy of Catherine Delmege, BristotGenetics Laboratory, Southmead HospitaL. Bristol)
a fluorescent DNA-binding dye and then projecting them in a fine jet of droplets acrossa focused laser beam, which excites the chromosomes to fluoresce. The fluorescence intensity is measuredby a photomultiplier and the results are analyzedby a computer that draws up a distribution histogram of chromosome size.This is referred to as tf om karyotype. Flow cytometry can be used to ana,lyzean individual's chromosomes, although its clinical application is limited by its expense and the relatively poor separation achieved for
CHROMOSOM AE NSDC E L LD I V I S I O N
3
Fig.3.12 M - F I S Hs h o w i ncgo m p l ecxh r o m o s o mr e a r r a n g e m er nnvt o l v i n nc u l t u r ebdt o o d g r o m o s o m4e s8 1 31 8a n d2 1a so b s e r v ei d ch (Courtesy lymphocytes Harwett. Oxon, UK, of Dr Rhona Anderson, Research Councit Radiation andGenome Unii,MedicaL StabrLrty a n dA p p t i eldm a g i n)g
certain chromosomes,most noticeably those in the C group. It finds greater application in separating preparations of single chromosomes for the construction of chromosome-specific DNA libraries and in the manufacture of chromosome paints for FISH. The reversepainting procedure usesa flow-sorted portion of
the detection of regions of allele loss and gene amplification (p. 199). Tumor or 'test' DNA is labeled with a green paint, and control normal DNA with a red paint. The two samples are mixed and hybridized competitively to normal metaphase chromosomes,and an image is captured (Fig. 3.13). If the test sample contains more DNA from a particular chromosome region
unidentilied chromosome material, such asa small supernumerary marker or ring, as a paint for hybridization to a normal metaphase spread. The origin of the unidentified chromosome segment is then revealed by identifying the chromosome(s)to which it
than the control sample,that region is identified by an increasein the greento red fluorescenceratio (Fig. 3.14).Similarly a deletion in the test sampleis identified by a reduction in the green to red
hybridizes.
The application of CGH has been extended to include the analysis of single cells for prenatal diagnosis following whole-genome amplification to provide sufficient material for analysis. However, its utility is limited by its resolution and technicaldifficulty. Current limits of resolution are l0megabases ( 1 0 0 0 0 0 0 0 b a s e s ,o r l 0 M b ) f o r l o s s e sa n d 2 M b f o r g a i n s , providing a starting point for positional cloning (p. 74) but not
COM PA R A T IV GE E N OMIC H Y B R ID IZ ATION Comparative genomic hybridization (CGH) was originally developedto overcome the difficulty of obtaining good-quality metaphasepreparations from solid tumors. This technique enables
fluorescenceratio.
37
3
CHROMOSOM AE NSDC E L LD I V I S I O N
faster and more sensitivethan conventional metaphaseanalysis for the identification of constitutional rearrangements (with the exception of balanced translocations) and might replace conventional karyotyping if and when the cost of the arrays becomes6nanciallyviable.
C H R O M O S ONMOEM E N C L A T U R E By convention eachchromosomearm is divided into regions and eachregion is subdivided into bands,numbering alwaysfrom the centromereoutwards (Fig. 3.16).A given point on a chromosome is designatedby the chromosomenumber, the arm (p or q), the region and the band (e.9. 15q12).Sometimesthe word region is
Fig.3.13 C o m p a r a t igveen o m ihcy b r i d i z a t (r C o nG Ha)n a t y ssi sh o w i nagr e a s o fg e n ea m p L i f i c a tai n od nr e d u c t i o( d n e l e t i oinn)t u m o rD N A D A P I d i a m i d r n o p h e n y l i nFdI o T tCef l,:u o r e s c ei si no t h i o c y a n (aCt eo u r t e s y of Dr PeterLichter; GermanCancer Research CenterHeidelberq, : n d A n n l i p d l m : n i n n /) "-v"'v
precise localization of genes involved in tumor development. Mitroarra.y, or array, CGH is likely to supersedemetaphase
omitted, so that 15q12would be referred to simply as band l2 on the long arm of chromosome 15. A shorthand notation system exists for the description of chromosomeabnormalities(tble 3.2). Normal male and female karyotypes are depicted as ,l6,XY and 46,XX, respectively.A male with Down syndrome as a result of trisomy 2l would be representedas47,X1 * 21, whereasa femalewith a deletionof the short arm of one number 5 chromosome (cri du chat syndrome; p. 264) would be representedas 46,XX,del(5p). A chromosome report reading 46,Xlt(2;4)(p23;q25) would indicate a male with
CGH.
38
ARRAYCGH
Table3.2 Symbots usedindescribrng a karyotype
Cytogenetic techniques are traditionally based on microscopic analysis.However, the increasing application of microarray technology is also having a major impact on cytogenetics. Although array CGH is a molecular biology technique, it is included in this chapter becauseit has evolved from metaphase CGH and is being used to investigatechromosomestructure. Array CGH also involves the hybridization of patient and reference DNA, but metaphase chromosomes are replaced
Term
Exptanation
p
Shortarm
q
Longarm
cen
Centromere
det
Detetron;eq46.XX,det('1Xq21)
as the target by large numbers of DNA sequencesbound to g l a s ss l i d e s ( F i g . 3 . 1 5 ) T h e D N A t a r g e t s e q u e n c e sc a n b e mapped clones (yeast artificial chromosome [YAC], bacterial artificial chromosome [BAC], Pl-derived artificial chromosome [PAC] or cosmid) or oligonucleotides.They are spotted on to the microscope slides using robotics to create a microarral', in which each DNA target has a unique location. Following hybridization and washingto removeunbound DNA, the relative levels of fluorescenceare measured using computer software. Arrays with 30000 overlapping mapped clones (one clone per megabase)are available,but the highest resolution is achieved with oligonucleotide arrays, which can include up to 500000 probes.
dup
Duptrcatron: e g 46XYdup(13Xq1+)
fra
Fragilesite
i
l s o c h r o m o s o m ee;g 4 6 , X . i ( X q )
inv
Inversion:eg46XX,inv(9xp12q12)
ish
/n-situhybridization
r
Ring,eg 46:XX,r(21)
t
Transtocation; eg 46.XY.t(2:4)(q21:q21)
ter
Termrnat or end;re tipofarm,e g pteror qter
/
Mosaicism: eg 46.XY147,XXY
+ or -
Sometimes usedaftera chromosome armintextto gainor lossof partofthatchromosome; indicate e g 46,XX,5p-
The application of microarray CGH has extended from cancer cytogeneticsto the detection of any t1,peof gain or loss, including the detection of subtelomeric deletions in patients with unexplained intellectual impairment. Array CGH is
AE NSDC E L LD I V I S I O N CHROMOSOM
cnromosomes cell average slide average
Ratio Profile
05075112515
I
i
L.1Jif I
II
5 59;
I
i
I I I
I 1
n=14
6
n=l 5
2
3
n:14
ll=
=17
I
5
.t0
q
7
4
11
n=] 4
n-
12
n,16
r9
B
s
I
E
t
H
l3
E 't5
l.t
n = 1I
n tr
r--l E
N F -
5
n=l 7
17
€ EStt
E L-r
t! 2n
1R
16
tt=18
21
I
x
s=1,7
F i s .3 . 1 4 C G H r a t o o . o f i r e s f o r t h e C G H a n a l y s i s s h o w n3i 1 n3 FT r gh e v e r t , c a , [ i n e s a d , a c e " t t o e a c h c h r o m o s o m e s h o w f [ u o r e s c e n c e r a t i o s o f andApptiedlmaging) O 5-15 betweentestand controlDNA (Courtesyof Dr PeterLrchterGermanCancerResearchCenterHeidelberg,
ArrayCGH
C o n v e n t i o n aCl G H
.4.
;
Fis.3.15
e
H y b r i d i s a t i oann d a n a l y s i s
2 1.5 ,l
? os E^ N o
-u.c
-1
10
-t.J
-2 D i s t a n c ei n m i l l i o n so f b a s ep a i r s
andarray of conventtonal Comparison invotve the CGHBothtechniques tabeLed of differentraLLy hybridrzation DNA,butthetargets normalandpatient aremetaphase ofthehybridization ancmlcroarrays, chromosomes Theresultsshowdeletions respectively. 10qanddetetion of chromosome ofthreecloneson a 1-Mbbacterial (BAC) array. chromosone artifrciaL (ArrayCGHdatacourtesy of DrJohn Reference NationaI Genetics Barber, Satisbury.) Laboratory [Wessex],
3
CHROMOSOMES ANDCELLDIVISION
Centrioles
Interphase
Nucleolous N u c l e a rm e m b r a n e
1
s-
Centromere
B i p o l a sr p i n d l ef i b e r
12
Centromere
Prophase
3
Xq
1 1
3 Metaphase
+
2 ,5
o
7
Anaphase
Fig.3.16 X chromosome showing theshortandlongarmseachsubdivrded rntoregions andbands
a reciprocal translocation involving the short arm of chromosome 2 at region 2 band 3 and the long arm of chromosome4 at region 2 band 5. This system of karyotype nomenclaturehas been extendedto include the results of FISH studies. For example, a karyotype that reads 46,XX.ish del(15)(qll.2qll.2XDl5510-) refers to a female with a micro-deletion involving l5qll.2 identified by in-situ hybridization analysis using a probe for the Dl55l0 locus (Dl55l0 = DNA from chromosome 15 site l0). This individual will have either Prader-Willi or Angelman syndrome, as discussedin Chaoter 18.
Fis.3.17 Stagesof mitosis
CELL DIVISION MrT0stS At conception the human zygote consists of a single cell. This undergoes rapid division, leading ultimately to the mature human
40
adult consistingof approximately I x l0ra cells in total. In mosr organsand tissues,such as bone marrow and skin, cells continue to divide throughout life. This processof somatic cell division, during which the nucleus also divides, is known as mitosis. During mitosis each chromosome divides into two daughter chromosomes,one of which segregatesinto each daughter cell.
Consequently the number of chromosomes per nucleus remains unchanged. Prior to a cell entering mitosis, each chromosome consists of two identical sister chromatids as a result of DNA replication having taken place during the S phase of the cell cycle (p. 4l). Mitosis is the process whereby each of these pairs of chromatids separatesand dispersesinto separatedaughter cells. Mitosis is a continuous processthat usually lasts l-2 h, but for descriptive purposes it is convenient to distinguish five distinct stages.These are prophase, prometaphase, metaphase,anaphase and telophase(Fig. 3.U).
ANDCELLDIVISION CHROMOSOMES
3
Prophase During the initial stageof ltrophassthe chromosomescondense and the mitotic spindle begins to form. Tho centriolesform in each cell, from which mirotubulesradiate as the centriolesmove towards opposite poles of the cell.
Prometaphase
Exitfrom cellcycle (non-d ividing
Dving prometaphasethe nuclear membrane begins to disintegrate, allowing the chromosomes to spread around the cell. Each chromosomebecomesattachedat its centromereto a microtubule of the mitotic spindle.
Metaphase ln metaphasethe chromosomes become aligned along the equatorial plane or plate of the cell, where each chromosomers attached to the centriole by a microtubule forming the mature spindle.At this point the chromosomesare maximally contracted and, therefore, most easily visible. Each chromosome resembles the letter X in shape,as the chromatids of each chromosome have separatedlongitudinally but remain attachedat the centromere, which has not yet undergone division.
Anaphase In analthasethe centromere of each chromosome divides longitudinally and the two daughter chromatids separateto opposite poles of the cell.
Telophase By telophasethe chromatids, which are now independent chromosomesconsistingof a single double helix, have separated completely and the two groups of daughter chromosomes each become enveloped in a new nuclear membrane. The cell cytoplasmalsoseparates(cytokinesis),resulting in the formation of two new daughter cells, each of which contains a complete diploid chromosomecomplement.
T H EC E L LC Y C L E The period between successivemitoses is known as the interphase of the cell cycle (Fig. 3.18). In rapidly dividing cells this lasts for between 16 and 24h. Interphase commences with the Gt (G = gap) phase during which the chromosomesbecome thin and extended.This phase of the cycle is very variablein length and is responsiblefor the variation in generation time between different cell populations Cells that have stopped dividing, such as neurons, usually arrest in this phaseand are said to have entered a non-cyclic stageknown as G6. The G1 phaseis followed by the S phase(S = synthesis),when DNA replication occurs and the chromatin of eachchromosome is replicated.This resultsin the formation of two chromatids,giving eachchromosomeits characteristicX-shaped configuration.The
F i s .3 . 1 8 S t a g e so f t h e c e LcLy c t eG 1a n d G 2a r et h e f i r s t a n ds e c o n d ' r e s t i n g ' stagesof interphaseS is the stageof DNA repticatronM, mitosis
processof DNA replication commencesat multiple points on a chromosome(p. l3). Homologouspairsofchromosomesusuallyreplicatein synchrony. However, one of the X chromosomes is always late in replicating. This is the inactive X chromosome (p. 98) that forms the ser chromatinor so-calledBarr body,which can be visualizedin interphase in female somatic cells. This used to be the basis of a rather unsatisfactorymeans of sex determination based on analysisof 'buccal smear'. cells obtained by scraping the buccal mucosa- a Interphase is completed by a relatively short G2 phase during which the chromosomes begin to condense in preparation for the next mitotic division.
MEt0Sls ,L4eiosisis the process of nuclear division that occurs during the final stage of gamete formation. Meiosis differs from mitosis in three fundamental ways: l. Mitosis results in eachdaughter cell having a diploid chromosome complement (46). During meiosis the diploid count is halved so that each mature gametereceivesa haploid complement of 23 chromosomes. 2. Mitosis takesplacein somaticcells and during the early cell divisions in gamete formation. Meiosis occurs only at the final divisionof gametematuration. 3. Mitosis occurs as a single one-stepprocess.Meiosis can be consideredastwo cell divisionsknown asmeiosisI and meiosisII, each ofwhich can be consideredas having prophase,metaphase, anaphaseand telophasestages,as in mitosis (Fig. 3.19).
41
CHROMOSOMES ANDCELLDIVISION
Earlypachytene
Late pachytene
Telophase I
Anaphase ll
Telophase ll
Fis.3.19 Stages of meiosis
42
AE NSDC E L LD I V I S I O N CHROMOSOM
M e i o s i sI
I Anophose
This is sometimesreferred to as the reduction division, becauseit is during the first meiotic division that the chromosomenumber
The chromosomesnow separateto opposite poles of the cell as the spindle contracts
3
is halved.
I Telophose ProphaseI Chromosomesenter this stagealreadysplit longitudinally into two chromatids joined at the centromere.Homologous chromosomes pair and, with the exception of the X and Y chromosomesin
Each set of haploid chromosomeshas now separatedcompletely to oppositeends of the cell, which cleavesinto two new daughter or 1oq/tes. gametes,so-called secondarysqermatoc)/tes
male meiosis,exchangeof homologoussegmentsoccurs between non-sister chromatids, that is, chromatids from each of the pair
M e i o s i sl l
of homologous chromosomes.This exchangeof homologous segments between chromatids occurs as a result of a process known as crossingorer or recombination.The importance of
This is essentiallythe sameas an ordinary mitotic division. Each chromosome,which exists as a pair of chromatids, becomes aligned along the equatorialplane and then splits longitudinally, leading to the formation of two new daughter Bametes,known as
crossingover in linkageanalysisand risk calculationis considered later (pp. 130,336) During prophase I in the male, pairing occurs between homologoussegmentsof the X and Y chromosomesat the tip of their short arms, with this portion of each chromosome being known as the pseudoautosomal regton (p. I l2).
spermatidsor ova.
of meiosis The consequences
Leptotene
When consideredin terms of reproduction and the maintenance of the species,meiosis achievestwo maior obiectives.Firstly it facilitateshalving of the diploid number of chromosomesso that each child receiveshalf of its chromosome complement from each parent. Secondly it provides an extraordinary potential for
The chromosomesbecomevisible as thev start to condense.
generatinggeneticdiversity.This is achievedin two ways:
Zygotene
l. When the bivalentsseparateduring prophaseof meiosisI, they do so independently of one another This is consistentwith Mendel's third law (p. 5). Consequently each gamete recelves a selection of parental chromosomes.The likelihood that any two gametes from an individual will contain exactly the same
The prophasestageof meiosisI is relativelylengthy and can be subdividedinto five stages.
Homologous chromosomes align directly opposite each other, a process known as synapsis,and are held together at several points along their length bv filamentous structures known as synapt onemaI complexes. Pachytene Each pair of homologous chromosomes, known as a biztalent, becomestighdy coiled. Crossingover occurs,during which homologous regions of DNA are exchangedbetweenchromatids. Diplotene The homologous recombinant chromosomes now begin to separate but remain attached at the points where crossing over has occurred. These are known as chiasmata.On average, small, medium and large chromosomeshave one, two and three chiasmata,respectively,giving an overall total of approximately 40 recombinationeventsper meiosisper gamete.
chromosomesis 1 in 223,or approximately1 in 8 million. 2. As a result of crossingover,eachchlomatid usually contains portions of DNA derived from both parental homologous chromosomes.A large chromosome typically consists of three or more segments of alternating parental origin. The ensuing probability-that any two gameteswill have an identical genome is therefore inlinitesimally small. This dispersion of DNA into different gametesis sometimesreferred to as'gene shuffling'.
GAMETOGENESIS
Diakinesis
The processof gametogenesisshowsfundamental differencesin males and females(Table 3.3). These have quite distinct clinical
Separationof the homologouschromosomepairs proceedsasthe
consequencesif errors occur.
chromosomesbecomemaximallv condensed.
OOGENESIS I Metophose The nuclearmembranedisappearsand the chromosomesbecome alignedon the equatorialplaneofthe cell where they havebecome
Mature ova develop from oogonia by a complex series of intermediatesteps.Oogoniathemselvesoriginatefrom primordial germ cells by a processinvolving 20 to 30 mitotic divisions that
attachedto the spindle, as in metaphaseof mitosis.
occur during the lirst few months of embryonic life By the
43
3
CHROMOSOMES ANDCELLDIVISION
the time of ovulation, when a single secondaryoocyte is formed. This receivesmost of the cytoplasm. The other daughter cell
Tabte3.3 Differences in qametoqenesis in malesand females Males
Females
Commences
Puberty
Eartyembryonic tife
Duration
60-65days
10-50years
Numbersof mitoses in gameieformation
30-500
20-30
Gameteproduction peTmerosrS
4 spermatids
1ovum* 3 potarbodies
Gameteproduction
100-200mittion perejacutate
1ovumpermenstrual cycte
from the first meiotic division consistslargely of a nucleus and is known as a polar body. Meiosis II then commences,during which fertilization can occur.This secondmeiotic division resultsin the formation of a further polar body (Fig. 3.20). It is probable that the very lengthy interval between the onset of meiosis and its eventual completion, up to 50years later, accounts for the well documented increasedincidence of chromosome abnormalities in the offspring of older mothers (p. a6). The accumulating effects of 'wear and tear' on the primary oocyte during the dictyotene phase probably damage the cell's spindle formation and repair mechanisms, thereby predisposingto non-disjunction (p. l6).
SPERMATOGENESIS completion of embryogenesisat 3months of intrauterine life, the oogonia have begun to mature into primary oocytes that start to undergo meiosis. At birth all of the primary oocytes have entered a phase of maturation arrest, known as d,ictyltene, in which they remain suspendeduntil meiosis I is completed at
In contrast, spermatogenesisis a relatively rapid process with an averageduration of 60-65 days. At puberty spermatogonia, which will already have undergone approximately 30 mitotic divisions, begin to mature into primary spermatocyteswhich enter meiosisI and emergeas haploid secondaryspermatocytes.These
ncepflon
Conception
Spermatogonia
ff** Fetal life $
Primary spermarocyre
Primary oocyle
$Birth *M
Puberty ffi
o
Dictyotene E.
ul a t i o n
w
Secondary oocyte
P o l a rb o d i e s
60-65 days
zysot.f;D Spermatozoa
Oogenesis
Fis.3.20 44
Stages ofoogenesis andspermatogenesis n.haploid number
Spermatogenesis
ANDCELLDIVISION CHROMOSOMES
then undergo the second meiotic division to form spermatids, which in turn develop without any subsequentcell division into mature spermatozoa,of which 100 to 200 million are present in
Trisomy
each ejaculate. S p e r m a t o g e n e s iiss a c o n t i n u o u sp r o c e s si n v o l v i n g m a n y mitotic divisions, possibly as many as 20 to 25 per annum, so that mature spermatozoaproduced by a man of 50yearsor older
The presence of an extra chromosome is referred to as trisomy. Most casesof Down syndrome are due to the presence of an additional number 2l chromosome; hence Down syndrome is often known as trisomy 21. Other autosomal trisomies compatible with survival to term are Patau syndrome (trisomy 13) (p. 26il and Edwards syndrome (trisomy l8) (p. 264)'
could well have undergone severalhundred mitotic divisions. The observed paternal age effect for new dominant mutations (p. I 13) is consistentwith the concept that many mutations arise as a consequenceof DNA copy errors occurring during mitosis.
Most other autosomal trisomies result in early pregnancy loss, with trisomy 16 being a particularly common finding in firsttrimester spontaneousmiscarriages.The presenceof an additional sex chromosome (X or Y) has only mild phenotypic
AB CHROMOSOM EN O R M A L I T I E S Specific disorders caused by chromosome abnormalities are consideredin Chapter 18. In this section discussionis restricted to a review of the different types of abnormality that may occur. These can be divided into numerical and structural, with a third categoryconsistingof different chromosomeconstitutionsin two or more cell lines (Box 3.1)
N U M E R I C AALB N O R M A L I T I E S Numerical abnorrnalitiesinvolve the loss or gain of one or more chromosomes, referred to as aneuploidlt,or the addition of one or more complete haploid complements, known aspolyp loidy. Loss of a single chromosomeresults in monlslmJ/.Gain of one or two homologous chromosomes is referred to as trisomy a:ndtetrasomlt, respectively.
Box 3.1 Typesof chromosome abnormatity Numerical Aneuptoidy Monosomy Trisomy Tetrasomy Potyptoidy Tdploidy Tetraptoidy StructuraI Transiocatrons procaI Reci Robertso nian Deletions Insertrons lnversrons Paracentric Pericentric Rings tsocnTomosomeS Differentcel[ lines (mixoptoidy) Mosaicism Chimerism
3
effects(p. 99). Tiisomy 21 is usually causedby failure of separationof one of the pairs of homologous chromosomes during anaphaseof maternal meiosis I. This failure of the bivalent to separate is called non-d,isjunction.Less often, trisomy can be caused by nondisjunction occurring during meiosis II when a pair of sister chromatids fails to separate. Either way the gamete receives two homologous chromosomes (disomy)' and if subsequent fertilization occurs a trisomic conceptusresults (Fig. 3.21)'
Theoriginof non-disiunction The consequencesof non-disjunction in meiosis I and meiosis II differ in the chromosomes found in the gamete. An error in meiosis I leads to the gametecontaining both homologs of one chromosome pair. In contrast, non-disiunction in meiosis II resultsin the gametereceivingtwo copiesof one of the homologs of the chromosome pair. Studies using DNA markers have shown that most children with an autosomal trisomy have inherited their additional chromosomeas a result of non-disiunction occurring during one of the maternal meiotic divisions (Thble 3'4). Non-disjunction can also occur during an early mitotic division in the developing zygote. This results in the presence of two or more different cell lines, a phenomenon known as (p.52). mosaicism
originof meioticerrorleadlngto Tabte3.4 Parental aneuptoidY Chromosomeabnormatity
Paternat(%)
Maternat(%)
13 Trisomy
15
85
18 Trisomy
10
90
21 Trrsomy
5
95
80
20
47XXX
5
95
47.XXY
45
55
47XYY
100
0
45,X
45
3
CHROMOSOM AE NSDC E L LD I V I S I O N
Nondisjunction
n
sfl I
N o r m a lm o n o s o m igc a m e t e s
D i s o m i cg a m e t e s
N u l l i s o m igca m e t e s
D i s o m i c N u l l i s o m i c N o r m a lm o n o s o m i c gamete gamete gametes
Fis.3.21 S e g r e g a t i oa nt m e i o s i os f a s i n g t ep a i ro f c h r o m o s o m ei nsA n o r m am I e i o s i sB, n o n - d i s j u n c t iionnm e i o s i Isa n dC n o n - d i s j u n c t iionn m e i o s i lsl .
The causeof non-disjunction The cause of non-disjunction is uncertain. The most favored explanation is that of an aging effect on the primary oocyte, which can remain in a state of suspended inactivity for up to 50years(p. 44). This is basedon the well documentedassociation between advancing maternal age and increased incidence of Down syndrome in offspring (seeTable 18.4;p.263) A maternal ageeffect has also been noted for trisomies 13 and 18. It is not known how or why advancingmaternal agepredisposes to non-disjunction, although researchhas shown that absenceof recombinationin prophaseof meiosisI predisposesto subsequent non-disjunction. This is not surprising, as the chiasmatathat are formed after recombinationare responsiblefor holding eachpair of homologous chromosomestogether until subsequentseparauon occurs in diakinesis.Thus failure of chiasmataformation could allow each pair of homologs to separateprematurely and then segregaterandomly to daughter cells. In the female, however, recombinationoccursbeforebirth whereasthe non-disjunctional event occurs any time between 15 and 50years later. This
46
suggeststhat at leasttwo factors can be involved in causingnondisjunction: an absenceof recombination between homologous chromosomesin the fetal ovary, and an abnormality in spindle formation many years later. An alternative explanation for the associationof advancing maternal agewith increasedrisk of autosomaltrisomy is that survival
of trisomic embryoscould be the result of an age-relatedreduction in 'immunologic'competence. Firm evidencefor this theory is limited. Other factors that have been implicated in causing nondisjunction include radiation and delayed fertilization after ovulation. In animals it has been shown that an increased incidence of aneuploid embryos can result from lengthening of the interval between ovulation and fertilization. It has been suggestedthat this could account for the relationship between maternal age and the incidence of Down syndrome, as with increasingage intercourse is likely to occur lessfrequently, with delayed fertilization therefore being more likely. The story is further complicated by the fact that in some species,such as Drosophila,non-disjunction is under geneticcontrol. This could account for those occasionalfamilies that seem to be prone to recurrent non-disjunction.
Monosomy The absenceof a single chromosomeis referred to asmonosomy. Monosomy for an autosome is almost always incompatible with survival to term. Lack of contribution of an X or a Y chromosome results in a 45,X karyotype,which causesthe condition known as Turner syndrome (p. 272) As with trisomy, monosomy can result from non-disjunction in meiosis.If one gamete receivestwo copies of a homologous
CN ED L LD I V I S I O N CHROMOSOMESA
chromosome(dtsomy),the other correspondingdaughter gamete will haveno copy of the samechromosome(nullisomy).Monosomy can alsobe causedby lossof a chromosomeasit movesto the pole ofthe cell during anaphase,an event known as'anaphaselag'.
Potyptoidy Polyploid cells contain multiples of the haploid number of chromosomessuch as 69, triploidy, or 92, tetruplolly. In humans triploidy is found relatively often in marerial grown from spontaneousmiscarriages,but survival beyond mid-pregnancv is rare. Only a few triploid live births havebeen describedand all died soon after birth. Triploidy can be caused by failure of a maturarion meiotic division in an ovum or sperm, leading,for example,to retention of a polar body or to the formation of a diploid sperm. Alternatively it can be causedby fertilization of an ovum by two sperm: this is known as disperml When triploidy results from the presence of an additional set of paternal chromosomes, the placenta is usually swollen with what are known as hydatidiform changes (p. 96). In contrast, when triploidy results from an additional set of maternalchromosomes,the placentais usually small.Triploid-v usuall-vresults in early spontaneousmiscarriage(Fig. 3.22).The differencesbetweentriploidy due to an additional setof paternal chromosomes or maternal chromosomes provide evidence for important'epigenetic' and'parent of origin' effectswith respect to the human genome. These are discussed in more detail in Chaoter 6
il lfl rtl
11
3
S T R U C T U RA B LNORMALITIES Structural chromosomerearrangementsresult from chromosome breakagewith subsequentreunion in a different configuration. They can be balancedor unbalanced.In balancedrearrangements the chromosome complement is complete, with no loss or gain of genetic material. Consequently,balancedrearrangementsare generallyharmlesswith the exception of rare casesin which one of the breakpoints damagesan important functional gene.However, carriersof balancedrearrangementsare often at risk of producing children with an unbalancedchromosomalcomplement. When a chromosome rearrangement is unbalanced the chromosomal complement contains an incorrect amount of chromosomematerial and the clinical effectsare usually serious.
Translocations A translocationrefers to the transfer of geneticmaterial from one chromosome to another.A reciprocal translocation is formed when a break occurs in each of two chromosomeswith the segments being exchangedto form two new derivative chromosomes. A robertsonian translocation is a particular type of reciprocal translocationin which the breakpointsare locatedat, or closeto, the centromeresof two acrocentricchromosomes(Fig. 3.23).
ReciprocoI tronsIocotions A reciprocal translocation involves breakageof at least two chromosomes with exchangeof the fragments. Usually the
12 R e cpi r o c aI
l8
c!.
.!tq
19
20
r)* 21
*-*s 22
Fis.3.22 Karyotype fromproducts of conception ofa spontaneous m i s c a r r i a sgheo w i ntgr i p t o i d y
Fis.3.23 TypesoftransLocation
47
3
CHROMOSOM AE NSDC E L LD I V I S I O N
chromosome number remains at 46 tnd, if the exchanged fragments are of roughly equal size, a reciprocal translocation can be identified only by detailed chromosomalbanding studies or FISH (see Fig. 3.ll). In general,reciprocaltranslocations are unique to a particular family, although, for reasonsthat are unknown, a particular balancedreciprocaltranslocationinvolving the long arms of chromosomesl1 and 22 is relatively common. The overall incidence of reciprocal translocationsin the general population is approximately 1 in 500.
22 S i t e so f 0reaKage Normal chromosomes
Segregation at meiosis The importance of balancedreciprocaltranslocationslies in their behavior at meiosis,when they can segregateto generatesignificant chromosomeimbalance.This can lead to early pregnancyloss or to the birth of an infant with multiple abnormalities.Problems arise at meiosis becausethe chromosomes involved in the translocation cannot pair normally to form bivalents. Instead they form a cluster known as a pach1tenequadriaalent(Fig. 3.2a).
B al an c e d t r an s l o c a t i o n
D
The key point to note is that each chromosome aligns with homologousmaterial in the quadrivalent. 2:2 segregatiozWhen the constituent chromosomes in the quadrivalent separateduring the later stagesof meiosis I they
AC Pachytene qu a dr i v al e n t r nm e r o s r s
can do so in several different ways (Table 3.5). If alternate chromosomessegregateto each gamete, the gamete will carry a normal or balancedhaploid complement (Fig. 3.25) and with fertilization the embryo will either have normal chromosomes or carry the balanced rearrangement. If, however, adjacent chromosomes segregatetogether, this will invariably result in the gameteacquiring an unbalancedchromosome complement For example, in Figure 3.24, if the gamete inherits the normal number 1l chromosome (A) and the derivative number 22 chromosome(C), then fertilization will result in an embryo with
\ /-.-P l \ 2 =
/_,_____-_f_P
1r.+
tl
D
Fis.3.24 g chromosomes Howa balancedreciprocaL transtocation involvrn 11and22leadsto theformation ofa quadrrvalent at pachytene in r< meiosisI Thequadrivatent isformedto maintain l66pnlnnnr p anr n g
(seeFigs3.24and3.25) Tabte3.5 Patterns ofsegregation ofa reciprocaItranstocation Patternof segregation
Segregatingchromosomes
Chromosomeconstitutioningamete
222 Atternate
A+D
NormaI
B+C
Batanced translocation
(non-homotogous Adjacent-1 centTomeres segregate together)
A+CorB+D
(homotogous Adlacent-2 centromeres segregate together)
A + B o r C+ D
Unbalanced, leading to a combination of partia[ monosomy andpartial trr(nm\/
rn tho
7\/n^fo
3:1 T h r e ec h r o m o s o m e s
A+B+C A+B+D A+C+D B+C+D
Unbatanced, leading to tnsomyinthezygote
0nechromosome
A B
Unbatanced, leading to monosomy inthezygote
c 48
D
ANDCELLDIVISION CHROMOSON4ES
'-+--j =+rr------C€ B llll IJII VV
pachytene qu a dr i v aIen t
D
yieldsnormal Alternate segregation or balanced haploid complement
3
trisomy for the derivative 22 chromosome is the only viable unbalanced product. All other patterns of malsegregationlead to early pregnancy loss. Unfortunately, tertiary trisomy for the derivative 22 chromosome is a serious condition in which affected children have multiple congenital abnormalities and severe learning difficulties. Risks in reciprocal translocations When counseling a carrier of a balanced translocation it is necessaryto consider the particular rearrangementto determine whether it could result in the birth of an abnormal baby.This risk is usually somewhere between lolo and l0o/o. For carriers of the 1l.22 translocationdiscussed,the risk has been shown to be 5olo.
Robe rtsonion tron slocotions AB yieldsunbalanced Adjacent-1 segregation haploid complement
A Robertsonian translocation results from the breakageof two acrocentric chromosomes(numbers 13, 14, 15, 2l and 22) at or close to their centromeres,with subsequentfusion of their long arms (seeFig. 3.23).This is alsoreferred to as centricfusion. The short arms of each chromosome are lost, this being of no clinical importance as they contain genes only for ribosomal RNA, for which there are multiple copies on the various other acrocentric chromosomes.The total chromosome number is reduced to 45. As there is no loss or gain of important genetic
AB yieldsunbalanced Adjacent-2 segregation haploid complement
material, this is a functionally balanced rearrangement. The overall incidence of Robertsonian translocationsin the general population is approximately 1 in 1000, with by far the most common being fusion of the long arms of chromosomesl3 and 1 , 1( l 3 q 1 4 q ) . Segregation at meiosis As with reciprocaltranslocations,the importanceof Robertsonian translocations lies in their behavior at meiosis. For example, a carrier of a l4q21q translocation can produce gametes with (Fig 3.26):
AB
F i g .3 . 2 5 patterns Thedrfferent of2:2segregatron thatcanoccur fromthe quadrivatent shown rnFrg3 24 SeeTabte 35
monosomy for the distal long arm of chromosome 22 and trisomy for the distal long arm of chromosome 11. Another possibility is that three chromosomes 3:l segregation segregateto one gametewith only one chromosomein the other gamete.If, for example,in Figure 3.24 chromosomesl1 (A),22 (D) and the derivative22 (C) segregatetogether to a gametethat is subsequentlyfertilized, this will result in the embryo being trisomic for the materialpresentin the derivative22 chromosome. This is sometimesreferred to as tertiary trisoml. Experiencehas shown that, with this particular reciprocaltranslocation,tertiary
l. A normal chromosome complement (i.e. a normal l4 and a normal 2l). 2 . A b a l a n c e dc h r o m o s o m e c o m p l e m e n t ( i . e . a l 4 q ? l q translocationchromosome). 3. An unbalancedchromosome complement possessinBboth the translocationchromosomeand a normal 21. This will result in the fertilized embryo having Down syndrome. 4. An unbalancedchromosomecomplement with a normal 14 and a missing21. 5 An unbalancedchromosomecomplement with a normal 21 and a missing 14. 6. An unbalanced chromosome complement with the translocationchromosomeand a normal 14 chromosome' The last three combinationswill result in zygoteswith monosomy 21, monosomy 14 and trisomy 14, respectively.All of these combinations are incompatible with survival beyond early pregnancy.
49
3
CHROMOSOM AE NSDC E L LD I V I S I O N
H ll
Normal chromosomes
U
14
14
21
21
B al an c e d 14121carrier
P o s sbil e g am e t e s 21
14121
Normal
Normal carrler
14
0utcome
14121 2 1 Down's syndrome
14
21
14
14121
v
Lethal
Fis.3.26 Formation ofa 14q2'1q robertsonian transtocation gametechromosome andthepossibte patterns thatcanbe produced at meiosis
50
Translocation Down syndrorne The major practical importance of Robertsoniantranslocations is that they can predispose ro the birth of babies with Down syndromeasa result of the embryo inheriting two normal number 21 chromosomes (one from each parent) plus a translocation chromosome involving a number 21 chromosome (Fig. 3.27). The clinical consequencesare exactly the same as those seenin pure trisomy 21. However, unlike trisomy 27, the parents of a child with translocation Down syndrome have a relatively high risk of having further affectedchildren if one of them carriesrhe rearrangementin a balancedform. Consequently the importance of performing a chromosome analysis in a child with Down syndrome lies not only in confirmation of the diagnosis,but also in identilication of those children with a translocation. In roughly two-thirds of these latter children with Down syndrome, the translocation will have occurred as a new (de noao)event in the child, but in the remaining one-third one of the parents will be a carrier. Other relatives might also be carriers. Therefore it is regarded as essentialthat efforts are made to identify all adult translocation carriers in a family so thar rhey can be alerted to possiblerisks to future offspring. This is sometimesreferred to as translocation tracing,or'chasing'.
Fis.3.27 parnting showin Chromosome g a 14q21q Robertsonian translocation tna childwithDownsyndromeChromosome 21is shownInbtueandchromosome 14inyetlow(Courtesy of Meg Heath. CityHospitaL, Nottrngham )
CHROMOSOMESC AN EL DLD I V I S I O N
3
Risks in Robertsonian translocations Studies have shown that the female carrier of either a 13q21qor a l4q2lqRobertsonian translocationruns a risk of approximately 10o/ofor having a baby with Down syndrome, whereasfor male carriers the risk is l-3olo. It is worth sparing a thought for the unfortunate carrier of a 2lqZlq robertsonian translocation AII gametes will be either nullisomic or disomic for chromosome 21. Consequentlyall pregnancieswill end either in spontaneous miscarriageor in the birth of a child with Down syndrome.This is one of the very rare situations in which offspring are at a risk of greater than 50o/ofor having an abnormality. Other examples are the children of a mother with untreated phenylketonuria (p. 162), parents who are both heterozygous for the same autosomaldominant disorder (p. 107), and parentswho are both homozygous for the sa,megenecausing an autosomal recessive disorder,such as sensorineuraldeafness.
Deletions A deletioninvolves loss of part of a chromosome and results in monosomy for that segment of the chromosome A very large deletion is usually incompatible with survival to term, and as a generalrule any deletion resulting in lossof more than 2oloof the total haploid genomewill havea lethal outcome. Deletions are now recognizedasexisting at two levels.A'large'
Fi9.3.28 (Cambro) paintrng chromosome 5 paint using Chromosome whrch 5 (arrowed) showing a smallportionof chromosome 13 SeeFiq329 fromchromosome marksthesiteofan insertion (Courtesy Nottingham CityHospitaL, of MegHeath, )
chromosomal deletion can be visualized under the microscope. Several deletion syndromes have been described, such as the WolfHirschhorn and cri du chat syndromes, which involve loss of materialfrom the short arms of chromosomes4 and 5, respectively (p. 264). More recently submicroscopic microdeletions have been identified with the help of high-resolution prometaphase cytogeneticsaugmented by FISH studies. For example, it has been shown that severalpreviously unexplainedconditions, such as the Prader-Willi and Angelman syndromes,can be causedby microdeletions(p 116, I l7).
lnsertions An insertionoccurs when a segmentof one chromosomebecomes inserted into another chromosome(Figs 3.28 & 3.29). If the inserted material hasmoved from elsewherein another chromosome then the karyotype is balanced. Otherwise an insertion causes an unbalancedchromosomecomplement. Carriers of a balanced deletion insertion rearrangementare at a 50o/orisk ofproducing unbalanced gametes,as random chromosome segregationat meiosis will result in 50o/oof the gametesinheriting either the deletion or the insertion, but not both.
lnversions An inaersionis a two-break rearrangement involving a single chromosomein which asegmentisreversedin position (i.e.inverted) If the inversion segment involves the centromere it is termed a pericentricinaersion(Fig. 3.30A). If it involvesonly one arm of the chromosomeit is known as a paracentricinuersion(Fig. 3.308).
Fig.3.29 pe a i n t r nugs i n gc h r o m o s o m 1e 3p a i n(tC a m b i o ) Chromosom 1e 3o r i g i ni n s e r t eidn t o s h o w r nm g a t e r i a l oc fh r o m o s o m (Courtesy of MegHeath, CityHospital 5 (arrowed) chromosome N o t t r n g h a) m
51
3
CHROMOSOM AE NSDC E L LD I V I S I O N
relatively large.The larger these are, the more likely it is that their effects on the embryo will be so severethat miscarriageensues For a large pericentric inversion the duplicated and deleted segments will be relatively small so that survival to term and beyond becomesmore likely.Thus, in general,the larger the size of a pericentric inversion the more likely it becomesthat it will result in the birth of an abnormal infant. The pooled results of severalstudieshaveshown that a carrier of a balancedpericentric inversion runs a risk of approximately 5-10o/ofor having a child with viable imbalance if that inversion has already resulted in the birth of an abnormal baby.The risk is nearer lolo if the inversion has been ascertainedbecauseof a history of recurrentmiscarriage. Paracentric inversions If a cross-overoccurs in the inverted segment of a paracentric inversion this will result in recombinant chromosomesthat are either acentric or dicentric (Fig 3 3lB). Acentric chromosomes, which strictly speakingshould be known aschromosomalfragments, cannot undergo mitotic division, so that survival of an embryo with such a rearrangementis extremely uncommon. Dicentric chromosomesare inherently unstable during cell division and are, therefore,alsounlikely to be compatible with survival of the embryo. Thus, overall, the likelihood that a balanced parental paracentric inversion will result in the birth of an abnormal baby is exremely low
F i s .3 . 3 0 A Pericentricand B paracentricinversions(Courtesyof DrJ. Dethanty.GattonLaboratory,London)
Inversions are balanced rearrangementsthat rarely cause problems in carriers unlessone of the breakpointshas disrupted an important gene.A pericentricinversioninvolving chromosome number 9 occursasa common structural variantor polymorphism, also known as a heteromorphism,and is not thought to be of any functional importance. Howeveq other inversions,although not causing any clinical problems in balanced carriers, can lead to significant chromosome imbalance in offspring, with important clinical consequences.
Segregotionot meiosis Pericentric inversions An individual who carries a pericentric inversion can produce unbalancedgametesif a cross-overoccurs within the inversion segment during meiosis I, when an inversion Ioop forms as the chromosomes attempt to maintain homologous pairing at synapsis.For a pericentric inversion, a cross-overwithin the loop will result in two complementaryrecombinantchromos<,rmcs, one with duplication of the distal non-inverted segmentand deletion
52
of the other end of the chromosome,and the other having the opposite arrangement(Fig. 3.31A) If a pericentric inversion involves only a small proportion of the total length of a chromosome then, in the event of crossing over within the loop, the duplicated and deletedsegmentswill be
Ringchromosomes A ring chromosome is formed when a break occurs on each arm of a chromosome leaving two 'sticky' ends on the central portion that reunite as a ring (Fig. 3.32). The two distal chromosomal fragments are lost so that, if the involved chromosome is an autosome,the effectsare usually serious. Ring chromosomes are often unstable in mitosis so that it is common to find a ring chromosomein only a proportion of cells. The other cells in the individual are usually monosomic because of the absenceof the ring chromosome.
lsochromosomes An isochromosomeshows loss of one arm with duplication of the other. The most probable explanation for the formation of an isochromosomeis that the centromere has divided transversely rather than longitudinally. The most commonly encountered isochromosomeis that which consistsof two long arms of the X chromosome.This accountsfor up to l5olo of all casesof Turner syndrome(p.272).
MIXOPLOIDY) M O S A I C I SAMN DC H I M E R I S(M Mosaicism Mosaicismcan be defined as the presencein an individual, or in a tissue, of two or more cell lines that differ in their genetic constitution but are derived from a single zygote, that is, they have
CHROMOSOM AE NSDC E L LD I V I S I O N
ED
CBDE
ED
BCA
3
F i s .3 . 3 1 Mechanism over of production inversions by crossing of recombinant unbalanced andB paracentric chromosomes fromA pericentric in an inversion [oop.(Courtesy of DrJ Dethanty, GattonLaboratory, London)
the same genetic origin. Chromosome mosaicismusually results from non-disjunction in an early embryonic mitotic division with the persistenceof more than one cell line. If, for example, the two chromatids of a number 2l chromosome failed to separateat the second mitotic division in a human zygote (Fig. 3.33), this would result in the four-cell zygote having two cells with 46 chromosomes,one cell with 47 chromosomes(trisomy 2l) and one cell with 45 chromosomes(monosomy 2l). The ensuing cell line with 45 chromosomeswould probably not survive,so that the
resulting embryo would be expected to show approximately 33olo mosaicism for trisomy 21. Mosaicism accounts for l-2o/o of all clinically recognizedcasesof Down syndrome. Mosaicism can also exist at a molecular level if a new mutation arisesin a somatic or early germline cell division (p. ll4). The possibility of germline or gonadalmosaicismis a particular concern when counselingthe parentsof a child in whom a condition such as Duchenne muscular dystrophy (p. 297) is an isolatedcase.
Chimerism Chimerismcan be defined as the presence in an individual of two or more geneticallydistinct cell lines derived from more than one zygote,that is, they havea different geneticorigin. The word chimera is derived from the mythological Greek monster that had the head of a lion, the body of a goatand the tail of a dragon. Human chimeras are of two kinds: dispermic chimerasand blood chimeras.
Fis.3.32 PartiaLkaryotype showing a ringchromosome 9 (Courtesy of Meg Heath. CityHospita[, Nottingham )
Dispermicchimeros These are the result of double fertilization whereby two genetically different sperm fertilize two ova and the resulting two zygotes
53
3
CHROMOSOM AE NSDC E L LD I V I S I O N
Rooney D E, Czepulkow'skiB H 1997Human chromosomepreparation. Essentialtechniques John Wiley, Chichester A laboratorj,handboohdescribingthe dtJJbrent methodsaaailablefor chromosome analysts. blurring the SpeicherM R, Carter N P 2006The new cytogenetics: boundarieswith molecularbiology.Nat Rev Gen 6:782-792 An up-to-dateret:ien of the excitingadaancesin FISH and array-based. techniquesTherman E, SusmanM 1993Human chromosomes. Structure,behaviour and effects,3rd edn Springer,NewYork A usefuland comprehensif,^e introductiont0 hum&nc.yt0genetics. Tiio J H, Levan A 1956The chromosomenumber of man Hereditas 42: 1-6 A landmarhpaper that described a reliablemethotlJbrstudltinghuman chromosomes and gaxebirth to the subjectof clinical cJltlgenettcs.
1 c e l lz y g o t e
Website
2ndnitotic
Normal disomy
National Center for Biotechnology Information. Microarrays: chipping awayat the mysteriesof scienceand medicine. Online Available: http://wrvwncbi nlm nih gov/About/primer,/microarrays.html
Monosomy
Fis.3.33 Generation of somaticmosaicismcausedby mitotrcnon-disjunction
fuse to form one embryo. If the tlvo zygoresare of different sex, the chimeric embryo can develop into an individual with true hermaphroditism (p. 275) and an XX/XY karyotype. Mouse chimerasof this type can now be produced experimentallyin the laboratory to facilitate the study of gene transfer.
Bloodchimeros Blood chimerasresult from an exchangeof cells,via the placenta, between non-identical twins in utero. For example, 90o/oof one twin's cells can have an XY karyotype with red blood cells showing predominantly blood group B, whereas 90oloof the cells of the other twin can have an XX karyotype with red blood cells showing predominantly blood group A. It has long been recognizedthat, when twin calvesof opposite sex are born, the female can have ambiguous genitalia. It is now believed that this is becauseof gonadal chimerism in the female calves,which are known asfreemartins.
FURTHER READING
54
Barch M J, Knutsen T, SpurbeckJ L (eds) 1997The AGT cytogenetics laboratory manual, 3rd edn. Lippincott-Raven, Philadelphia A largemultiauthor laboratoryhadbooh produtedby theAssociationof Genetic Tbchnologists. Gersen S L, Keagle M B (eds) 2005The principles of clinical cvrogenerics, 2nd edition Humana Press,Totowa, New Jersey A detailedmultiauthorguideto all aspectsof laboratoryantl clinical rytogenetics. Mitelman F (ed ) 1995An international system for human cytogenetic nomenclature Karger, Basel A reportgixing d.etailsof hon chromosome abnormalities,intlwling the resulnof FISH studies,shouldbedestibed
ELEMENTS @ fn. normal human karyotype is made up of 46 chromosomesconsisting of 22 pairs of autosomesand a pair of sex chromosomes,XX in the female and XY in the male. @ Eactr chromosomeconsistsof a short (p) and long (q) arm ioined at the centromere. Chromosomes are analyzed using cultured cells, and specific banding patterns can be identified by means of special staining techniques. Molecular cytogenetic techniques, such as fluorescence in-situ hybridization (FISH), comparative genomtc hybridization (CGH) and array CGH can be usedto detect and characterizesubtle chromosomeabnormalities. @ During mitosis in somatic cell division the two sister chromatids of each chromosomeseparate,with one chromatid passingto each daughter cell. During meiosis, which occurs during the final stage of gametogenesis, homologous chromosomespair, exchangesegments,and then segregateindependently to the mature daughter gametes. @ Chro-orome abnormalities can be structural or numerical. Numerical abnormalities include trisomy and polyploidy. In trisomy a single extra chromosome is present, usually as a result of non-disjunction in the first or second meiotic division In polyploidy three or more complete haploid sets are present instead of the usual diploid complement. @ Structural abnormalities include translocations, inversions,insertions, rings and deletions.tanslocations can be balanced or unbalanced. Carriers of balanced translocationsare at risk ofhaving children with unbalanced rearrangements;these chidlren are usually physically and mentally handicapped.
CHAPTER
DNAtechnology and app[ications
In the history of medicalgenetics,the'chromosomebreakthrough' in the mid-1950s was revolutionary. In the past three decades, DNA technology has had a profound effect, not only in medical genetics (Fig. 4.1) but also in many areasof biological science ( B o x4 . 1 ) .
mRNA
DNA
cDNA
Restriction
t
I
The identihcation of restriction endonucleases,the development of the DNA cloning vectors,the introduction of the Southernblot technique and Sangersequencingin the 1970s,the development of the polvmerasechain reaction in the 1980s,and the impact of capillarl' sequencing and microarray technolog-vin the 1990s, rank as seminal developmentsin the field. DNA technology can be split into trvo main areas:DNA cloning and methods of DNA analysis.
G e n ei n s e r t i o ni n r e p l i c a t i n cge l l s
Nu c le o t i d e sequence.
D N AC L O N I N G DNA cloning is the selective amplilication of a specific DNA fragment or sequenceto produce relatively large amounts of a homogeneousDNA fragment to enableits structure and function to be analyzedin detail. DNA cloning falls into two main types: techniques that use natural in-aixo cell-basedmechanismsof DNA replication and the more recentlydevelopedcell-freeor in-titro polymerasechain reactlon.
IN-VIVO CELL.BASED DNACLONING
A m i n oa c i d 5 e qu e nc e
AI
l+
Testfor h o m o l o g yb y h y br i di z a t i o n
Linkage Transformed with fragment ceils polymorphism
D i a gn o s i s A n t e n a t a lp, r e c l i n i c a l , carner
F i g .4 . 1 genetics inmedicat ofDNAtechnology Some oftheappLrcations
There are six basic steps in in-t:it:o cell-l.asedDNA cloning.
Although fragments of DNA can be produced by mechanical shearingtechniques,this is a very haphazardprocessproducing fragments that vary in size. In the early 1970sit was recognized
occurring on the two complementary DNA strands when read in one direction of polarity, e.g. 5'to 3' (Table 4.1) The longer the nucleotide recognition sequenceof the restriction enzyme, the lessfrequently that particular nucleotide sequencewill occur bv chance and therefore the larger the averagesize of the DNA
that certain microbes contain enzymes that cleave doublestranded DNA in or near a particular sequenceof nucleotides. These enzymesrestrict the entry of foreign DNA into bacterial
fragmentsgenerated. Well over 300 different restriction enzymeshavebeen isolated lrom various bacterial organisms.Restriction endonucleasesare
cells and were therefore called restrictionenzymesThey recognize a palindromic nucleotide sequenceof DNA of betweenfour and eight nucleotidesin length, i.e. the samesequenceofnucleotides
named according to the organism from which they are derived, e g. EroRI is from Escherichiacoli and was the first restriction enz)me isolatedfrom that organism.
Generation of DNAfragments
55
4
DNATECHNOLOGYAND APPLICATIONS
+
Box 4.1 Applications of DNAtechnotogy
AATTC--
Genestructure/mappi ng/functron genetics Poputation Ctinicatgenetics generic Preimolantatron diagr-osis PrenataI diagnosis Presymptomatic diagnosis Carrierdetection Diagnosis andpathogenesis of disease Genetic - infective. Acquired matignant Biosynthesis growthhormone. e g insutrn, interferon, immunzation Treatment ofgenetic disease Genetherapy Agriculture e g nrtrogen fixaton
--CTTAA
--CCC
GGG--
-_GGG CCC--
t Fis.4.2
Tabte4.1 Someexamotes of restriction endonucteases withtheirnucleotide recoqnition sequence andcleavage sites Enzyme
Organism
Cleavagesite
5',
3',
Bom\l
Boci[LusomyloltquefociensHG.GATCC
EcoRl
Escherichio coliRY13
G r AATT C
Haelll
Hoemopht[usoegyplius
GG.CC
Hindlll
Hoemophtlus influenzoeRd
A. A G CTT
Hpol
Hoemopht[usporotnfLuenzoe
GTT.AAC
Psd
Providencio stuortti
CT G CAo G
Smol
Serrotiomorcescens
CCC.GGG
5oll
StreptomycesolbusG
G.TCGAC
The complementary pairing of basesin the DNA molecule means that cleavageof double-stranded DNA by a restriction endonuclease always creates double-stranded breaks, which, depending on the cleavagepoints of the particular restriction enzyme used, results in either a staggeredor a blunt end (Fig. 4.2). Digestion of DNA from a specific source with a particular restriction enzyme will produce the samereproduciblecollection of DNA fragmentseachtime the processis carried out.
Recombination of DNAfragments
56
DNA from any source,when digestedwith the same restriction enzyme, will produce DNA fragments with identical complementary ends or termini. When DNA has been cleaved by a restriction enzyme that produces staggeredtermini, these are referred to as being'sticky'or'cohesive', becausethey will unite under appropriate conditions with complementary sequences
The staggeredand bLuntendsgeneratedby restrictiondigestof doubte-stranded DNA by EcoRland Srnol Sitesof cte:v:np nf thp DNA strandsare indicatedby arrows
produced by the same restriction enzyme on DNA from any source. Initially the cohesive termini are held together by hydrogen bonding but are covalently attached with the enzyme called DNA ligase.The union of two DNA fragments from different sourcesproduces what is referred to as a recombinant DNA molecule
Vectors A aector, or replicon, is the term for the carrier DNA molecule used in the cloning processwhich, through its own independent replication within a host organism, will allow the production of multiple copies of itself. The incorporation of theforeign or target DNA into a vector allows the production of large amounts of that DNA fragment. For naturally occurring vectors to be used for DNA cloning, they need to be modilied to ensure that the foreign DNA is inserted at a specific location and that recombinant vectors containing foreign inserted DNA can be detected.Many of the early vectors were constructed so that insertion of the foreign DNA in a gene for antibiotic resistanceresulted in loss of that function (Fig'.4.3). The five main types of vector commonly used include plasmids,bacteriophages, cosmid,s, znd bacterial and yeast artfficial chromosomes. The choice of vector used in cloning dependson a number of factors, such as the particular restriction enzyme being used and the size of the foreign DNA to be inserted Some of the early vectors,such as plasmidsand bacteriophages, were severely Iimited in terms of the size of the foreign DNA fragment that could be inserted. Later generationsofvectors, such as cosmids, can take inserts up to approximately 50kb in size. A cosmid is essentiallya plasmid that has had all but the minimum vector DNA necessaryfor propagation removed (i.e. the ras sequence),
DNATECHNOLOGY ANDAPPLICATIONS
dish. Recombinant vectors can be screenedfor by a detection system;for example,loss of antibiotic resistancecan be screened for by replica plating on agar containing the appropriate antibiotic (see Fig. 4.3). Thus, if the enzyme AtI were used to generate DNA fragments and to cut the plasmid pBR322, any recombinant
Ap'. Pstl
p S C 0l 1
4
pBR322
plasmids produced would make the bacterial host cells they transform sensitiveto ampicillin, as this gene would no longer be functional, but they would remain resistant to tetracycline. Replica plating of the master plates from the cultures allows identilication of individual specificrecombinant clones.
Fis.4.3 T w op l a s m i dosr i g i n a lul ys e di n r e c o m b i n aDnN t At e c h n o t o g y genes(,4p1 showing drugresistance ampiciLLin resistance; T-'
-^\ ^^! -t^-..-^^ ^t -^^+, L . +L^c, -L-o,- r, ,y- !l l.^' s^ . ^ - r c ) T->r -L^ o rru c TO D dc t e a v a g e-s.rr t^e- s o f restriction
endonucteases thatarepresent intheDNAontyonceforuseas a ctoning site
to enableinsertion of the largestpossibleforeign DNA fragment and still allow replication. More recently,the developmentof bacterialand.yeastartifcial (BACs and YACs) allows the possibility of cloning chromosomes DNA fragmentsof between300 and 1000kb in size.YACsconsist of a plasmid that containswithin it the minimum DNA sequences necessaryfor centromere and telomere formation plus DNA sequencesknown as autonomous replitati0nsequences, all of which are necessaryfor accurate replication within yeast.YACs have the advantage that they can incorporate DNA fragments of up to 1000kb in size as well as allow replication of eukaryoticDNA with repetitive DNA sequences,which often cannot take place in bacterialcells. Many eukaryotic genesare very large,being up to 2-3 million basepairs (bp) in length (p. 377).YACs allow detailed mapping of genesof this size and their flanking regions,whereas the use of conventional vectors would require an inordinate number of overlappingclones.
Transformationof the host organism After introducing the foreign DNA fragment into the vector, the recombinantvector is introduced into speciallymodified bacterial or yeasthost cells The bacterial cell membrane is not normally permeable to large molecules such as DNA fragments but can be made permeableby a variety of different methods, including exposure to certain salts or high voltage; this is known as becomingcrmpetent.Usually only a singleDNA moleculeis taken up by a host cell undergoing the processknown as transformution. If the transformed cells are allowed to multiply, large quantities of identical copiesof the original singletarget DNA or cloneswill be produced (Fig. 4.4).
Screeningfor recombinant vectors Once the transformed cells have multiplied in culture medium, they are plated out on a master plate of nutrient agar in a Petri
Selectionof specificclones A number of techniques has been developed to detect the presence of clones with specific DNA sequence inserts. The most widely used method is nucleic acid hybridization (p. 60). Colonies of transformed host bacteria with recombinant clones are used to make replica plates that are lyzed and then blotted on to a nitrocellulose filter to which nucleic acid binds. The DNA of the replica blot is then denatured to make the DNA single stranded, which will allow it to hybridize with single-stranded, radioactively labeled DNA or RNA probes (p. 59), which can then be detected by exposure to an X-ray film, or what is known as a,utoradiograpfu.In this way a transformed host bacterial colony containing a sequencecomplementary to the probe can be detectedand, from its position on the replica plate, the colony containing that clone can be identified on the master plate, 'picked' and cultured separately(Fig. 4.5). Alternatively, if an antibody is available to a protein and an expressionvector is used for the DNA cloning, the replica filter clonescan be screenedfor by the presenceor absenceof binding of the antibody to detect clones containing recombinant vectors with the DNA fragment containing the gene (or part of) of lnterest.
D N AL I B R A R I E S Different sources of DNA can be used to make recombinant DNA molecules.DNA from nucleated cells is termed total or genomicDNA. DNA made by the action of the enzyme reverse transcriptaseon messengerRNA (nRNA) is called complementary DNA or cDNA. It is possibleto enrich for DNA sequencesof particular interest by using a specific tissue or cell type asa source of mRNA; for instance,immature red blood cells (reticulocytes) containing predominantly globin nRNA resulted in cloning of the genesfor the globin chains ofhemoglobin (p. 148). The collection of recombinant DNA molecules generatedfrom a specific source is referred to as a DNA library @.9. a genomic or cDNA library). A DNA library of the human genome using plasmids as a vector would need to consist of severalhundred thousand clones to be likely to contain the whole of the human genome.The use ofYACs as cloning vectorswith DNA digested by infrequently cutting restriction enzymes means that the whole of the human genome can be contained in a library of 13000 to 14000clones.
57
4
DNATECHNOLOGYAND APPLICATIONS
D i s r u p t i oann d centrifugation
I
VV
Foreign DNA1
t :hX".',T.tt. Cleavage
ri+AA I
Tc
c f n n rT C
TTTT,TTIT[|[,TTil cTTAAIG cTTAAIG -/ A n
Plasmid c hr m e r a
T
Transformation
I
V
R e pIi c a t i o n
Fig.4.4 (From Generation p[asmid ofa recombinant using EcoRl andtransformation ofthehostbacteriaL A E1981 organism Emery Recombrnant DNAtechnotogy Lancet ti:1406-1409 withpermssion )
C E L L . F R EDEN AC L O N I N G One of the most revolutionary developmentsin DNA technology is the technique first developedin the mid-1980s known as the polymerasechain reattion or PCR. PCR can be used to produce vast quantitiesof a target DNA fragment provided that the DNA sequenceof that region is known.
The polymerasechainreaction DNA sequenceinformation is usedto designtwo oligonucleotide p r i m e r s ( a m p l i m e r s )o f a p p r o x i m a t e l y 2 0 b p i n l e n g t h complementaryto the DNA sequencesflanking the target DNA fragment. The first step is to denature the double-stranded DNA by heating.The primers then bind ro rhe complemenrary DNA sequencesof the single-strandedDNA templates.DNA polymeraseextends the primer DNA in the presenceof the
58
deoxvnucleotidetriphosphates(dATP, dCTR dGTP and dTTP) to synthesize the complementary DNA sequence.Subsequent heat denaturation of the double-stranded DNA, followed by annealingof the same primer sequencesto the resulting singlestranded DNA, will result in the synthesisof further copies of
the target DNA. Some 30 to 35 successiverepeatedcyclesresults in more than I million coptes (amplicons)of the DNA target, sufficient for direct visualizationby ultraviolet fluorescenceafter ethidium bromide staining, without the need to use indirect detection techniques(Fig. 4.6). PCR allows analvsis of DNA from any cellular source containing nuclei; in addition to blood, this can include less invasivesamplessuch as buccalscrapingsor pathologicalarchival material. It is also possible to start with quantities of DNA as small as that from a single cell, as is rhe casein preimplantation genetic diagnosis(p 325). Great care has to be taken with PCR, however,becauseDNA from a contaminatingextraneoussource, such as desquamatedskin from a laboratory worker, will also be amplified. This can lead to false-positiveresults unless the appropriatecontrol studiesare used to detect this possiblesource of error. Another advantageof PCR is the rapid turn-around time of samplesfor analysis.Use of the heat-stablelaa DNA polymerase isolatedfrom the bacterium Thermophilusaquaticus,which grows naturally in hot springs, generatesPCR products in a matter of hours rather than the days or weeks required for cell-basedlzcioa DNA cloning techniques
DAPPLICATIONS DNATECHNOLOGYAN
P l a t eo n
Transformed bacteria
4
Cycle0
DNA Unamplified sequencet Targeted Cycle 1 Denature and anneap l rimers
R e pilc a p l a tn i g
Primer extension
Cycle2
D e n a t u r ea n d
primers anneal
Primer extension
Fis.4.5 ldentrfrcation DNArnserts of recombinant DNAclones withspecrfrc resistance, by[ossofantibiotrc nucterc acidhybrrdizatron and r'
Cycle3
'l^--i'^^r-^hU
ouLUrouru9roPrry.
D e n a t u r ea n d a n n e a lp f l m e r s
Real-time PCR machines have reduced this time to less than t h, and fluorescencetechnology is used to monitor the generationof PCR products during each cycle, thus eliminating the need for gel electrophoresis. DNA cloning by PCR, in contrast to in-ztit-tocell-based techniques, has the disadvantagethat it requires knowledge of the nucleotide sequenceof the target DNA fragment and is best used to amplify DNA fragments of up to lkb, although longrange PCR allows the amplification of larger DNA fragments of up to 20-30 kb.
Primer extension
OFDNAANALYSIS TECHNIOUES Many methods of DNA analysisinvolve the use of nucleic acid probes and the processof nucleic acid hybridization.
NUCLEICAC PIRDO B E S Nucleic acid probes are usually single-stranded DNA sequences that have been radioactively or non-radioactively labeled and can be used to detect DNA or RNA fragments with sequencehomology. DNA probes can come from a variety of sources, including random genomic DNA sequences,specific genes,cDNA sequencesor oligonucleotide DNA sequences produced synthetically based on knowledge of the protein
CYcle4-25
Fig.4.6 seriaI showing chainreaction ofthepotymerase Diagram with andextension of DNA primeranneaLing, denaturation numbersin eachcycle ofthetargetDNAfragment doubling A DNA probecanbe labeledby a variety amino-acidsequence. includingisotopiclabelingwith "'P and nonof processes, i s o t o p i cm e t h o d su s i n g m o d i f i e d n u c l e o t i d e sc o n t a i n i n g fluorophores(e.g.fluoresceinor rhodamine).Hybridization
59
4
DNATECHNOLOGYAND APPLICATIONS
of a radioactively labeled DNA probe with cDNA sequences on a nitrocellulose filter can be detected by autoradiography, whereas DNA fragments that are fluorescently labeled can be detected by exposure to rhe appropriate wavelength of light, for example fluorescent in-situ hybridizatton (FISH)
(p.34)
Restriction enzyme
Electrophoresis gel onagarose
*
Denaturation w i t ha l k a l i
Blotting Drypaper towels Cellulose nitratefilter Gelcontaining denatured DNA Filterpaper Buffer
N U C L E IACC I DH Y B R I D I Z A T I O N Nucleic acid hybridization involves mixing DNA from two sources that have been denatured by heat or alkali to make them single stranded and then, under the appropriate conditions, allowing cornplementary base pairing of homologous sequences.If one of the DNA sourceshas been labeledin some way (i.e. is a DNA probe), this allows identification of specific DNA sequencesin rhe other source.The two main methods of nucleic acid hybridization most commonly used are Southern and northern blotting.
Southernblotting Southern blotting, named after Edwin Southern who developed the technique, involves digesting DNA by a restriction enzyme which is then subjected to electrophoresis on an agarosegel. This separatesthe DNA or restriction fragments by size, the smaller fragments migrating faster than the larger ones. The DNA fragments in the gel are then denaturated with alkali, making them single stranded. A 'permanent' copy of these single-strandedfragments is made by transferring them on to a nitrocellulose filter which binds the single-stranded DNA, the socalled,Southern blot. A particular target DNA fragmenr of interest from the collection on the filter can be visualized by adding a single-stranded 32Pradioactively labeled DNA probe that will hybridize with homologous DNA fragments in the Southern blot, which can then be detected by autoradiography(Fig. 4.7). An exampleof the use of Southern blotting for diagnostictesting in patientswith fragile X is shown in Fig. 4.8.
H y b r i d i z a t i owni t h
X
I 5.2kb (inactive X)
X
Expose to X-rayfilm
1|
,
Autorad iograph showing band(s)
2.8kb(activeX)
Fis.4.8
60
Southernblotto detectmeihyl.ation of theFMRIpromoter in patients wrthfragite X DNAdigested withFcoRlandthe Fis.4.7 methytation sensrtive enzymeBstZlwasprobedwith0x19, Diagram oftheSouthern btottechnique showing sizefractronation whichhybridizes to a CpGislandwithinlheFMR|promoter oftheDNAfragments bygeLetectrophoresis, denaturation ofthe Patient 1 isa fematewitha methylated patrents expansion. 2,3 doub[e-stranded DNAto becomesingtestranded, andtransfer and6 arenormatfemales, patient 4 is anaffected ma[eandpatient to a nitrocettutose fi[terthatis hybrrdized witha 32Pradroactivety 5 isa normalmale(CourtesyofA Gardner: Department tabeted DNAprobe of Molecular Genetics, Southmead Hospitat. Bristot)
DNATECHNOLOGYANDAPPLICATIONS
4
Northernblotting Northern blotting differs from Southern blotting by the use of mRNA as the target nucleic acid in the same procedure; mRNA is very unstablebecauseof intrinsic cellular ribonucleases. Use of ribonucleaseinhibitors allows isolation of mRNA that, if run on an electrophoreticgel, can be transferred to a filter. Hybridizing the blot with a radiolabeled DNA probe allows determination of the size and quantity of the mRNA transcript, a so-called nlrthern blot. With the advent of real-time reversetranscriptase PCR, and microarray technology for gene expression studies (Fig. 4.9), northern blotting is utilized lessoften.
DNAmicroarrays DNA microarraysare basedon the sameprinciple of hybridization but on a miniaturized scale.which allows simultaneous
qo C Q
on
-
!
v
Fif.c-=F=o=o .? ! ^: ,ii
efr
Y= .=
F
,;
Sa =
2 kb 1.5kb 1 kb
o.s kb
F i g ./ * . 1 0 byPCRto test mutation oftheGAArepeatexpansion Ampiificaiion bromide withethidium arestained ataxtaProducts for Fnedreich gel Lanes1andB show ona 15%agarose andelectrophoresed with [anes2 and4 showpatients standards, 500-bpLadder-srze controts, Lanes 3 and6 showunaffected expansions, homozygous 7 is carrierandLane expansion lane5 showsa heterozygous (Courtesy of Department of K.Thomson, controL thenegative Exeter.) DevonandExeterHospitat, Royat Genetics, Molecu|.ar
::t
analysisof tens or hundredsof thousandsof targets'Short, fluorescentlylabeledoligonucleotidesattachedto a glass microscopeslidecan be usedto detecthybridizationof target DNA under appropriateconditions.The color patternof the 9 497 46-
A ti_
2 . 3 -7
1.35300bp 200bp 1 0 0b p
2476p 1 4 0b p 1 1 1b p
0.24-
Fis.4.9 ALrquots representation ofa cDNAmicroarray. Diagrammatic ustnga aregrtdded on a glasstemplate ofcDNAsof interest roboiTestandreference RNAsampLes. computer-controLLed fluorochromes byreverse withdifferently colored Labeled to hybridize withthecDNAs transcription, aremixedandallowed to Laser tightand Thetemptates areexposed onthemicroarray genes patterngenerated identifying is compared, theexcrtation thereference and between in expression thatshowdifferences testsampLes
Fig. t,.11 byRFLPThenormaI C282Y oftheHFEgenemutation Detection of247 withRso/togiveproducts is digested 387-bpPCRproduct recognition anadditional creates mutation and140bp TheC282Y 29bp Lane1showsa of247.111and givingproducts siteforRso/, patients homozygous, 2-4 show Lanes standard ladder-size 1OO-bp respectlvely. mutation, the C282Y normalfor and heterozygous
61
4
DNATECHNOLOGYAND APPLICATIONS
microarray is then analyzed automatically by computer. Four classesofapplication havebeen described:(l) expressionstudies to look at the differential expression of thousands of genes at the mRNA level; (2) analysis of DNA variarion for mutarion detection and single nucleoride polymorphism (SNP) typing ( p . 6 7 ) ; ( 3 ) t e s t i n g f o r g e n o m i c g a i n s a n d l o s s e sb y a r r a y comparative genomic hybridization (CGH) (p. 37); and (4) a combination of the latter two, SNP-CGH, which allows the detection of copy-neutral genetic anomaliessuch as uniparental disomy(p 115).
Sizeanalysisof PCRproducts Deletion or insertion mutations can sometimes be detected simply b-ydetermining the size of a PCR product For example, the most common mutation that causescystic fibrosis, 4F508 (p.Phe508de1),is a 3-bp deletion that can be derecred on a p o l y a c r v l a m i d eg e l S o m e t r i n u c l e o t i d e r e p e a t e x p a n s i o n mutations can be amplified by PCR (Fig. a.l0)
Restriction fragmenttengthpolymorphism If a base substitution createsor abolishesthe recognition site of a restriction enzyme, it is possible to test for the mutation
MUTATION DETECTION The choice of method depends primarily upon whether rhe test is for a known sequencechange or to identify the presenceof any mutation within a particular gene.A number of techniques can be used to screen for mutations that differ in their easeof use and reliabilitrvThe choice of assaydependson manJrfactors, including the sensitivity required, cost, equipmenr, and the size and structure (including number of polymorphisms) of the gene (Table4.2). Identification of a possiblesequencevarianrbv one of the mutation screeningmethods requires confirmation by DNA sequencing.Some of the most common techniquesin current use are describedbelow.
by digesting a PCR product with the appropriare enzyme and separatingthe products by electrophoresis(Fig. 4. I l).
- refractorymutationsystem Amptification (ARMs)PCR Allele-specificPCR utilizes primers specificfor the normal and mutant sequencesThe most common design is a two-tube assay with normal and mutant primers in separatereactions together rvith control primers to ensurethat the PCR reactionhas worked. An example of a multiplex ARMS assayro detect 12 different c1,-stic fibrosis mutations is shown in Fig. 4.12.
Tabte4.2 Methodsfor detectinq mutations Method
Known/unknownmutations
Southernbtot
Known(orunknownrearrangement) Trinucteotideexpanstons nfragile X andmyotonic dystrophy
Sizing of PCRproducts
Known
p Phe5O8det CFIRmutation; trinucleotide Srmprecneap expansions in HD andSCAgenes
ARN4S-PCR
KNOWN
CFIRmutations
possib[e Muttrplex
0tigonucteotide ligatron
Known
CFIRmutations
possible Muttiplex
RealtimePCR
Known
FactorV Lerden
Expensive equipment
Conformation-sensitiveUnknown capittary etectrophoresis (CSCE)
Anygene
H i g h - i h r o u g h o um t e t h o dt h a t c a n u s e c a p i [ [ a r sy e q u e n c e p r tatform
Denaturrng HPLC
Anygene
Unknown
Exampte
Advantages/disadvantages Labolous
Rcnr rrrpc dcdirriod
l-]l--lPl l-
instrument withhighmaintenance High-resotutron mett (HRM)
62
Highsensrtivity; high-throughput method
5equenci ng
Knownor unknown
Anv nonc
Gotdstandard butexpensive
DNAmicroarray
Knownor unknown
Anygene
Highthroughput; expensive equipment Sensitivity forunknown mutations maybelimited
Massspectroscopy
Knownor unknown
Anygene
Highthroughput: expensjve equipment Sensitivity forsome mutation typestimited
DNATECHNOLOGYANDAPPLICATIONS
4
Patient Tube
*
ApoB
+
(N) p.Phe5o8del
1 7 1 7 - 1>GA >
(M)) p.PhesoEdel
+ oDc
Fis.4.12 Detection af CFTRmutations bytwo-tube Patient 2 isa compound ARN4S-PCR Patrent 1 s heterozygous forAF508(pPhe508det) h e t e r o z y g o t e f o r p P h e 5 O S d e t a n d c l TPl Ta-t 1i eGn>t 3Ai s h o m o z y g o u s n o r m a t f o r t h e 1 2 m u t a t i oPnr si m t eesrtsef do r t w o i n t e r n a I c o n t r o l(sA p o Ba n d0 D C )a r ei n c l u d ei d ne a c ht u b e
15 B l u e
l5 Green
15Yellow
Fis.4.13 D e t e c t i oanf C F T R m u t a t i o n s u s i n g agnoonl u c l e o t i d e [ i g a t r o n M a susLat yi p L e x P C R aemsp] 5Lef x o n s o f t h e C F I R g eOn [ei g o n u c l e o t r d e s andarethen to anneaI sequences foreachmutation aredesigned tothePCRproducts to adlacent suchthattwooligonucleotides anneal r n r n ohr r , I ' n : t r nTnh o? ? . n u t a t i o nasr ed i s c r i m i n a tuesdi n ga C O m b , n a tO a tb e l T s h i sp a t i e ni st a z ea - d d r f f e r e . rctol yl o r efdt u o r e s c et n ,O fs n -tesyof M Owens, (Cou Genetics, heterozygote Department of Motecutar compound fortheAF508(pPhe508det) ancp G55lD n utaLions RoyaL DevonandExeterHospitat, Exeter.)
63
4
DNATECH NOLOGYAND APPLICATIONS
0ligonucleotide tigationassay(0LA) A pair of oligonucleotides are designed to anneal to adjacent s e q u e n c e sw i t h i n a P C R p r o d u c t . I f t h e y a r e p e r f e c t l y hybridized, they can be foined by DNA ligase.Oligonucleotides complementarv to the normal and mutant sequences are differentially labeled and the products identified by computer software(Fig. a.l3).
R e a l - t i m eP C R There are multiple hardware platforms for real-time PCR and 'fast' versions that can complete a PCR reaction in under 30 min. TaqManrM and LightCyclerrM use fluorescence technology to detect mutations by allelic discrimination of PCR products. Figure 4 14 givesan exampleof the fluorescenceresonanceenergy transfer (FRET) probe detection of the factorV Leiden mutation.
(0Un'chips') DNAmicroarrays DNA microarrays hold the promise of rapid mutation testing.They involve synthesizing custom-designed20 25bp oligonucleotide sequencesfor both the normal DNA sequenceand known andl or possiblesingle nucleotide substitutions of a gene.These are attachedto a'chip'in a structured arrangementin what is known as a microaruay.The sampleDNA being screenedfor a mutation is amplified by PCR, fluorescentll,labeled and hybridized with the oligonucleotidesin the microarray (Fig. 4.15). Computer analysisof the color pattern of the microarray generatedafter hybridization allows rapid automated mutation testing. The
prospect of gene-specificDNA chip microarrays may lead to a revolution in the speed and reliability of mutation screening, provided the technology is affordable and the technique can be demonstrated to be robust. The detection of known base substitutions, or SNPs, has been very successful,but screening for unknown mutations has oroved more difficult.
tiquid Denaturinghigh-performance (DHPLC) chromatography This technique detects the presence of heteroduplexes owing to their abnormal denaturing profiles. PCR products from patients with heterozygousmutations will form heteroduplexes if denatured by heating (to separatethe double-strandedDNA) and then cooled slowly.Homozygous mutations can be detected by mixing the PCR products with normal sequenceproducts to generateheteroduplexes.DHPLC provides a sensitivedetection platform with a relativelyhigh throughput capacity.
-sensitivecapillary Conformation (CSCE) electrophoresis CSCE is used to detect the presenceof heteroduplexesusing fluorecencetechnology.It is fasterand achieveshigher throughput than DHPLC as PCR products can be multiplexed by using multiple fluorescent dyes.An alteration in the DNA sequence can result in a different conformation, which has a different electrophoreticmobility, and an appropriatepolymer can be used for identification.
PCRproduct
B 3.0 2.8 z.o
2.4 2.2 2.0 U
1 Q
C
n ^
g o
L
r.o t . L
1.0
0.8 0.6 0.4 0.2 0.0
54
460 48.0 s0.0 52.0 s40 560 580 60.0 62.0 64.0 660 680 70.0 72.0 "C Meltinq temperature
Fi1.4.14 PCRto detect ReaL-time theFactor V LeidenmutationA,Whenthetwo probeshybridrze otigonucteotide to the PCRproduct, thedyesarebrought rnto closeproximity andredfluorescent tightis emitted byfluorescence -esonance energyt.ansfer(FRET) B, Melting curveanatysrs separares thetwoatte[es. asthesensorprobe dissocrates fromthemutantatle[e ata lowertemperature Theredlrne showsa normaL controt; thebtueline showsa patient heterozygous for Factor V L e i d e na,n dt h eg r e e nl i n es h o w sa patient homozygous forFactorV Leiden rsothocyanate: FITC, ftuoresceir LC. (Courtesy LightCycler of Dr L Harries. D e p a r t m eonftM o l e c u t G a re n e t i c s , RoyaI DevonandExeterHospitaL, txeter.J
ANDAPPLICATIONS DNATECHNOLOGY
4
F i 9 .4 . 1 5 'HNFIA mutations Detection of HNFIAmutations usinga DNAmrcroarray. normalandmutantprobesfor75different The chip'contains to thechip products spotted intriplrcate whichwerehybndized Patient DNAwasamplrfred labeled bymuttiplex PCRto yietdfluorescentty Institute ofTechnoLogy, A, ControIsamp[e Advanced B, Patrent heterozygous foran HNFlAmutation(Courtesy of N Huh,Samsung SouthKorea )
Homozygous variant1 Heterozygous variant1 Heterozygous vatiant2 F
= f
E
q
o
E
z.
8 2 7 5 8 3 8 3 2 58 3 5 8 3 7 5 8 4 8 4 2 58 4 5 8 4 7 5 8 5 8 5 2 58 5 5 8 5 7 5 8 6 8 6 2 58 6 5 8 6 7 5 8 7 8 7 2 5 Degrees
Fig.4.16 (HRM) toa control afternormalization profLLes samples areshown High-resoLution mettcurve MeLtrng mutant analysis fornormaland c> :o m nlo trrPtc
F : . h , i :vroi t: nt or t t L rhr .o. > o. 6 _l i. f f. p lpn1 mcltinn nrn{ilp _. -. LoLtt
High-resolution melt curveanalysis(HRM)
D N As e q u e n c i n g
This technique employs a new class of fluorescent dyes that intercalatewith double-stranded,but not single-stranded,DNA. The intercalatingdye is incorporatedin the PCR reactionand the products are then heatedto separatethe two strands.Fluorecence levels decreaseas the DNA strands dissociateand this 'melting' profile depends on the PCR product size and sequence(Fig. 4.16). HRM appears to be very sensitive and can be used for high-throughputmutation screenin g
The 'gold standard' method of mutation screening is DNA s e q u e n c i n gu s i n g t h e d i d e o x y c h a i n t e r m i n a t i o n m e t h o d developedin the 1970sby Fred Sanger.This method originally employedradioactivelabelingwith manual interpretation of data' The use of fluorescent labels detected by computerized laser svstemshas improved easeof use and increasedthroughput and accurac]'.Today'scapillary sequencerscan sequencearound I Mb (1 million bases)per day.
65
4
DNATECHNOLOGY ANDAPPLICATI ONS
DNA Polymerase + 5'CCTGCAGGCTGGGCG 3 'G G A C G T C C G A C C C GC C T G T G C5 '
CCTGCAGGCT CCTGCAGGCTG CCTGCAGCCTGG CCTOCAGGCTGGG CCIGCAGGCTGGGT CCTGCAGOCTGGGCG CCTGCAGGCTGGGCGG CCIGCAGGCTGGGCGGA CCT6CAGGCTGGGCOGAC CCTGCAGGCTGGGCGGACA C C T GC A GG C T G GC C GG A C A { ] C C T GC A GG C T G GG C GG A C A C G
Nuc l e o t i d e s e que n c e
A m i n oa c i d s e qu e n c e
M M
D D
R R
R R
L L
G/a
L I L
+
+ OualitV(0-100):44
G C K0 2 N o r m a b l
1,500 G
A
155 G T
G
A
C
160 C G
C
G
G
165 C
C 22
G 16
G 16
165 C C 44 44
C
T
G
170 AG
G
C
T
C 59
T 59
1,000 500 0
Patient_GCK_2_811_047.ab1 OualitV(0-100):45
2,000 G r,500 59 r,000 500 0
65
155 A T G 59 59 59
G 59
A C 59 59
160 C G 44 44
T G 44 45
170 AG G 45 45 45
Fig.4.17 Ftuorescent dideoxy DNAsequencing primer(shownin red)bindsto thetempLate Thesequenctng andprimessynthesrs ofa (A)Thesequencing comptementary DNAstrandinthedirection indicated reactron includes fourdNTPsandfourddNTPs, eachlabeled w i t h a d i f f e r e n t f l u o r e s c e nCtodm y ep e t i t i o n b e t w e e n t h e d N T P s a n d d d N T P s r e s u t t s i n t h e p r o d u c t i o n o f a c o t t e c t i o n o f f r a g m e n t s ( whicharethenseparated (C)A heterozygous byelectrophoresis (GGC>TGC; to generate an etectropherogram pGty44Cys mutation, gtycine>cysteine), is identified bythesoftware
APPLICAT]ONS DNATECHNOLOGYAND
Dideoxl' sequencing involves using a single-stranded DNA template (e.9. denatured PCR products) to s.vnthesizenew complementary strands using a DNA polymeraseand an appropriate oligonucleotide primer. In addition to the four normal deoxynucleotides(dNTPs), a proportion of each of the four respective dideoxynucleotides (ddNTPs) is included, each
Dosage analysisby quantitative fluorescent PCR (qF-PCR) is routinely used for rapid aneuploidy screening,for example in prenatal diagnosis (p. 315). Microsatellites (see below) located on chromosomes 13, l8 and 21 may be amplified within a multiplex and trisomies detected,either by the presenceof three
The dideoxynucleotides labeledwith a different fluorescentd--ve. lack a hydroxvl group at the 3'carbon position; this prevents phosphodiesterbonding, resulting in each reaction container consisting of a mixture of DNA fragments of different lengths
(Fis 4.19)
that terminate in their respective dideorynucleotide, owing to chain termination occurring at random in each reaction mixture at the respective nucleotide When thc reaction products are separatedby polyacrylamide gel or capillary electrophoresis,a ladder of DNA sequencesof differing lengths is produced. The DNA sequencecomplementarv to the single-strandedDNA template is generatedby the computer software and the position of a mutation may be highlighted with an appropriate software package(Fig. a.l7).
Massspectroscopy is a high-resolution technique originallyMass spectroscop-v The development of matrixder,elopedfor protein anal-vsis. assistedlaser desorption/ionization time-of-flight (MALDITOF) technologv allows analysis of hundreds of DNA s a m p l e sr v i t h i n m i n u t e s . H i g h - t h r o u g h p u t S N P t y p i n g i s now a common application of this technolog--qbut detection o f s m a l l i n s e r t i o n s o r d e l e t i o n s i s m o r e c h a l l e n g i n gw h e n DNA scanning for unknown mutations b-v MALDI-TOF sequenclng
ANALYSIS DOSAGE Most of the methods describedabovewill detect point mutations, small insertions and deletions. Deletions of one or more exons are common in boys with Duchenne muscular dystrophy and mal be identified b1,a multiplex PCR that revealsthe absenceof one or morc PCR products. However, these mutations are more difficult to detect in carrier femalesas the normal gene on the other X chromosome'masks'the deletion. Large deletion and duplication mutations have been reported in a number of disorders and may encompassa single exon, severalcxons or an entire gene (e.g. HNPR p. 287, HMSN tvpe l, p. 286). Multiplex ligation-dependent probe amplification (MLPA) is a new high-resolution method used to detect d e l e t i o n sa n d d u p l i c a t i o n s ( F i g . 4 . 1 8 ) . E a c h M L P A p r o b e consists of two fluorescently labeled oligonucleotides that can hybridize, adjacentto eachother,to a target genesequence.When hybridized, the two oligonucleotidesare joined by a ligaseand the probe is then amplified by PCR (eacholigonucleotideincludes a universal primer sequenceat its terminus). The probes include a variable-lengthstuffer sequencethat enablesseparationof the PCR products by capillary electrophoresis.Up to 40 probes can be amplifiedin a singlereaction.
4
allelcs or by a dosageeffect where one allele is overrepresented
A P P L I C A T I OONFD N AS E O U E N C E POLYMORPHISMS There is an enormous amount of DNA sequencevariation in the human genome (p. 12) Two main types, single nucleotide polymorphisms (SNPs) and hypervariabletandem repeat DNA length (VNTR) polymorphisms, are predominantly used in geneticanalvsis
SingtenucleotidePolYmorPhisms Around I in 1000 bases within the human genome shows r.ariation. SNPs are most frequently biallelic and occur in coding and non-coding regions. If a SNP lies within the r e c o g n i t i o n s e q u e n c eo f a r e s t r i c t i o n e n z y m e ' t h e D N A fragments produced by that restriction enzyme will be of different lengths in different people. This can be recognized by the altered mobility of the restriction fragments on gel e l e c t r o p h o r e s i s , s o - c a l l e d r e s t r i c t i o nf r a g m e n t l e n g t h polymorphismsor RFLPs. Early genetic mapping studies used Southern blotting to detect RFLPs, but current technology enables the detection of any SNP. New high-throughput methods such as DNA microarrays have led to the creation of a dense SNP map of the human Benome and will assist g e n o m e s e a r c h e sf o r l i n k a g e s t u d i e s i n m a p p i n g s i n g l e gene disorders (p. 282) and associationstudies in common diseases.
Variablenumbertandemrepeats VNTRs are highly polymorphic and are due to the presenceof variable numbers of tandem repeatsof a short DNA sequence that havebeenshown to be inherited in a mendelianco-dominant fashion (p. 107).The advantageof usingVNTRs over SNPs is the large number of alleles for eachVNTR compared with SNPs, u h i c h a r em o s t l l b i a l l e l i c .
Minisate[[ites 'core' sequencewith Alec Jeffre-vsidentified a short l0-15-bp homology to many highly variable loci spread throughout the human genome (p. 17). Using a probe containing tandem repeatsof this core sequence'a pattern of hypervariableDNA fragments is identified. The multiple variable-size repeat sequences identified by the core sequence are known as minisutellites.These minisatellites are highly polymorphic, and a profile unique to an individual (unless they have an identical
67
4
DNATECHNOLOGY ANDAPPLICATI ON5
DNA
Probehybridization PCRprimer sequence
Probeligation PCRprimer sequence PCRprimer sequence
Amplification of probes using fluorescent-labeled orimers
Separation and quantitation
c
c
c c
c
cc
c c
c
c
2000 1000 M E N 1e x o n 1 -800kb N
oE CG
trtlitt
7 -600kb-200kb
c
cc
cc
CC
€ - 2000 a = 1000 MENl exon -800kb
-5.sMb
7 -600kb-200kb
Fis.4.18 A, lLLustration of muttiptex Ligation-dependent (MLpA) probeampLification methodB, Detection ofa detetion encompassing exons1 and2 oftheMEN1geneC,controlprobe(Courtesy of M Owens, Department of Motecular Genetics, RoyalDevonandExeierHospita; Exeter.)
58
APPLICATIONS DNATECHNOLOGYAND
D21S143s
D2151270
D135634
4
D 18 5 5 3 5
900 600 300
Trisomy 21
120
D21S143s
140
D21S11
180
D2151270
D135634
D18 5 5 3 5
320
Fig.4.19 OF-PaRfnrr:nidnrpn:t:laneup[oidy marken foreachmicrosatettite withtwoaLLeLes testingTheupperpane[showsa normaIcOntrol, (D21S11) (microsatetlites effect or a dosage D2151435.D2151270) ThelowerpaneliLlustrates trisomy21witheitherthreeattetes (Courtesy Genetics, Institute of Medical of ChrisAnderson, Microsatellite markersforchromosomes 13and18showa normaIprofrLe Hospitat ofWaLes. University Cardiff )
twinl) is describedas a DNA fi,ngerprint. The techniqueof DNA lingerprintinghasbeenusedwidely in paternitytesting (Fig.a.20)andfor forensicpurposes.
method: recombination between the microsatelliteand the gene may give an incorrect risk estimate,and the possibility of genetic heterogeneity(where mutations in more than one gene causea disease)should be borne in mind.
Microsate[[ites The human genomecontains some 50000 to 100000 blocks of a variable number of tandem repeatsof the dinucleotide CA:GI so-called CA repeats or mitrosatellites(p. 17). The difference in the number of CA repeats at any one site between individuals is highly polymorphic and these repeats have been shown to be inherited in a mendelian co-dominant manner. In addition, highly polymorphic trinucleotide and tetranucleotide repeats havebeenidentihed, and can be used in a similar way (Fig. 4.21). These microsatellites can be analyzed by PCR and the use of fluorescentdetection systemsallows relatively high-throughput analysis Consequently,microsatellite analysishas largely replaced DNA fingerprinting in the applicationsof paternity testing and establishingzygosity.
of genetracking Ctinicalapplications If a gene has been mapped by linkage studiesbut not identified, 'track' the mutant it is possible to use the linked markers to haplotype within a family. This approach may also be used for known genes where a familial mutation has not been found. Closely flanking or intragenic microsatellitesare used most commonly, becauseof the lower likelihood of finding informative SNPs within families.Figure 4.22 illustratesa family where gene tracking has been used to determine carrier risk in the absence of a known mutation. There are some pitfalls associatedwith this
I CI S E A S E N N O N . G E N E TD DIAGNOSIS DNA technology,especiallyPCR, has found application in the diagnosis and management of both infectious and malignant disease.
lnfectiousdisease PCR can be used to detect the presence of DNA sequences specific to a particular infectious organism before conventional evidencesuch as an antibody responseor the results of cultures is available.An exampleis the screeningof blood products for the presenceof DNA sequencesfrom the human immunodeficiency virus (HIV) to ensurethe safetyof their use (e.g screeningpooled factor VIII concentrate for use in males with hemophilia A). Another exampleis the identification of DNA sequencesspecific to bacterial or viral organisms responsible for acute overwhelming infections,where early diagnosisallowsprompt institution of the correct antibiotic or antiviral agentwith the prospectof reducing morbidity and mortality. Real-time PCR techniquescan generate rapid results,with sometest resultsbeing availablewithin I h of a sample being taken.This methodology is particularly useful in the fi ght against methicillin-resis tanr S t ap hyIococcus aureus (MRS A), as patientscan be rapidly testedon admissionto hospital.Anyone found to be MRSA positive can be isolatedto minimize the risk of infection to other patients.
59
4
DNATECHNOLOGY AND,APPLICATI ONS
kinase inhibitor Imatinib are regularly monitored as resistant clones may develop. Following bone marrow transplantation, microsatellite or SNP markers may be used to monltor the successof engraftment b), analysis of donor and patientspecilicalleles.
m
BIOLOGICAL HAZARDS OFDNA TECHNOLOGY DNA technology has a great deal to offer to medicine but there is genuine concern, among the public in particular, that its potentially serioushazardsshould not be ignored. Recombinant
*{h *;*. w
t
DNA technology is being used to improve animal and plant stocks for food production, and recombinant microbial strains are being engineeredto deal with environmental wasteproducts.
*
x
Some factions suggest that insufficient consideration is being given to the seriouspotential consequencesthat could follow the introduction of thesetechniques.For example,it is claimed that the engineered microbial strains, if releasedinto the environment, could cause far more problems than they solve. These
iiw'
;
iW,r
:!i*
,,&tit&
t,** t:a:g*::
:,
Fis.4.2O Autoradrograph of a minisatettite DNAfingerprintoftwo parents. t h e i r t w oo f f s p r i n a g n da n u n r e l a t e idn d i v i d u aEl a c hb a n di n t h e l y y ee f f s p r r nigs p r e s e n t ' no n e o f t h et w o p a . e n t sa n dt h e d i f f e r , n g patternseen in the two matechiidrendemonstrates thatthey are non- identicaI twins (Courtesvof ProfessorA Markham. StJames's H o s p i t a Ll ,e e d s)
concerns, in many instances,are likely to be more theoretical than practical. The main concern surrounding DNA technology is the danger of producing transgenic organisms that could contain genes for cancer susceptibility or be resistant to all known antibiotics.After all, one of the host organismsthat is commonly used in such experimentsis E. coli,which is ubiquitous, being a normal bowel commensal.These are matters that have been of considerablepublic concern and were the subject of the famous Asilomar Conferences in California in the mid-1970s. The consensusof scientific opinion now; however,seemsto be that these dangershave been greatlv exaggeratedVarious authorities have laid down careful guidelines for the use of recombinant DNA techniques.
TECHNIQUE TS OM I N I M I Z E BIOHAZARDS There have been two main approachesto limiting the potential hazardsofDNA technology.These can be separatedinto physical and biological containment methods.
Physicatcontainment M a l i g n a ndt i s e a s e PCR may assist in the diagnosis of lvmphomas and leukemias by identifying translocarions,for example t(9;22), which is characteristicof chronic myeloid leukemia(CML). The exrreme sensitivity of PCR means that minimal residual diseasema-v be detected after treatment for these disorders, and earlv indication of impending relapsewill inform trearmenr oprions. For example, all patients with CML treated with the tyrosine
70
Here the object is to make sure that any potentially dangerous microorganisms are contained by the use of specially designed laboratorieswith appropriate ventilation systems Laboratories are graded,accordingto the type ofexperimentsbeing conducted, from C I (minimum containment),which involveslittle more than the use of careful techniques,to C IV (maximum containment), rvhere containment is of an exceptionallyhigh order. This high level of containment is used in laboratoriesinvolved in biolosical
NS NOLOGY ANDAPPLICATIO DNATECH
4
Fis.4.21
184,188
188,200
ofa tetranucteotide AnaLysis with markerina famiLy mrcrosateLlite GenotyperrM disorder. a dominant peaks wasusedto Labelthe software withthesizeofthePCRproducts wrth The200-bpalteteis segregating members in theaffected thedisorder (Courtesy of M Owens, ofthefamrly. Genetics. of Molecular Department HospitaL, andExeter RoyaLDevon txeter)
warfare,suchas Porton Down in the UK and Camp Detrick in the USA.
Biotogicalcontainment Host organisms used in recombinant DNA work have been 'crippled', so that they cannot survive outside the attenuated,or confines of specialized laboratory culture conditions. This is achievedby careful selection of particular mutants, which led, for example, to the production of the E. coliKlT strain 1776 (aftet the year of American independence!),which requires many complex growth factors if it is to survive outside the laboratory. At the sametime, complementarywork has produced safervectors.The |1.2
t4
u Fig.4.22 ina fami[y wrthDuchenne muscu|'ar dystrophy Gene tracking proband, llla wherenomutation hasbeenfoundintheaffected of of markers A, B andChasenabted theconstruction Anatysis haplotypes: theaffected hapLotype is shownbyan orangebox sisters wereat 50%priorriskof being Bothoftheproband's the[ow-risk showsthatlll,hasinherited carriersGenetracking to bea carrieIbutlll3hasinherrted hapLotype andis untikeLy LikeLy to bea carrierof thehigh-rrsk haplotype andistherefore riskofrecombination shou[d Duchenne muscular dystrophy.The notbeforgotten
combination of physical containment and the use of attenuated organisms should reduce the risk of any possible hazardFrom the evidence available to date, it seemsthat the hazards of geneticengineeringhave,perhaps,beenoveremphasizedin the past and that the risks are more imaginary than real. Nevertheless, great care will continue to have to be exercisedin this field, if for no other reason than to allay the fears of the general public, as exemplified by the adverse publicity surrounding genetically modihed foods.
READING FURTHER Elles R, Mountford R 2003 Molecular diagnosisof geneticdisease,2nd edn Humana Press,New Jersey in diagnostic usedfor genetictestingof commond'isorders Ke.ytechniques laboratories.
71
4 EmeryA E H, Malcolm S 1995An introduction to recombinant DNA rnedicine,2nd edn. John Wiley, Chichester The second, ed,itionof this text, phich cooersthe techniquesand applications of DNA technolog in clinical med.icine. Strachan! ReadA P 2004 Human molecular genetics,3rd edn. Garland Science,London A comprehensizse textbook of all aspectsofmolecular and cellulor biologt as it relatesto inherited diseasein hurnans. WeatherallDJ l99l The new geneticsand clinical practice,3rd edn. Oxford Medical, Oxford One of the original tetts that prozsidcda lucid atserzsieo of the application of DNA techniquesin clinical medicine.
Q Restriction enzymesallow DNA from any source to be cleavedinto reproduciblefragmentsbasedon the presenceof specificnucleotiderecognitionsequences. These fragmentscan be made to recombine,enabling their incorporationinto a suitablevector,with subsequent transformationof a host organismby the vector,leading to the productionof clonescontaininga particularDNA sequence. @ The polymerasechainreaction(PCR)hasrevolutionized medicalgenetics.Within hours,more than a million copiesof a genecan be amplified from a patient'sDNA sample.The PCR product may be analyzedfor the presenceof a pathogenicmutation, generearrangement or infectiousagent. @ Techniquesincluding Southern and northern blotting, DNA sequencingand mutation screening, real-time PCR and microarray analysiscan be used to identify or analyzespecificDNA sequencesof interest. Thesetechniquescan be usedfor analyzingnormal gene structureand function as well as revealingthe molecular pathologyof inherited disease. This providesa meansfor presymptomaticdiagnosis,carrier detectionand prenatal diagnosis,eitherby directmutationalanalysisor indirectly using polymorphicmarkersin family studies. @ Recombinant DNA technology is potentially biologicallyhazardousbut theseriskscanbe minimizedby physicaland biologicalcontainmentmethods.
72
CHAPTER
genes Mapping andidentifying formonogenic disorders
The identification of the gene associatedwith an inherited single-gene(monogenic) disorder, as well as having immediate clinical diagnostic application, will enable an understanding of the developmentalbasis of the pathology with the prospect of possible therapeutic interventions. The molecular basis for nearly 2000 diseasephenotypesis now known. The first human diseasegenes identilied were those with a biochemical basis where it was possibleto purify and sequence the gene product. The development of recombinant DNA techniquesin the 1980senabledphysicalmapping strategiesand led to a new approach, positional cloning. This describes the identilication of a genepurely on the basisof its location,without any prior knowledgeof its function. Notable early successes were the identification of the dystrophin gene (mutated in Duchenne musculardystrophy),the cysticfibrosistransmembraneregulatory gene and the retinoblastoma gene Patients with chromosome abnormalitiesor rearrangementshave often provided important clues by highlighting the likely chromosomal region of a gene associatedwith disease. In the 1990s a genome-wide set of microsatellites was constructed with approximately I marker per l0centimorgans (cM). These 350 markerscould be amplified by polymerasechain reaction (PCR) and facilitated genetic mapping studies that led to the identification of thousands of genes This approach has been supersededby DNA microarrays or 'single nucleotide polymorphism (SNP) chips'. Although SNPs (p. 67) are less informative than microsatellites,they can be scoredautomatically and microarrays are commercially availablewith up to 500000 SNPs distributed throughout the genome. The common step for all approachesto identify human disease genesis arriving at a candidategene (Fig. 5.1). Candidate genes ma1,be suggestedfrom animal models of diseaseor by homology, either to a paralrgrus human gene (e.9.where multigene families exist) or to an rrthlllgous gene in another species With the sequencingof the human genomenow complete,it is alsopossible to find new diseasegenesby searchingthrough geneticdatabases, r . e . ' i ns i l i n ' . Developments in high-throughput mutation screening techniques have also assistedin the identification of pathogenic mutations in candidate genes Consequently the timescale for identifying human diseasegeneshas decreaseddramaticallyfrom a period of years (e.9. the search for the cystic fibrosis gene in
the 1980s)to weeks or perhaps even days, now that the human genomesequenceis availablein oublic databases.
POSITION.INDEPENDENT OFHUMANDISEASE IDENTIFICATION GENES Before genetic mapping techniques were developed, the first human diseasegeneswere identilied through knowledge of the protein product For disorderswith a biochemical basisthis was a particularly successfulstrategy.
CLL O N I N G FUNCTIONA Funttional clonizgdescribesthe identification of a human disease gene through knowledge of its protein product. From the amino-acid sequenceof a protein, oligonucleotideprobes can be synthesizedto act as probes for screeningcomplementary DNA (cDNA) libraries (p. 57). The difficulty lies with the degeneracy of the genetic code, although a dcgeneruteoligonucleotid'ecanbe designedthat includes variablebasesat eachposition where there are multiple possiblenucleotides. An alternative approach is to generate an antibody to the protein that is then used to screen a cDNA expressionlibrary This cDNA expression library is made by cloning cDNAs into an expressionvector containing the necessaryregulatory sequences such that the host cell is able to produce the encodedproteins.
L ODELS U 5 EO FA N I M A M The recognition of phenotypic features in a model organism, such as the mouse, which are similar to those seen in persons affectedwith an inherited disorder,allowsthe possibility that the cloning of the genein the model organismcan lead to more rapid identification of the gene responsible in humans. An example of this approach was the mapping of the gene responsiblefor the inherited disorder of pigmentation and deafness known as Waardenburg syndrome (p. 89) to the long arm of human chromosome 2. This region of chromosome 2 shows extensive homologl', or what is known as q/nten.y,to the region of mouse
73
5
M A P P I NAGN DI D E N T I F Y IG NE GN E F SO RM O N O G E NDI ICS O R D E R S
L I N K A GA EN A L Y S I S T o m a pr e g i o n
GENETIC DATABASES genes Toidentifli in region
PATIENT WJTHCHROMOSOME TRANSLOCATION ORDELETION
it involvesan approachopposite to that of functional cloning, in uhich the protein is the startingpornt.
LINKAGE ANALYSIS Genetic mapping, or linkageanalysis(p. 131),is basedon genetic distances that are measured in centimorgans (cM). A genetic distanceof I cM is the distancebetweentwo genesthat show lolo recombination, that is, in 1oloof meiosesthe genes will not be co-inherited and is equivalent to approximately 1Mb (1 million bases).Linkage analysisis the first step in positional cloning that definesa geneticinterval for further analysis. Linkage analysiscan be performed for a single, large family or for multiple families, although this assumesthat there is no geneticheterogeneity(p. 370) The use oIgenetic markerslocated throughout the genome is described as a genrme-pidescan. In
PATHOGENIC MUTATION(S)
F i s .5 . 1 Pathwaystowardshuman diseaseqeneidentification
chromosome I to which the gene for the murine pigmentary mutant known as Splotch had been assigned.The mapping of the murine Pax3 gene, which codes for a transcription factor expressedin the developing nervous system, to this region suggestedit as a positionalcandidategenefor the disorder It r,vas suggestedthat the pigmentary abnormalities could arise on the basis that melanocytes,in which melanin synthesistakes place, are derived from the neural crest. Identilication of mutations in PAX3,the human homolog, confirmed it as the generesponsible for Waardenburgsyndrome.
M A P PNI GT R I N U C L E O T IR DEEP E A T DISORDERS An increasing number of human diseasesare attributable to expansionsof trinucleotide repeats,and in particular CAG repeat expansionswhich causeextended polyglutamatetracts in Huntington diseaseand many forms of spinocerebellarataxia. A method has been developedto seeknovel trinucleotide repeat expansionsin genomicDNA from affectedpatients;this resulted in the successfulidentification of a CTG repeat expansion in patients with spinocerebellarataxiatype 8.
PO S I T I ON ACLL ON IN G
74
Positionalcloning describesthe identification of a diseasegene through its location in the human genome, without prior knowledgeof its function It is alsodescribedas ret)erse genetics as
the 1990s, genome-wide scans used microsatellite markers (a commercial set of 350 markers was popular), but microarraysare now commerciallyavailable;they include up to 500000 SNPs and allow rapid genotyping with greaterstatisticalpower. Autoz.ygosit.y mapping(alsoknown as homozygosity mapping) is a powerful form of linkage analysis used to map autosomal r e c e s s i v ed i s o r d e r s i n c o n s a n g u i n e o u sp e d i g r e e s ( p . 2 5 7 ) . Autozygositv occurs when affected members of a family are homozygous at particular loci becausethey are identical by descentfrom a common ancestor. Linkage of cystic hbrosis (CF) to chromosome 7 was found by testing nearly 50 caucasianfamilies with hundreds of DNA markers. The gene was mapped to a region of 500kilobases (kb) between markers .MET md D7S8 at chromosome band 7 q 3 1 - 3 2 , w h e n i t b e c a m ee v i d e n t t h a t t h e m a j o r i t y o f C F chromosomes had a particular set of alleles for these markers (shared haplotype) that was found in only 25o/oof non-CF chromosomes.This finding is describedas linkagedisequilibrium and suggests a common mutation due to a founder effect (p 369). Extensivephysicalmapping studiesevenruallyled to the identification of four geneswithin the geneticinterval identified by linkageanalysis,and in 1989a 3-bp deletion was found within the cystic fibrosis transmembranereceptor QF7]H gene.This mutation (p.Phe508del)was presentin approximately70oloof CF chromosomes and 2-3o/o of non-CF chromosomes,consistent with the carrier frequency of I in 25 in caucasians.
Contiganalysis The aim of linkage analysisis to reduce the region of linkage as far as possiblein order to identify a candidateregion. Before publication of the human genome sequence,the next step was to construct a contig. This contig would contain a series of overlapping fragments of cloned DNA representing the entire candidate region. These cloned fragments were then used to screen cDNA libraries, to search for CpG islands (which are usually located close to genes),for zoo blotting (selectionbased on evolutionary conservation) and exon trapping (to identify coding regions via functional splice sites) The requirement for
I CI S 0 R D E R S S 0 RM 0 N 0 G E N D DD E N T I F Y IG NE GN E F I \ 4 A P P I N G AIN
cloning the region of interest led to the phrase'cloning the gene' for a particular disease.
C H R O M O S OEM ABNORMALITIES Occasionally, individuals are recognized with single-gene disorders who are also found to have structural chromosomal abnormalities. The first clue that rhe gene responsible for Duchenne muscular dystrophy (DMD) (p. 291) was located on the short arm of the X chromosome was the identification of a number of females with DMD who were also found to have a chromosomalrearrangementbetweenan autosomeand a specific region of the short arm of one of their X chromosomes.Isolation of DNA clones spanning the region of the X chromosome involved in the rearrangementled in one such female to more detailed gene-mapping information as well as to the eventual cloning of the DMD or dystrophin gene(p. 298). At the same time as these observations,a male was reported with three X-linked disorders: DMD, chronic granulomatous diseaseand retinitis pigmentosa.He alsohad an unusualXlinked red cell group known asthe Mcleod phenotype.It wassuggested that he could have a deletion of a number of geneson the short arm of his X chromosome,including the DMD gene,or what is now termed a clntiguousgenesyndrome.Detailed prometaphase chromosomeanalysisrevealedthis to be the case DNA from this individual rvas used in vast excessto hybridize in competitire reassociation,under specialconditions, with DNA from persons rvith multiple X chromosomesto enrich for DNA sequencesthat he lacked,the so-calledphenol enhancedreassociation/echnique, or pERl which allowed isolation of DNA clones containing portions of the D,MD gene. The occurrence of a chromosome abnormality and a singlegene disorder is rare, but identification of such individuals is important as it has led to the cloning of severalother important diseasegenesin humans, such as tuberous sclerosis(p. 306) and familial adenomatouspolyposis(p. 208)
C A N D I D A TGEE N E S for geneswith a function likely to be involved Searchingdatabases in the pathogenesisof the inherited disordercan alsosuggestwhat are known as candidategenes.If a diseasehas been mapped to a particular chromosomalregion, any genemapping to that region is a positional candidategene.Data on the pattern ofexpression, the timing and the distribution of tissueand cellstypesmay suggest that a certain positional candidategeneor genesis more likely to be responsiblefor the phenotypic featuresseenin persons affected with a particular single-genedisorder. A number of computer programs have been developed that can search genomic DNA sequencedatabasesfor sequencehomology to known genes,aswell as DNA sequencesspecific to all genes,such as the conserved intron--exon splice junctions, promoter sequences,polyadenltlation sitesand stretchesof open reading frames (ORFs) Identification of a gene with homology to a known gene causing a recognized inherited disorder can suggest it as a
5
possible candidate gene for other inherited disorders with a similar phenot.vpe.For example,the identification of mutations in the connexin 26 gene,which codesfor one of the proteins that constitute the gap junctions betweencells causing sensorineural hearing impairment or deafness,has led to the identification of other connexins responsiblefor inherited hearing impairment/ dcafness.
THATA TESTING CONFIRMATORY E ENE C A N D I D A TGEE N EI SA D I S E A S G Nlutations in candidate genescan be screenedfor by a variety of methods (p. 62) and confirmed by DNA sequencing (p. 65) Finding loss-of-function mutations or multiple different mutations that result in the samephenotype provides convincing evidence that a potential candidate gene is associatedwith a disorder For example, in the absenceof functional data to demonstrate the effect of the p.Phe508delmutation upon the CFTR protein, confirmation that mutations in the C,FIR gene caused cystic librosis was provided by the nonsensemutation p.Gl.v542X. Further support is provided by the observation that the candidategene is expressedin the appropriate tissuesand at the relevant stagesof development.The production of a transgenic animal model by the targeted introduction of the mutation into the homologousgene in another speciesthat is shown to exhibit phenotypic features similar to those seen in persons affected with the disorder, or restoration of the normal phenotype by transfcction of the normal gene into a cell line, provides hnal proof that the candidate gene and the diseasegene are one and the same
T H EH U M A NG E N EM A P The rate at which single-genedisorders and their genesare being mapped in humans is increasingexponentially(seeFig. 1.6' p. 8). Nlany of the more common and clinically important monogenic 'morbid anatomyof disordershavebeen mapped to produce the the human genome'(Fig. 5.2).
ER O J E C T T H EH U M A NG E N O M P NT H E B E G I N N I NAGN DO R G A N I Z A T I O F ER O J E C T H U M A NG E N O M P The concept of a map of the human genome was proposed as long ago as 1969byVictor McKusick (seeFig. 1.5,p' 7), one of the founding fathers of medical genetics.Human gene mapping rvorkshopswere held regularly from 1973to collatethe mapping data.The idea of a dedicatedhuman genomeproiect came from a meeting organized by the US Department of Energy (DOE) at Sante Fe, New Mexico, in 1986. The US Human Genome Project started in 1991 with an estimatedbudget of 200 million
75
F
5
MAPPTNGA t DNEDN T t F yG t NEGN EFSO R M O N O G ED N|ISCo R D E R S
FGFR3
1
4
6
q
8
't2
11
17
to
21
22
5
10
13
14
15
18
19
20
X ALD
Fis.5.2 A g e n em a po ft h eh u m a ng e n o m w e i t he x a m p l eosfs o m eo ft h em o r ec o m m o n o r i m p o r t a ns ti n g t ge e n e sa n dd i s o r d e r s al-AT q-Antitrypsin 14q32 deficrency immunodeficiency, ADAdeficiency AB0 9q34 AB0 btoodgroup AHp 9q34 porphyrra Acutehepatrc ACTH 2p25 Adrenocorticotrophic hormone Atp 11q23 3 porphyria Acuteintermittent oelrcrency AKU 3q2 Alkaptonuria ADA 2 0 q 1 3 1 1 S e v e rceo m b i n e d
DISORDERS FORMONOGENIC GENES ANDIDENTIFYING MAPPING
ALD APKDl
Xq28 16p13
APKD2
4q21-23
APOB APOE ARGl ARSB
2p24 19q132 6q23 5q11-13
AS ATA ATIII ATRX
15q11-13 11q223 1q23-25 Xq13 Yq11 16q21 15q261 17q21
A7tr
BB52 BLM BRCAl BRCA2 BWS C3 C5 C6 C7 C9 CAHl CBS CEP CFTR CKN2 CMHl CMH2 CMH3 CMTlA CMT!B CMT2 COLlAl COLlA2 COL2A1 COL3Al CYP1!81 DAZ DFNBl/A3 DM
Adreno[eukodystrophy Aduttpotycystic kidney disease, locus1 Aduttpolycystic kidneydisease, locus2 Annlinnnrntein R Annlinnnrntpin F
A r g i n a sdee f i c i e n a c yr g. i n i n e m i a typeVl, MucopoLysaccharidosis Maroteaux-Lamy syndrome Annelm:n !- .,1ALdXtd
crindrnmp
DMD/BMD DRPLA EDSVI EYAl F5 F7 F8 F9
r ^l ^^^:^^+^^:^ LCLdI lgtcLtd5td
Fl0 A n t r t h r o m bl llln retardatron FN mentaI s-Tha[assemia n - ^ ^ - ^ ^ - - ; r- r r O fT-O- L+L^U-T Fl2 H4UU>PCr trAD Lsyndrome Bardet-Bied Bloomsyndrome FBNl FamiLiat breast/ovaria n cancer FBN2 locus1 Famitiat breast/ovarian cancer FGFRl locus2 Beckwith-Wiedemann syndrome Cnmnloment f:ctnr ? FGFR2
and Duchenne Dystrophin. dystrophy Beckermuscular n oluysia 12p131J23 DentatorubropalIid dr s e a s e tn
Xp212
1q23 13q34 Xq28
a^^^,,l-+;^^ uudgutolrurr
^-^+^i^ \/ PluLclr I v
Xq271-272
a^^^,,l-+;^^ LUdgUtOtlul
(n??-nipr
a^-^,,1 -+;^^ {--+^. Vll uud9utoLrur I loLtul /\rl
protein Vll Coagutation protein Vlll, Coagutation h e m o p h i lAi a proteinlX,Christmas Xq27.1-272 Coagutation diseash ee , m o p h i LBi a 'i3q34 protein X Coagulation {--+^-Vl I loLLUr /\l
poLyposis, FamitiaL adenomatous syndrome Gardner Marfansyndrome Fibrrltin-1, 15q211 contracturaI 5q23-31 FibriL|.in-2, arachnodactyly 13q12 3 growthfactorreceptor 8p111-112 Fibrobtast syndrome Pfeiffer 1, 11p15 4 growthfactorreceptor Fibrobtast 10q26 19p13 2-133 Apert Pfeiffet, 2.Crouzon, Cnmnlpmpnt f:rtnr 5 9q341 fnmnlomonr {rr+nr A syn0r0me 5p13 growthfactorreceptor l^nmnlomont f:rtnr 7 Fibrob[ast 4p163 FGFR3 5p13 thanatophortc 3, achondropLasia, C n m n l p m p n t f : r t n r 9 5p13 dysptasia hyperpLasia, CongenitaI adrenat 6p213 hypercho[esterotemia 19p131J32 Famitiat FH 21- hydroxytase Fragite X mentaIretardation FRAXA(FMRl) Xq273 21q223 Homocystinuria ataxia 9q13-211 Friedreich porphyria FRDA 10q252-263Congenitalerythropoietic meursacLu t a r F a c i o s c a putohum 4q35 FSHMD fi brosis transmem brane 7q312 Cystrc rnnrlr rrt:neo aaar rla+nr dystrophy Gatactosemia 9p'l3 GAL 10q11 syndrome 2,tateonset Cockayne nevussyndrome, BasalceLL 9q31 GAP 14q12 Hypertrophic obstructive syndrome Gorlin cardiomyopathy type'1 GMg l angLiosidosts 33 3p21 GLBl 1q3 Hypertroph icobstructive -6- phosphate GLucose Xq28 G6PD type2 cardiomyopathy d e h y d r ogenase 15q22 Hypertrophic obstructive tYPe Vll, ridosis Lysa ccha copo M u 7q2111 GUSB type3 cardiomyopathy Stysyndrome 17pl12 disease Charcot-Marie-Tooth 11p15 5 HbB typelA B - G t o b igne n e l - . l rr n t i n n t n n dico:ce 4p163 HD rre-Tooth disease 1q22 Charcot-Ma i ni daseA,Tay-Sachs H m exosa 15q23-24 HEXA type1B drsease disease 1p35-36 Charcot-Marie-Tooth B,Sandhoff Hexosaminidase 5q13 HEXB type2 drsease 17q2131-22CoLLagen typel,c1chain. Hemochromatosis 6p213 HFE imperfecta osteogenesis Hypoxanthg i nuea n i n e Xq26-272 HGPRT type I. chain, 7q221 Co[[agen cr2 se, phosphoribosyltransfera imperfecta osteogenesis syndrome Lesch-Nyhan typell,Stickler syndrome 12q1311J32Cotlagen Locus MajorhistocompatibiLity 6p213 HLA 2q31 C o l t a g et ynp el l l ,q c h a i n , Hotoprosencephaty 7q36 HPE3 type lV syndrome Ehters-Danlos tyPeI. Mucopotysaccharidosis 4p163 hyperptasia, IDUA CongenrtaI adrenaL 8q21 Hurlersyndrome 11B-hydroxylase r Lt iignhct h a i n lmmunogLobu l-)eleted in :znncnprmi: 2p12 IGKC Yq11 '13q12 i , t i ng hct h a i n s l m m u n o g L o b u 22q11 IGLCl N o n - s y n d r o ms iecn s o r i n e u r a I p155 I n s u t i n - d e p e n dder an bt e t e s 11 //Vs third deafness, firstrecessive, type2 metlitus d o m i n a nLto c u s simptex, buLlosa EpidermoLysis 12q1lJ3 KRT5 2-133 Myotonic dystrophy 19q13 eu,
5
5q21-22
| ,Prul
77
5
MAPPING ANDIDENTIFYING GENES FORMONOGENIC DISORDERS
LGMDT MCAD MDS MENl MHS MITF MJD MPSVI MSH2
Koebner type Limb-grrdlemuscutar dystrophy -A dehyd Acy[coenzyme rogenase medium chain M i l l p r - f l i p L e r I' i'c-c-p n r-o-n. h ': l17p13 3 V syndrome '11q13 Muttipe t en d o c r r nnee o p t a s i a syndrome type1 19q13 1 Ma[ignanthyperpyrexia susceptibility, [ocus1 3p141 Waardenburg syndrome type2 14q243-31 Machado-Joseph disease, spinocerebeLLar ataxia type3 5q11-13 Maroteaux-Lamy syndrome 2p15-16 Hereditary non- polyposis cnlnrert:l
NCF2
1q25
renror
trrno 1
o iusse a s e , C h r o n igcr a n u L o m a t d neutrophiI cytosolic factor-2 deficiency Neurofibromatosis typeI,von R e c k l i n g h a uds iesne a s e Neurofibromatosrs typell. b r t a t e raacI o u s t ni ce u r o m a N r e m a n n - P di ci sk e a stey p eA a n dB N i e m a n n - P idciks e a stey p eC
NFl
17q112
NF2
22q122
/VP
11p15145 4
NPC /VP5 OTC p53
18q11-12 9q43 Xp211 17p131
PKU PROC PROS PRNP PWS PXMPl RB
12q241 2q13-14 3p11 1-q11 2
syndrome PhenyIketonu ria Protern C,coagutopathy disorder Protein S,coaguLopathy disorder
)ltn1)-ntar
Prinn
Nl-,1 ^-+^ll- -,,^!-^-^ | \crr-PoLtrrLd >yt tut ut I ttr
Orniihinetranscarbamylase nE? nrntpin I i-Fr:rrmoni
dice:qo
nrniorn
15q11 Prader-Witlr syndrome 1p21-22 Zellweger syndrome type2 13q141-142 RetrnobLastoma
US dollars per annum Other nations, notablv France, the UK and Japan, soon followed with their own major national human genome programs and were subsequentlyjoined by a number of other countries. These individual national projects were all coordinated by the Human Genome Organization (HUGO), which has three centers,one for the Americas basedin Bethesda, Maryland, one for Europe located in London, and one for the Pacific in Tokyo. Whilst the key objective of the Human Genome Project was to sequenceall 3 X l()ebasepairs of the human genome,this was just one of the six main obiectives/areasof work of the Human Genome Project.
H u m a ng e n em a p sa n d m a p p i n go f h u m a n inheriteddiseases
78
RET
10q11 2
RH
1p34-362
RPl RP2 RP3 rRNA SCAl SCA2 SPHl SMA
- q21 8p11 Xp1'13 Xp211
5q31 1p31
Designated genome mapping centers with ear-marked funding were involved in the coordination and production of genetic or recombination and physical maps of the human genome. The
s0D! SRY TBX5 TCOFl TRPSl T5Cl TSC2 TYR USHlA USHlB U5HlC USH2 VWS VHL VWF WD WRN
wsl WTl ZWSl
FamrtraI meduL[ary thyroid c a r c i n o mM a .E N2 4 a n d2 8 f a m i t i aHl i r s c h s p r udnigs e a s e R h e s unsu t d[ i s e a s R e ,h e s u s group btood R e t i n i tpi si g m e n t o sl oac, u s ' l pigmentosa, Retrnrtis locus2 pigmentosa, Retinitis Locus 3 R i b o s o mR a IN A Spinocerebe[[ar ataxra, [ocus] SpinocerebeLLar ataxia. Locus 2
6p23 12q24 14q22-232 S n h p r n n i t n c i < + \ / n t r I 5q122133 Spinalmuscular atrophy 21q221 Superoxide dismutase, famitiat m 0 r o nr e u r o n orseaSe S e x - d e t e r m i nri n e g i oY n testrs-determrnrng factor 12q213-22 Holt-Oram syndrome 5q32-33 1 Treacher-Collins syndrome 8q2412 Trichorhinopha[an s ygned raoLm e 9q34 Tuberous scterosis, Locus 1 16p13 3 Tuberous sclerosis, locus2 11q14-21 0 c u l o c u t a n e oaut bsi n i s m 14q32 Ushersyndrome typelA 11q13 5 Ushersyndrome typelB I-J-s " h e) r < , v n . ] r n m p t r r n e l C 11p15'l 1q41 Ushersyndrome typell 1q32 v a nd e r W o u dsey n d r o m e 3p25-26 v o nH i p p e [ - L i n dsayun d r o m e 12p13 3 vonWiLLebrand disease 13q143-211 W i t s o nd i s e a s e 8p112-12 Wernersyndrome 2q35 Waardenburg syndrome type1 11p13 W i l m st u m o r lg e n e 7q1123 Zettweger syndrome type'l
Yp113
genetic maps initially involved the production of fairly low-level resolution index, skeletonor framework maps, which were based on polymorphic variable-number di-, tri- and tetranucleotide tandem repeats(p. 16) spacedar approximarely 10-cM inrervals throughout the genome.The most recent high-level resolution maps have polymorphic markers that are, on average,spacedat intervalsof lessthan I cM The mapping information from these genetic maps has been integrated with high-resolution physicalmaps (Fig. 5.3). Access to the detailed information from these high-resolution genetic and physical maps allowed individual research groups, often interestedin a specificor parricular inherited diseaseor group of diseases, rapidly and preciselyto localizeor map a diseasegeneto a specificregion of a chromosome.
Development of new DNAtechnotogies A second major objective was the development of new DNA technologiesfor human genome research For example. at the
M O N O G ED NIIS CO R D E R S N EFSO R DD E N T I F YG I NEG M A P P I N G AI N
t L*.il^d--]
F i s .5 . 3
fYAc-l
I YACcontigs|
|
israndsI
A s u m m a rm y a po f h u m a nc h r o m o s o m3e,e s t i m a t et odb e eh s y s i c a L m a p pdiantgac o v e r e d 2 1 0M br ns i z ew. h i c hi n t e g r a t p genettc mapwithcumutattve andtheGenethon contigs by24YAC t t M ,C h u m a k ol ,vS c o tPt e ta 1 1 9 9 5 m a od i s t a n c e( sF r o mG e m m iR g a po fh u m a nc h r o m o s o m3e A s e c o n d - g e n e r aYt iAoC nc o n t i m permission Nature377:299-319.with )
r pTER 263
I
262 261 -R]58
,l
252 251
2 a1 -
A D351307
I
253
---B 03S1560 I c o:sre D vHr/RAF
I R7K134
E THRB
! D3S]293
5
R 15 8
1259
23
l5g5
221 1236 1 2 9| 1599
222 221 2t33
1 5 6 7r 5 3 3 1 2 6 61 2 3 3
2 13 2
I
2131
2r 2-
G
M5021 l 6r 9 1 2 7 7! 5 6 !r 6 1 r , 1 6 t 2 r260
2A3CT
I D3s2
2ll
H r42-1(3
72 73
30
I606-'_ 1295,1592 1 5 41 73 1 1 1300 1312
9l 93
1287 1235
HRCA-I
8)
E o:sr:es
I
122
D3S3 lvlJ1570
I
l
IK
rr r-UCHt2
t 2 € 11 2 9 5r 5 6 2 , 1 5 6 6
D MJ1399p
Not76
r593 244
i, ,\-
ot''"'
It I
t31l r 3r 2
lNotss
1 5 5 9t 2 7 l 1 5 5 9r 2 7 r 127
I
o o,s'ut, -
r 3r 3 r32-
lr2 tll
M o:srzsr u r',lr,,ru
I
"'[.DiSi6io
R477 l0A
t30 132 133 135
1 2 3 1t 5 6 3r 6 l 6 1572 I610 1273 1 3 r 01 5 3 6 1 5 7 51 5 7 9
U utsog P UV]P5
1332
! cos340
r 33 3
145 1539
2r3-H3
4
2 r3
I I
T
221
0
Mlrs08
222
153
1273 12941292
t53 159
1549,1576 13r6,1615 1309
164
r569 t550 r 5 5 7r 5 9 3 , r 6 0 9 r 5 5 7r 5 9 1 , 1 6 0 3 r306 t555 t303 1299 1 2 7 9t 3 1 5 1 5 9 4 1 2 3 0I 5 3 4
tFt
723
D R
MJ1s36
23
s
D3s1550
ltl D cottt sz
251 2s2- R221-34 2531 2 53 2
H3-4
2631 2 63 2
'" 272 273
29
131
R,48 3
1553 1 2 5 31 2 6 3
t o,r,rou
T
1252 r574 1555 1548 1565
! 03S1268
261 262-
I T
l., EV-]
t, v
Ix
1571,1613
I rotrss B Not1085
I ,
203 2t0
1262,1642
217 219
r580 1294
222 224
1 2 3 3t 3 l 4
I D3sis6s
D351617
W MJ12O7 o:stzzz
information from the Human Genome SequenceProiect.
S e q u e n c i nogf t h e h u m a ng e n o m e
t73
r 2r - R l
r 5 B 2r 6 r 3 r289
outset of the Human Genome Proiect, the technology involved in DNA sequencing was very time consuming, laborious and relatively expensive.The development of high-throughput automated capillary sequencersand robust fluorescent sequencing kits transformedthe easeand cost of large-scaleDNA sequencing projects. Current developmentsin the use of DNA microarray technologyare further revolutionizinganalyticapplicationsofthe
Iuotort ED3s126s I qTER
Although sequencingof the entire human genome would have been seento be the obvious main focus of the Human Genome Project, initially it was not the straightforward proposal it seemed.The human genomecontainslarge sectionsof repetitive DNA (p. 17) that are often technically difficult to clone and sequence.In addition, it would seem a waste of time to collect sequencedata on the entire genomewhen only a small proportion is made up of expressedsequencesor genes' the latter being most likely to be the regions of greatestmedical and biological importance. Furthermore, the sheer magnitude of the prospect of sequencingall 3 x l()ebasepairs of the human genomeseemed overwhelming. With conventional sequencing technology, as was carried out in the early 1990s,it was estimatedthat a single laboratory worker could sequenceup to approximately 2000bp per day. This meant that it would have taken 1'5X 106persondays to sequencethe whole of the human genome! Projectsinvolving sequencingof other organismswith smaller genomesshowedhow much work is involved as well as how the rate of producing sequencedata increasedwith the development of new DNA technologies.For example, with initial efforts at producing genome sequencedata for yeast,it took an international collaborationinvolving 35 laboratoriesin l7 countries from 1989 until 1995 to sequencejust 315000bp of chromosome3, one of the l6 chromosomesthat make up the 14 million basepairs of the yeast genome. Advances in DNA technologies meant' however,that by the middle of 1995 more than one-half of the yeast genome had been sequenced,with the complete genomic sequencebeing reported the following year. Further advancesin DNA sequencing technology led to publication of the full sequenceof the nematode Caenorhabditis elegansin 1998 and the 50 million base pairs of the DNA sequenceof human chromosome 22 at the end of 1999. As a
79
5
M A P P I NAGN DI D E N T I F Y IG NE GN E F S O RM O N O G E NDI C ISORDERS
consequenceof thesetechnicaldevelopments,the 'working draft' sequence,covering 90oloof the human genome,was published in February 2001.The finished sequence(over 99o/ocoverage)was announced more than 2years ahead of schedule in April 2003, the 50th anniversaryof the discovery of the DNA double helix Researchersnow haveaccessro the full catalogof 25 000 to 30 000 genes,and the human genomesequencewill underpin biomedical researchfor decadesto come Although the Human Genome Sequencing Project is complete, a number of new projects have been initiated as a direct consequence,including the Cancer Genome Project and the HapMap Project. The goal of the International HapMap Project is to develop a haplotype map of the human genome, the HapMap, which will describe the common DNA sequence variantspresentin 270 individuals from variouspopulations.The HapMap is expected to provide a key resource for research into genesaffecting health, diseaseand responseto drugs
Development of bioinformatics Bioinformatics was essentialto the overall successof the Human Genome Project. This is the establishment of facilities for collecting, storing, organizing, interpreting, analyzing and communicating the data from the project, which can be widely shared by the scientific community at large. It was vital for anyone involved in any aspect of the Human Genome Project to have rapid and easy accessto the data,/information arising from it. This dissemination of information was met by the establishmentof a large number of electronic databasesavailable on the World Wide Web on the internet (Appendix) These include protein and DNA sequence databases(e.g. GenBank and EMBL), databasesof genetic maps for humans (such as the GDB, Genethon, CEPH, CHLC and the Whitehead Institute sites)and other species(the Mouse Genome Databaseand the C. elegansdatabase),linkage analysis programs (e.g. the Rockefeller University website),annotatedgenomedata(Ensembland UCSC Genome Bioinformatics) and the catalogof inherited diseasesin humans (Online Mendelian Inheritance in Man, or OMIM). These developmentsin bioinformatics now allow the prospect of identifying coding sequencesand determining their likely function(s) from homologies to known genes, leading to the prospect of identifying a new gene without the need for any laboratory experimental work, or what has been called 'cloning in silico'
Comporotive genomics
80
In addition to the Human Genome Project there are separate genome projects for a number of other species,for what are known as 'model organisms'.These include various prokarvotic organisms such as the bacteria E. coli and,Haemophilusinfluenzae, as well as eukaryotic organisms such as Succharomycescereaisiue (yeast), C. elegans(flatworm), Drosophila melanogaster(fruit fly), Mus musculus(mouse), Rattus noroegicus(rat), Fugu rubripes rupripes (puffer fish), mosquito and zebrafish. Although the
impact of what is called comparatiaegenomicsis not necessarily immediately obvious, it is of vital importance in the Human Genome Project. For example, the availability of the total genome sequence of yeast revealed it to contain a total of approximately 6000 genes, only some 2300 of which had been previously identified from traditional genetic studies in yeast In addition, of the 3700 new genes identified by the sequencingproject, only approximately 2300 sharesignificant sequencehomology with any known genes from any other organism, that is, they are novel genes whose functions are unknown. The sequencing of the fruit fly has also revealedso far some 13000 genes,half of whose functions are unknown. Mapping of the human homologs of these newly identified genes from other species provides new'candidate' genesfor inherited diseasesin humans.
Functionalgenomics The second major way in which model organisms proved to be invaluablein the Human Genome Project was by providing the means to follow the expressionof genesand the function of their protein products in normal development as well as their dysfunction in inherited disorders.This is referred to asfunctional genomics, or what has alsobeen calledpast-genomic genencs. The ability to introduce targeted mutations in specific genes, along with the production of transgenic animals (p. 97), for example in the mouse, allows the production of animal models to study the pathodevelopmental basis for inherited human disorders, as well as serve as a test system for the safety and efficacyof genetherapy and other treatment modalities (p.342). Strategiesusing different model organismsin a complementary fashion,taking into accountfactorssuch asthe easeor complexity of producing transgenic organisms and the generation times of different species,allow the possibility ofrelatively rapid analysis of gene expression, function and interactions in providing an understandingof the complex pathobiologyof inherited diseases in humans.
ETHICAL, LEGALAND SOCIAL ISSUES OFTHE HUMAN G E N O MPER O J E C T The rapid advancesin the scienceand application of developments from the Human Genome Project have presented complex ethical issuesfor both the individual and society.These issuesinclude ones of immediate practical relevance,such as who owns and should control genetic information with respect to privacy and confidentiality; who is entitled to accessto it and how; whether it should be used by employers,schools,etc.; the psychological impact and potential stigmatization of persons positive for genetic testing; and the use of genetic testing in reproductive decision making. Other issuesinclude the concept of disability/ differences that have a genetic basisin relation to the treatment of genetic disordersor diseasesby gene therapy and the possibility of geneticenhancement,i.e. using genetherapy to supply certain characteristics,such as height. Lastly, issuesneed to be resolved
S O RM O N O G E NDI ICS O R D E R S M A P P I N G A NI D DE N T I F Y 1GNEGN E F
with regard to the appropriatenessand fairness of the use of the genetic technologiesthat come out of the Human Genome Project, with prioritization of the use of public resourcesand commercial involvement and property rights, especially with regard to patenting
FURTHER READING BotsteinD, White R L, SkolnickM, Davis R W 1980Construction of a genetic linkage map in man using restriction fragment length polymorphisms.AmJ Hum Genet 32: 314-331 OneoJ'theorigmalpalers describingthe conceptof linked restrictionfragment lengthpolymorphsms. Kerem B, RommensJ M, BuchananJ A et al 1989Identificationof the cysticfibrosisgene GeneticanalysisScience245: 1073-1080 Original paper describingcloningof the c.ystic fibrosisgene. McKusickV A 1998Mendelianinheritancein man, 12th edn Johns Hopkins University Press,London A tomputerizedtatalog oJ'thedominant,recessiu^e and X-linked mendeliantrain and disortlersin humansuith a briefrlinical commenlaryand detaik oJ the mulalional bavs, tJ knonn Also aaailableonline,updatedregularly. B, Kunkel L M, MonacoA P et al 1985Cloning the genefor Royer-Pokora - on the an inheritedhuman disorder- chronic granulomatousdisease basisof its chromosomallocation Nature 322:32 38 genethroughcontiguous Original paperdescribingthe identifcution of a disease deletions. chromosome StrachanT, ReadA P 2004 Human molecular genetics,3rd edn Garland Science,London A comprehensiae textboohofall aspeclsofmolecularand cellularbiologyas it relalesto inheriteddiseasein humans SulstonJ 2002The common thread:a storv of science,politics,ethicsand the human genomeJosephHenry Press,London projectby the man pho led A 2ersonalarcountof the humangenomesequencing the UK teamof vientists
5
ELEMENTS @ Position-independentmethods for the identification of monogenic disorders include functional cloning to identify genes from knowledge of the protein sequence and the use of animal models. A technique to identify novel trinucleotide repeat expansionsled to the identification of the SCl8 diseaselocus. @ Positional cloning describes the identification of a gene on the basis of its location in the human genome. Chromosome abnormalities may assist this approach by highlighting particular chromosome regions of interest. Genetic databaseswith human genome sequence data (in silico' a now make the possibility of identifying genes reality. @ Confirmation that a specific gene is responsible for a particular inherited disorder can be obtained by tissue and developmentalexpressionstudies,in-oitro cell culture studies, or the introduction and analysisof mutations in a homologous gene in another species.As a consequence the 'anatomy of the human genome' is continually being unraveled. @ O". of the goalsof the Human Genome Project was to sequencethe human genome. The sequencing was completed by an international consortium in 2003, and has greatly facilitated the identification of human disease genes.
81
Devetopmentat genetics
CHAPTER
'The history of man for the nine months preceding his birth would, probably,be far more interesting and contarn events of greatermoment than all the three scoreand ten yearsthat follow it.' Sarnuel Thylor Coleridge At fertilization the nucleus from a spermatozoonpenetratesthe cell membrane of an oocyte to form a zygote. This single cell
Tabte6.1 Maineventsin the devetopment of a human infant Stage
Time from conception
Pre-embryonic Firsice[[division Zygotereachesuierrnecavity lmptantatron Formation of brtaminar disc Lyonization in femate Formation of tritaminar discand primitivestreak Embryonicstage Organogenesrs BrarnandspinaI cordareforming Firstsignsof heartandtimbbuds Brain, eyes,heartandlimbs deveLoping rapidty BoweIandtungsbeginnrng to devetop Digitshaveappeared Ears, kidneys, liverandmuscleare devetoping Patate closesandjointsform Sexualdifferentiation almost comptete Fetalstage Fetatmovements felt Eyelids openFetusis nowviable rarrih cnori:lizor'1
82
30 h 4 days 5-6 days 12days 16days 19days
Lengthof embryo/fetus
O2 mm 1mm
4-Bweeks 4 weeks
4 mm
6 weeks
17mm
8 weeks
4 cm
10weeks 12weeks
6 cm 9 cm
and, whilst many mysteries remain, the rate of progress in understandingkey eventsand signaling pathwaysis rapid. A fetus is recognizablyhuman after about 12weeksofpregnancy - the first trimester. Normal developmentrequires an optimum maternal environment but genetic integrity is fundamental; this has given rise to the field of developmental genetics.Most of what we know about the molecularprocessesinevitablycomesfrom the study of animal models,with great emphasison the mouse,whose genomecloselyresemblesour own. Prenatallife can be divided into three main stages'. pre-embryonic, embryonicandfetal (Table 6 l) During the pre-embryonic sragea small collectionof cellsbecomesdistinguishable,first as a doublelayered or bilaminar disc,and then as a triple-layered,or uilaminar d,nc(Fig 6.1) that is destined to develop into the human infant. During the embryonic stage,cranio-caudal, dorso-ventral and proximo-distal axes are established,as cellular aggregationand differentiation lead to tissue and organ formation. The final fetal stageis characterizedby rapid growth and development as the embryo, now known as a fetus, matures into a viable human infant. On average,this extraordinary process takes approximately 38 weeks.By convention pregnancyis usually dated from the first day of the last menstrual period (LMP), which usually precedes conception by around 2weeks, so that the normal period of gestationis often stated(incorrectly) as lasting 40 weeks.
FERTI LIZATION AND GASTRU LATION 16-18weeks 24-26weeks
20 cm 35 cm
28-38weeks
40-50cm
r:ro
Rapidweightgarndueto growth andaccumutation offatas [ungsmature
divides to become two, then four, and when the number has doubled some 50 times the resulting organism comprises more than 200 distinct cell types and a total cell number of about 10000 trillion. This is a fully formed human being with complex biochemistryand physiology,capableof exploring the cosmosand identifying subatomic particles.Not surprisingly, biologists and geneticistsare intrigued by the mechanismsof early development
Fertilization, the processby which the male and female gametes fuse, occurs in the fallopian tube. Of the 100 to 200 million spermatozoa deposited in the female genital tract only a few hundred reach the site of fertilization. Of these, usually only a single spermatozoon succeedsin penetrating first the corona
GENETICS DEVELOPMENTAL
B u c c o p hray n g e a I memora ne Ectoderm Mesoderm Endoderm P r e c h o r d apll a t e mesoderm N e u r apl l a t e
Notocord
," ]
P r i m i t i v es t r e a k
C l o a c am l embrane
Fig.5.1 A s c h e m a t itcr i l a m i n adr i s c s, e c t i o n eadl o n gt h e r o s t r o - c a u d a L axrs Cettsfrom ihe futureectoderm(mid blue)migratethroughthe prim'tivestreakto fo.rr Lheendoderm(trghtbtue)and -esoderm (gray)Formationof the neutraIptatein the overtyingectoderm, destinedto be the centraInervoussystem,invotvessonic hedgehogsignalrng(p 85)from the notochordand prechordial platemesoderm (Redrawnwith permissionfrom LarsenW-J1998 E s s e n t r a ot sf h u m a ne m b r y o [ o g yC.h u r c h i L t ti v i n g s t o nN e ,e w Y o r k )
5
12 to 16 cells by 3 days, when it is known as a morula. A key concept in developmentat all stagesis the emergenceof polari4r within groups of cells - part of the process of differentiation that generatesmultiple cell types with unique identities. Whilst precisemechanismsremain elusive,observationssuggestthat this begins at the very outset; in the fertilized egg of the mouse, the point of entry of the sperm determinesthe plane through which the first cell cleavagedivision occurs. This seminal event is the first step in the development of the so-called dorso-ventral, or primary body, axis in the embryo. Further cell division leads to formation of a blastocyst,which destinedto form the consistsof an inner cell massor embr.yoblast, embryo, and an outer cell mass or trophlblast,which gives rise to the placenta.The processof converting the inner cell mass into firstly a bilaminar and then a trilaminar disc (seeFig. 6.1) is known as gilsuulation,and takesplace between the beginning of the secondand the end of the third weeks. Between4 and 8 weeksthe body form is established,beginning with the formation of the primitive streakat the caudalend of the embryo. The germinal layers of the trilaminar disc give rise to structures (Box 6.1). The and endod,ermal mesodermal ectod,ermal, neural tube is formed and neural crest cells migrate to form sensory ganglia,the sympatheticnervoussystem,pigment cells,and both bone and cartilagein parts of the face and branchial arches. Disorders involving cells of neural crest origin, such as neurofibromatosis (p. 287), are sometimes referred to as This period between4 and 8 weeksis described neurocristopathies. as it is during this interval that all as the period of organogenesis, of the major organsare formed asregionalspecializationproceeds in a cranio-caudaldirection down the axis of the embryo.
radiata, then the zona pellucida, and finally the oocyte cell membrane, whereupon the oocyte completesits second meiotic division(seeFig. 3.19,p.42). After the sperm has penetrated the oocyte and the meiotic process has been completed, the two nuclei, now known as pronuclei, fuse, thereby restoring the diploid number of 46 chromosomes.Germ cell and very early embryonic development are two periods characterizedby widespread changesin DNA methylation patterns - epigenetic reprogramming (see below, p. 98). Primordial germ cells are globally /emethylated as they mature and are subsequently methylated de noao during gametogenesis, the time when most DNA methylation imprints are established.After fertilization a second wave of change occurs.The oocyte rapidly removesthe methyl imprints from the sperm'sDNA, which has the effect of resettingthe developmental stopwatch to zero. By contrast, the maternal genome is more passively /amethylated in such a way that imprinting marks resist demethylation. A third wave of methylation, de noz,o, establishesthe somatic cell pattern of DNA methylation following implantation. These alternating methylation stateshelp to control which genesare active,or expressed,at a time when two genomes, initially alien to eachother, collide. The fertilized ovum or zygote undergoesa seriesof mitotic divisions to consist of two cells by 30h, four cells by 40h and
FAMILIES GENE DEVELOPMENTAL Information about the genetic factors that initiate, maintain and direct embryogenesis is incomplete. However, extensive
B o x 6 . 1 0 r g a na n dt i s s u eo r i g i n s Ectodermal nervoussystem Central system Perpheralnervous F pd e r r n i Isn c t u d nnga i ra n dr a i l s glands Subcutaneous DentalenameI MesodermaI tissue Connective Cartlageandbone muscte Smoothandstriated system Cardiovascutar taIsystem Urogen Endodermal Thymusandthyroid system Gastrointestinal Liverandpancreas
83
5
DEVELOPMENTAL GENETICS
genetic studies of the fruit fly, Drosophila melanogaster,a;nd vertebratessuch as mouse, chick and zebrafish have identified several genes and gene families that play important roles in the early developmentalprocesses.It has also been possible through painstaking gene expressionstudies to identify several key developmentalpathways,or cascades,to which more detail and complexity is continually being added. The gene families identified in vertebratesusually show strong sequencehomology with developmental regulatory genesin Dra sophila.Recent studies in humans have revealedthat mutations in various members of these genefamilies can result in either isolatedmalformations or multiple congenital anomaly syndromes (seeThble 16.5,p.245). Many developmentalgenesproduce proteins called transcription factors (p. 2l), which control RNA transcription from the DNA template by binding to specific regulatory DNA sequencesto form complexesthat initiate transcription by RNA polymerase. Transcription factors can switch geneson and off by activating or repressing gene expression. It is likely that important transcription factors control many other genes in coordinated sequentialcascadesand feedbackloops involving the regulation of fundamental embryological processessuch as induction (the processin which extracellularsignalsgive rise to a change from one cell fate to anotherin a particular group ofcells), segmentatiln, migration, d.ffirentiation and programmed cell death (known as aprptlsts). It is believed that these processesare mediated by growth factors, cell receptors and chemicals known as morph0gens. Across speciesthe signaling moleculesinvolved are very similar. The protein signals identihed over and over again tend to be members of the transforminggrowthfactor-B (TGF-B) family, the wingless(Wnr) family and the hetlgehog(HI{) famrly.In addition, it is clear within any given organism that the same molecular pathwaysare reused in different developmentaldomarns.
EARLY PATTERNING The emergenceof the mesoderm heraldsthe transition from the stage of bilaminar to trilaminar disc, or gastrulation.Induction of the mesoderm - the initiation, maintenanceand subsequent patterning of this layer- involvesseveralkey families of signaling factors.The Na dal family isinvolved in initiation, -FGFs(fibroblast growth factors) and Wnts are involved in maintenance, and BMPs (bone morphogenetic proteins) are involved in patterning the
84
mesoderm. Signaling pathways are activated when a key ligand binds specificmembrane-bound protein receptors.This usually Ieads to the phosphorylation of a cytoplasmic factor, and this in turn leads to binding with other factor(s) These factors translocate to the nucleus where transcriptional activation of specifictargetsoccurs. In the case of Nodal and BMP pathways,ligand binding of a specific heterotetramer membrane-bound protein initiates the signaling, which is common to all members of the TGF-B family. The cytoplasmic mediators are Smad factors. The embryo appears to have gradients of Nodal activity along the dorsalventral axis, although the sigificanceand role of these gradients in mesoderminduction are uncertain.
The Wnt pathway has two main branches: one that is B-catenin dependent (canonical) and the other independent of B-catenin. In the canonical pathway Wnt ligand binds to a FrizzledllRP heterodimer membrane-bound protein complex and the downstreamintracellular signalinginvolvesa G-protein. The effect of this is to disrupt a large cytoplasmic protein complex that includes Axin, the adenomatouspolyposis coli (APC; see p. 208) protein, and the glycogen synthase kinase30 (G.SK--?p) protein. This prevents the phosphorylation of B-catenin, but when B-catenin is not degraded it accumulatesand translocatesto the nucleus where it activatesthe transcription of dorsal-specific regulatory genes. Binding of the ligand to the FGF receptor results in dimerization of the receptor and transphosphorylation of the receptor'scytoplasmic domain, with activation of Ras and other kinases, one of which enters the nucleus and activates target transcription factors. There is no known human diseasephenotype due to mutated WNT genes, but overexpression of BMP4 has been found in the rare bony condition fibrodyplasia ossificansprogressiva (FOP). FOP has recently been shown to be causedby mutated AC|/RI, which encodes a BMP type I receptor, and mutated BMP receptor 2 has beenshown to be a causeof familial primary pulmonary hypertension.BMPs and Nodal genesare part of the IGF-B superfamily.
S O M I T O G E N EASNI D ST H EA X I A L SKELETON The vertebrate axis is closely linked to the development of the primary body axis during gastrulation, and during this process the presomitic mesoderm (PSM), where somites arise, is laid down in higher vertebrates. Wnt and FGF signals play vital roles in the specification of the PSM. The somites form as blocks of tissue from the PSM in a rostro-caudal direction (Fig. 6.2), each being laid down with a precise periodicity that, in the 1970s, gave rise to the concept of the 'clock and wavefront' model. Since then molecular techniques have given substance to this concept, and the key pathway here is notch-delta signaling and the 'oscillation clock' - a precise, temporally defined, wave of cyclinggeneexpression (c-hairy in the chick, lunatic fringe and,hes genes in the mouse) that sweeps from the tail-bud region in a rostral direction and has a key role in the process leading to the defining of somite boundaries Once again, not all of the components are fully understood, but the nltch rec€ptorand its ligands, d,elta-like-l and tleltalike-3, together with presenilin-l and mesodermposterior-2, work in concert to establish rostro-caudal polarity within the PSM such that somite blocks are formed. Human phenotypes due to mutated genes in this pathway are now well known and include presenile dementia (presenilin-l), which is dominantly inherited, and spondylocostaldysostosis(delta-like-3,mesoderm p0sterilr-2 and, lunatic fringe), which is recessively inherited (Fig. 6.3). Another componenr of the pathway is JAGGEDI, which, when mutated, results in the dominantly inherited and
GENETICJ DEVELOPMENTAL
6
ROSTRAL
oo oC CC oo C o oC oc C c oC oc oC o
G l o b asl o m i t ei d e n t i t y a l o n ge n t i r ea x i s - H o xg e n e s
l
Segmentation, somite boundary formation - Notch-delta, MesP2
O s c i l l a t i o/nc y c l i n gg e n e - Infg
ParaxiaI mesoderm (PSM)
S p e c i f i c a t i oonf P S Mi d e n t i t y - T-box,FgfS
F i s .5 . 3
CAUDAL
Fis.6.2 S o - i t o c e n e s r s a ^ c N o l c h - f l e l t a n a t h r v a vT - n n x n p n c s h a v e a ' ' ! - v ' _ i 4
r o l ei n P S Ms p e cf i c a t r ownh i l stth es e g m e n t a t icol no c kd e p e n d s o no s c rat tf ' o no, r c y c t i . lg e. n e tsh a ta r ei m p o r t a ri n t somite formation boundary wheregenesoftheNotch-Delta pathway polarity estabtish rostro-caudal H0Xgeneshavea gtobalfunction in estab[ishing somiteidentity alongtheentirerostro-caudaL '
l ^
|
I
' l ^ ^ ^ ^ ^
axrs (Adaptedtrom lrcktet tedl2tJtJ3Parterning in vertebrate devetopmentOxfordUniversityPress,Oxford)
very variable condition known as Alagille syndrome (arteriohepatic dysplasia)(Fig. 6.4). Recently,mutations ln NOTCH2 havebeen shown to causesome casesof Alasille svndrome.
THE S O NI CH E D GE H OG-P A T C H E D- GLI PATHWAY The Sonic hedgehoggene(51111)is as well known for its quirky name as for its function. SHH induces cell proliferation in a tissue-specificdistribution and is expressedin the notochord, the brain, and the zone of polarizing activity of developing limbs. Following cleavageand modification by the addition of a cholesterol moiety, the 51111protein binds with its receptor, Patched (Ptch), a transmembrane protein. The normal action
in patient with deve[opment ofthevertebrae Disrupted inthedeltotype1,dueto mutations spondylocostaLdysostosis (Courtesy pathway of liAe-3gene,parrofthenotchs,gnaLing f l r M e r i eM . c F n t a o aK' 1e.n ^ e d v - G a lC t oenn l r eI o n d n n )
Mole cular defectsin any part of this pathwaylead to a number of apparently diverse malformation syndromes (see Fig. 6.5). N{utations in, or deletions of, SHH (chromosome 7q36) cause holoprosencephaly(Fig. 6.6), in which the primary defect is incomplete cleavageof the developing brain into separate hemispheres and ventricles. The most severe form of this malformation is cyclopia - the presenceof a single central eye. (The complexity of early developmentcan be appreciatedby the fact that a dozen or so chromosomal regions have so far been implicated in the pathogenesisof holoprosencephaly[p. 246].) Nlutations in PTCH (9q22) result in Gorlin syndrome (nevoid basal cell carcinoma syndrome; Fig. 6 7), which comprises multiple basalcell carcinomas,odontogenickeratocysts,bifid ribs, calcihcationof the falx cerebri and ovarianfibromata. Mutations in SMO (7q31) are found in some basal cell carcinomas and medulloblastomas.Mutations in CLI3 (7p13) cause PallisterHall and Grieg syndromes, which are distinct entities with more or less the same body systems affected. However, there
of Ptch is to inhibit another transmembrane protein called Smoothened (Smo), but when bound by Shh this inhibition
are also links to other conditions, in particular the very variable syndrome (SLOS), which may include Smith-Lemli-Opitz holoprosencephalyas well as some characteristicfacial features,
is releasedand a signaling cascadewithin the cell is activated. The key intracellular targetsare the GLI family of transcription factors (Fig. 6.5)
genital anomalies and syndactyly. This condition is due to a defect in the final step of cholesterolbiosynthesis,which in turn may disrupt the binding of Shh with its receptor Ptch. Some,
85
DEVE[OPMENTALGENETLCS
AI
SHH
Ho lo p r o s n e c e p h lay
I
I
V
N - S HH
cholesterolal
Smith-Lemli-0pitz syndrome
* G o r l i n( n e v o i db a s a l c e l lc a r c i n o m a ) syndrome
C e lm l embrane
ptionfactors GLItranscri
S o m eb a s a cl e l l c a r c t n o m aasn d m e dul l o bl a s t om a s Greig c e p h al o p o l y s y n d a c t y l y syndrome P a l l i s t e r - Hsayl ln d r o m e R ub e n s t eni- T a y b i s y n dr o m e
*,{
F i g .6 . 5 lr
T h e S n n i r 'h' p- -n:n- e n-nYn ( S h n l - P : l r n e d { P l r n ) --C' rl -n": l h r nJr ;Y a n O
{"
c o n n e c ro n w L ho i s e a s e D i f ' e ' e n Le i e r e n t s i n t ^ e p a t n w a ya c r a s
(arrows)or inhibitors(bars)The Shh proteinis rnitially activators cleaved t o a n a c t i v eN - t e r m n a l f o r m w , h i c hi s t h e nm o d f r e db y t h ea d d i t l o n o f c h o [ e s t e r oTlh e n o r m a l a c t i o o n f P t c hi s t o i n h i b i t S m o ,b u t w h e nP t c hl s b o u n db y S h ht h s i n h i b i t i oins r e m o v e da n d t h ed o w n s t r e a m s i g n a nl g p r o c e e d sC R E B B Pc A M Pr e s p o n s e e l e m e n t - bn d n g b i n d i n gp r o t en
Fig.6.tr A, BoywithAtagitlesyndromeand confirmedmutationtnJAGGED| -he o ' t h c o n g e n i t ah.e a r td s e a s eB , w h o p r e s e n t ew s a m eb o ya o t h e r f e w y e a r se a r t r ew r t h h ' s p a r e n r sH r s h a sa p i g m e n t a r y retinopathy and was posttivefor the same genemutatron
or all, of the featuresof SLOS may therefore be due to loss of integrity in this pathwav (p. 276). Furthermore, a cofactor for the Gli proteins, CREBBP (16p13) is mutated in RubensteinT[-vbi syndrome.
transcription factors or morphogen signals,as well as operating at many other levels, on genes that mediate cell adhesion, cell division rates,cell death and cell movement.Thev specifycell fate and help to establishthe embryonic pattern along the primary (rostro-caudal) axis as well as the secondarv (genital and limb
In Drosophilaa classof genesknown as the homeotic geneshas been shown to determine segmentidentitl.. Incorrect erpression of thesegenesresults in major structural abnormalities;the Antp gene, for example, which is normally erpressed in the second
bud) axis.The-v therefore play a major part in the development of the central nervous svstem, axial skeleton and limbs, the gastrointestinaland urogenital tracts, and external genitalia Drosophilahas eight 11ar genes arranged in a single cluster, but in humans, as in most vertebrates,there are four homeobox geneclusterscontaining a total of 39 HOX genes(Fig. 6.8). Each
thoracic segment, rvill transform the adult fly's antennae into legs if incorrectly expressedin the head.Homeotic genescontain a conserved180-basepair (bp) sequenceknown asthe homeobox, which is believedto be characteristicof genesinvolved in spatial
cluster contains a series of closely linked genes.In vertebrates such as mice it has been shown that these genesare expressed in segmentalunits in the hindbrain and in global patterning of the somites formed from axial presomitic mesoderm. In each
H O M E O B O X ( H OGXE) N E S
85
pattern control and development.This encodesa 60-amino-acid domain that binds to DNA in Hox-responseenhancers.Proteins from homeobox (or HOX)-containing genes are therefore important transcription factorsthat activateand repressbatteries of downstreamgenes.At least 35 downstreamtargetsare known The Hox proteins regulate other 'executive' genes that encode
ENTALGENETICS DEVELOPM
6
F i s .6 . 6 'F :oerr : jl o r {r oc :or rr u r q r o) <
|, n
r nr c ou n) c- 6r n rn rnul nr un P r Lh c: lP' r r o r y .
T' h o a',oc rrc cyc)
:-o o c
rl^^^ Lru>c
-nna+hor rugcLr rcl
and there is a midlinecLeftLipdue to failureof normaIprotabia development
llOX cluster there is a direct linear correlation between the position of the gene and its temporal and spatial expression. Thesc obscrvationsindicate that these genes plav a crucial role in earlv morphogenesis.Thus, in the developing limb bud (p. 93) HOXA9 is cxpressedboth anteriorlv to, and before, HOX10, and so on. N{utations rn HOXAI3 causea rare condition knorvn as the hand-foot-genital svndrome. This shows autosomal dominant inheritance and is characterizedby shortening of the first and lifth digits, rvith hvpospadiasin males and bicornuate uterus in females.Experiments r'vith mouse Hoxul3 mutants have sholn that exprcssion of another gene, EphA7, is severell' reduced. Therefore, if this geneis not activatedb.t Hoxal3, there is failure to form the normal chondrogenic condensationsin the distal limb primordial Mutations in HOXDI3 result in an equall.vrare limb developmentalabnormality knorvn as s-ynpolydactylyThis also showsautosomaldominant inheritance and is characterized by insertion of an additional digit between the third and fourth
Fig.6.7 G o r ln ( n e v o i db a s a ct e l lc a r c i n o m as)y n d r o m eA . T h i s6 - y e a r - o l d girl from a Largefamilywiih Gortinsyndromehas macrocephaty and a cherubicappearanceB, Her affectedststerdevelopeda (arrowed)in the mandib[e keratocysi rapidlyenlargingodontogenic roots of her teeth the at the age of 9years.disptacing
Iingers and the fourth and fifth toes, which are webbed (Fig. 'fhe phenot,r-pcin homozygotes is more severe,with the 6 9) mctacarpalsand metatarsalsbcing convertedinto short carpaland Reported mutations take the form tarsal-likebones,respectir.el-v of'an increascin the number of residues in a polyalanine tract. This triplet-repeat expansion probably alters the structure and function of the protein, thereby constituting a gain-of-function mutation (p.26). To date, these are the only two 11OX genes proved to be mutated in human malformations. They are each located at the 5' end of their respectiveclusters and cooperate in the dcvelopment of caudal structures along the primary body axis, the most distal part of the limb, and the genital tubercle.
87
6
DEVELOPMENTAL GENETICs
A Drosophila
5'
3' Abd-B Abd-A Ubx
Human bein .q
HOXA chr'7p14
A13
A11
A10
A9
HOXB ch.17q21
HOXC chr'12q13
HOXD chr'7q31
BB
c8
DB
Antp
5cr
Dfd
At
46
A5
A4
87
86
85
84
c6
c5
c4
D4
pb
lob
A3
A2
A1
83
82
81
D3
D1
Fig.6.8 A, Drosophilio haserghtHoxgenesrna singtectuster whereas thereare39 H0Xgenesin humans, arranged rnfourclusters [ocated on chromosom es7p,17q,12q and2qfortheA,B.CandD clusters, patterns respectively B, Expressron of HoxandHOXgenesalongthe rostt'o-caudaI axisin invertebrates andvertebrates, respectively. Invertebrates thec[usters areporotogous andappearto compensaie for (Redrawn oneanother. fromVeraksa A,DetCampoM,McGinnrs patterning W 2OOO genesandtheirconserved DevetopmentaI functions: a i r tnho r m i < < i)n q f r o mm o d e l o r g a n i s tmosh u m a n sM o lG e n eM 6 SR 6 - 1 OrO t etab
Fig.6.9
88
CLrnrcal(A) and (B) radiographic vrewsof the handsin synpoLyoacryLy
GENETICS DEVELOPMENTAL
6
Given that there are 39 ,F1OXgenesin mammals it is surprising that no other recognizedsyndromesor malformations havebeen attributed to HOX gene mutations. One possibleexplanationis that most flOX mutations are so devastatingthat the embrvo cannot survive. Alternatively, the high degree of homology between HOX genes in the different clusters could lead to functional redundancy so that one HOX genecould compensate for a loss-of-function mutation in another.In this context HOX genes are said to be paralogousbecausefamily members from different clusters, such as HOXAI3 and HOXD|3i are more similar than adjacentgenesin the samecluster. Severalother developmentalgenesalso contain a homeoboxlike domain. These include MSX2 and EMX2. Mutations in ,4,ISX2 can cause craniosynostosis- premature fusion of the
F i s .5 . 1 0 canthorum in an infant lrisheterochromia andmarkeddystopia type1,dueto a mutationin PAX3. syndrome withWaardenburg
cranial sutures. Mutations in EMX2 cause a severe cerebral malformation known as schizencephalgin which there is a large full-thickness cleft in one or both cerebralhemispheres.
PA I R E D - B O(P X A X )GE N E S The paired-box is a highly conserved DNA sequence rhat encodesa 130-amino-acidDNA-binding transcription regulator domain. Nine PIX genes have been identified in mice and humans.In mice thesehavebeen shownto play important roles in the developingnervoussystemand vertebral column. In humans loss-of-function mutations infive PAX geneshave been identified in associationwith developmentalabnormalities(Table 6.2). Waardenburgsyndrome type I is causedby mutations in PAX3. It showsautosomaldominant inheritanceand is characterizedby sensorineuralhearing loss, areasof depigmentation in hair and skin, abnormal patterns of pigmentation in the iris, and widely spaced inner canthi (Fig. 6.10). Waardenburg syndrome shows genetic heterogeneity;the more common type 2 form, in which the inner canthi are not widely separated,is sometimescaused by mutations in the human microphthalmh (MITfl gene on chromosome3 The importance of expression of the PAX gene family in eye development is illustrated by the effects of murarions in PAX2 and PAX6. Mutations in PAX2 cause the renal-coloboma
Tabte5.2 DeveLopmental abnormalities associated with P/Xqenemutations Gene
Chromosome location
Developmental abnormatity
PAX2
10q24
Renal-cotoboma syndrome
PAX3
2q35
Waardenburg syndrome type1
PAX6
11p13
Aniridia
PA,X8
2q12
Absentor ectopic thyroidgtand
PAX9
14q12
Otigodontia
F i s .6 . 1 1 A n e y es h o w i n ga b s e n c eo f t h e i r i s( a n i r i d i aT)h e c o r n e as h o w s (Courtesyof Mr R Gregson.Oueen's abnormalvascuLarization M e d i c aCt e n t r eN. o t t i n g h a m )
s-vndrome,in which renal malformations occur in association with structural defects in various parts of the eye, including the retina and optic nerve. Mutations in PAX6 lead to absence of the iris, which is known as aniridia (Fig. 6.11). This is a ke-v feature of the WAGR syndrome (p. 266), which results from a contiguous gene deletion involving the PAX6 locus on chromosome11.
HMGBOX( SOX)GENES SRY- TYPE SRI is the Y-linked gene that plays a maior role in male sex determination (p. 96). A family of genes known as the SOX genes shows homology with SRY by sharing a 79-aminoacid domain known as the HMG (high-mobility group) box. This HMG domain activates transcription by bending DNA in such a way that other regulatory factors can bind with the promoter regions of genesthat encode for important structural proteins. These SOX genes are thus transcription regulators
89
6
DEVELOPMENTAL GENETICS
and are expressedin specific tissues during embryogenesis. For example, SOXI, SOX2 and SOXJ are expressed in the developingmouse nervous system. In humans it has been shown that loss-of-function mutations in SOX9 on chromosome 17 cause campomelic dysplasia. This very rare disorder is characterizedby bowing of the long bones, sex reversal in chromosomal males and verv poor longterm survival In-sttu hybridization studies in mice have shown that SOX9 is expressedin the developing embryo in skeletal primordial tissue,where it regulatestype II collagenexpression, as well as in the genital ridges and early gonads. SOX9 is now thought to be one of several genes that are expressed downstream of SRY in the processof male sex determination (p. 96). Mutations in SOXI0 on chromosome 22 catse a rare form of Waardenburg syndrome in which affected individuals have a high incidence of Hirschsprung disease.Mutations in SOX2 (3q26) have recently been shown to causeanophthalmia or microphthalmia together with esophagealatresiaand genital hypoplasia in males: the anophthalmia-esophageal-genital (AEG) syndrome.
T.BOX(TBX)GENEs The T genein mice playsan important role in specificationof the paraxialmesodermand notochord differentiation Heterozvgotes for loss-of-function mutations have a short tail and malformed sacral vertebrae.This gene, which is also known as Brach.yur.y, encodesa transcription factor that contains both activator and repressor domains. It shows homolog.v with a series of genes through the shared possessionof the T domain, which is also referred to asthe T:box. These Tlbox or IBX genesare dispersed throughout the human genome, with some family members existing in small clusters.One of these clusters on chromosome 12 contains TBX3 md IBX5. Loss-of-function mutations in IBXJ cause the ulnar-mammary syndrome in which ulnar rav developmentalabnormalities in the upper limbs are associated with hypoplasia of the mammarv glands Loss-of-function mutations in TBXS cause the Holt-Oram syndrome. This autosomaldominant disorder is characterizedbv congenitalheart abnormalities,most notably atrial septal defects,and upper limb radial ray reduction defects that can vary from mild hypoplasia (sometimes duplication) of the thumbs to almost complete absenceof the forearms.
Z I N CF I N G E R GENES
90
The term zinc finger refers to a finger-like loop projection consisting of a series of four amino acids that form a complex with a zinc ion. Genes that contain a zinc finger motif act as transcription factors through binding of the zinc finger to DNA. Consequently they are good candidatesfor single-gene developmentaldisorders(Table 6.3). For example, a zinc finger motif-containing gene knorvn as GLI3 on chromosome 7 has been implicated as the cause of two developmentaldisorders. Large deletions or translocations
Tabte5.3 DeveLopmentaL abnormalities associated with genescontaining a zincfingermotrf Gene
Chromosome location
Developmentat abnormality
GLl3
7p13
GreigsyndromeandPattister-Hall syndrome
WTl
1'1p13
Denys-Drash syndrome
ZIO
13q32
Hotoprosencephaly
ZIC3
Xq26
Lateralitydefects
involving GLI3 catse Greig cephalopolysyndactyly,which is characterized by head, hand and foot abnormalities such as polJ'dactylyand syndactyly (Fig 6.12A) In contrast, frameshift mutations in GLI3 have been reported in the Pallister-Hall syndrome (Fig. 6.12B), in which the key featuresare polydactyly, hypothalamichamartomataand imperforate anus. Mutations in anotherzinc finger motif-containing geneknown as WTI on chromosome 1l can causeboth Wilms' tumour and a rare developmentaldisorder, the Denys Drash syndrome, in which the external genitalia are ambiguous and there is progressiverenal failure as a result of nephritis. Mutations in two other zinc finger motif-containing genes, ZIC2 and ZIC3, have recently been shown to cause holoprosencephaly and laterality-defects, respectivel]'.Just as polarity is a key concept in development, so too rs laterality, with implications for the establishment of a normal left-right body axis. In very early development, integrity of man-vof the same gene families previouslv mentioned Nodal, Sonic Hedgehog and Notch - is essentialto the establishmentof this axis.Clinicalll; situssolitusis the term given to normal left-right asymmetry and sr,tus tnrersus to reversalof the normal arrangement.Up to 25o/oof individuals with situs inversus have an autosomal recessivecondition Kartagenersyndrome,or ciliary dyskinesia.Other terms usedare isomerismsequence, heterotaxy,asplenia/polyasplenia,and Iaemark syndrome.Laterality defects are characterized by abnormal position